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Abstract 
Background: Disorders of lung development cause death and disability in the 
young and old: novel insights into developmental regulators can aid therapeutic 
strategies. The Ca2+ATPase SERCA, already implicated in asthma and cystic 
fibrosis, appears to play a key role in lung development. SERCA inhibition with 
cyclopiazonic acid (CPA) in vitro, reduces both airway branching and peristalsis 
reversibly and dose dependently, whilst also halting myogenesis. It is unclear 
however, whether changes in branching are mediated via SERCA dependent 
contractility, or whether SERCA is a direct regulator of airway branching. 
Aims: (i) to further explore the CPA-induced embryonic lung phenotype by 
assaying gene expression and cell proliferation; and (ii) to determine effects of 
genetic perturbation of SERCA function in vivo on airway branching 
morphogenesis, in the absence of contractility (using a Drosophila model). 
Methods: Embryonic mouse (E11.5) lung explants were cultured +/- CPA at an 
air/fluid interface. Standard techniques were used to rear Drosophila and SERCA 
expression manipulated using conditional, heat-sensitive mutants and RNAi 
targeted to the trachea. Positively labelled, loss-of-function ‘flip-out’ RNAi and 
mutant clones were produced using heat-shock induced FLP-recombinase. Gene 
expression was assayed using real-time RT-PCR and SERCA function assessed 
using calcium dyes and genetic indicators. Embryonic and larval fly airways were 
imaged using fluorescent proteins and immunostaining, with live or fixed-sample 
confocal microscopy. Immunofluorescent staining was used to assess protein 
expression and cell proliferation.  
Results: SERCA inhibition with CPA significantly up or down regulated mRNA 
levels of key genes involved in lung branching morphogenesis, myogenesis and 
angiogenesis in vitro. CPA treatment also reduced cell proliferation dose-
dependently in the lung epithelium and mesenchyme. In the fly embryo, neither 
conditional SERCA mutants nor targeted RNAi significantly affected tracheal 
morphology. However, residual SERCA mRNA and protein function was evident at 
this stage of development. Tracheal maturation, in the form of gas filling was 
significantly impaired though, in embryos expressing a conditional SERCA 
mutation. In larvae, development of the dorsal air sac primordium (ASP) was 
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severely disrupted by targeted SERCA RNAi and this phenotype could be 
reproduced when sufficient numbers of loss-of–function clones were present. 
SERCA inhibition reduced the number of mitotic cells in the ASP and 
correspondingly, SERCA deficient clones comprised fewer cells than control 
counterparts: SERCA regulation of airway cell proliferation was therefore 
evident across species. Fewer SERCA deficient cells reached the tip of the ASP 
during morphogenesis compared to controls, whereas a greater proportion 
remained in the stalk, findings that indicate a cell-autonomous defect in cell 
migration. Changes in morphology were independent of changes in expression of 
the key ASP signalling pathways MAP kinase and Notch. Expression of the ASP tip-
cell marker escargot was expanded in SERCA deficient larvae, with a number of 
positive cells being abnormally present in the stalk. This finding could be 
explained by a failure of these cells to migrate to the tip, alternatively by 
changes in cell fate. Given key roles of tip cells in morphogenetic signalling, 
escargot may play a role in SERCA inhibition-induced dysmorphogenesis. 
Conclusions: SERCA has an essential, conserved role in airway branching 
morphogenesis across species: this role appears independent of contractility. 
SERCA regulates cell migration and proliferation processes in the airway, findings 
that may have wider relevance, e.g. in proliferative disease, metastasis and 
tissue regeneration. Given evidence in plants and fungi of Ca2+ cycling regulating 
budding, findings here may indicate a role for SERCA as a generic regulator of 
iterative branching across biology, with clear implications for further research. 
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1.1 Disorders of lung development result in a spectrum 
of disease  
Defects in prenatal development frequently manifest in the newborn infant as 
congenital disorders: there is now increased recognition that adult diseases also 
have origins in fetal life (Gluckman, Hanson, Cooper, & Thornburg, 2008; Hales 
& Barker, 1992). Defects in lung organogenesis present in the young and old, 
both as structural lung anomalies and inadequate respiratory function. The 
burden of such disease is considerable, both in terms of acute mortality and 
long-term morbidity. Understanding normal pulmonary development is therefore 
paramount to discovery of novel therapeutics for these frequently devastating 
disorders. 
1.1.1 Pulmonary hypoplasia 
Pulmonary hypoplasia encompasses a range of conditions characterised by 
impaired lung development. Initially defined by inadequate alveolar formation, 
the term is also used to describe inadequacies of pre-alveolar lung development 
and / or inadequate pulmonary vascularisation (Askenazi & Perlman, 1979; 
Kitagawa, Hislop, Boyden, & Reid, 1971; Reale & Esterly, 1973; Wigglesworth, 
Desai, & Guerrini, 1981). Historically these diagnostic features were obtained at 
autopsy, but advances such as magnetic resonance imaging now allow 
determination of lung size prenatally: given that measuring lung volume may not 
accurately predict pulmonary function, care must be taken when trying to use 
such techniques prognostically (A. Lee, Kratochwil, St√ºmpften, Deutinger, & 
Bernaschek, 1996). Pulmonary hypoplasia may be an isolated lesion, as primary 
pulmonary hypoplasia, or more frequently, occur in conjunction with other 
congenital abnormalities (Page & Stocker, 1982; Swischuk, Richardson, Nichols, 
& Ingman, 1979). Lung hypoplasia can be associated with an array of birth 
defects, affecting many systems. Two key examples are discussed below. 
The Bochdalek-type of congenital diaphragmatic hernia (CDH) is a birth defect 
comprising a posterolateral diaphragmatic defect, intrathoracic herniation of 
abdominal viscera, and varying degrees of pulmonary hypoplasia (Figure 1.1) 
(Bochdalek, 1848). With an incidence of approximately 1:2500 live births in 
population-based studies, it is as common as cystic fibrosis (J. Colvin, Bower, 
Dickinson, & Sokol, 2005; Gallot et al., 2007). Despite advances in treatment, 
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such as improved ventilation strategies and novel surgical approaches, true 
mortality rates, taking into account factors such as stillbirths, may be as high as 
40% (Lansdale, Alam, Losty, & Jesudason, 2010; Stege, Fenton, & Jaffray, 2003; 
Wung, Sahni, Moffitt, Lipsitz, & Stolar, 1995). Much of this acute mortality is due 
to effects of pulmonary hypoplasia and persistent pulmonary hypertension. Long-
term pulmonary morbidity is also common. Survivors display impaired respiratory 
function, sometimes requiring repeat hospital admission and oxygen therapy in 
the longer term (Muratore et al., 2001). Given these high rates of mortality and 
morbidity are refractory to existing interventions, research into new approaches 
for treating CDH is required.  
The aetiology of isolated CDH and lung hypoplasia is still largely unknown. It was 
thought that pulmonary manifestations of CDH were due to compression of the 
developing lung by herniated viscera: discovery that lung abnormalities precede 
herniation fostered understanding of CDH as a global embryopathy (Jesudason, 
Connell, Fernig, Lloyd, & Losty, 2000; Keijzer, Liu, Deimling, Tibboel, & Post, 
2000). A small proportion of CDH is syndromal, often with known genetic 
determinants e.g. isochromosome 12p (tetrasomy 12p; Pallister-Killian 
syndrome) (Pallister et al., 1977). However, given the implication of a range of 
disparate genetic candidates (e.g. COUP-TFII and Fog2), epigenetic factors (e.g. 
retinoic acid) and environmental influences (e.g. maternal alcohol intake) in the 
aetiology of CDH, attempts to correct single aberrant developmental pathways 
with novel molecular or gene based therapies, seem unlikely to be successful 
(Ackerman et al., 2005; Andersen, 1941; Felix et al., 2008; You et al., 2005). 
Development of therapies to tackle the most problematic part of CDH, that is 
pulmonary hypoplasia and pulmonary hypertension, has therefore been the focus 
of most work in this area. One notable example of such work is fetal endoscopic 
tracheal occlusion (FETO): conceived after observations of pulmonary 
hyperplasia in cases of laryngeal atresia, experiments to occlude the trachea in 
fetal lambs demonstrated improvements in lung growth (DiFiore et al., 1994; 
Hedrick et al., 1994; Wilson, Difiore, & Peters, 1993). Pioneering work led to 
translation of this technique; modern approaches to this therapy involve 
minimally invasive, endoscopic insertion of a balloon into the fetal trachea and 
subsequent removal prior to birth (Figure 1.1) (Deprest, Gratacos, & Nicolaides, 
2004; Harrison et al., 1998). Despite initial clinical trials failing to demonstrate 
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convincing benefits, a recent randomised controlled trial suggested that when 
FETO is used in the most severely affected cases, survival rates improve 
(Harrison et al., 2003; Ruano et al., 2011). Controversy persists over whether or 
not current methods to select supposedly high-risk cases for FETO are 
sufficiently accurate in their prognostication of postnatal outcome (Ba'ath, 
Jesudason, & Losty, 2007). 
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Figure 1.1 Congenital diaphragmatic hernia (CDH) 
Panel A. Schematic diagram of an infant with CDH: a diaphragmatic defect, herniation of 
abdominal viscera into the thorax and pulmonary hypoplasia are demonstrated. (Illustration 
adapted from Children’s Hospital of Philadelphia website www.chop.edu/img/fetal-diagnosis-and-
treatment/congenital-diaphragmatic-hernia-img.html). 
Panel B. Schematic diagram of fetal endoscopic tracheal occlusion (FETO): insertion and inflation 
of a balloon in the fetal trachea using an endoscope passed through the mother’s abdominal wall 
into the fetal mouth. (Illustration adapted from Jani et al. Percutaneous fetal endoscopic tracheal 
occlusion (FETO) for severe left-sided congenital diaphragmatic hernia. Clinical Obstetrics and 
Gynecology. 2005; 48: 910-22) (Jani et al., 2005).  
This text box is where the unabridged thesis included the following 
third party copyrighted material: 
 
http://www.chop.edu/img/fetal-diagnosis-and-treatment/congenital-
diaphragmatic-hernia-img.html 
 
Jani J et al. (2005). Percutaneous fetal endoscopic tracheal occlusion 
(FETO) for severe left-sided congenital diaphragmatic hernia. Clinical 
Obstetrics and Gynecology, 48(4), 910-922. 
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The first association of oligohydramnios and pulmonary hypoplasia was observed 
in 1946 by Potter, when abnormalities in the lungs of fetuses with bilateral renal 
agenesis were reported (Potter, 1946). The importance of adequate volumes of 
amniotic fluid for pulmonary development is further demonstrated by lung 
maldevelopment in a range of obstructive uropathies e.g. posterior urethral 
valves and also in cases of prolonged amniotic fluid leakage (e.g. prolonged 
preterm rupture of amniotic membranes) (I. T. Thomas & Smith, 1974). The 
exact physiological role of amniotic fluid in pulmonary development is not fully 
understood, but a combination of mechanical and biochemical effects are likely 
(Adzick, Harrison, Glick, Villa, & Finkbeiner, 1984; Moessinger, Harding, 
Adamson, Singh, & Kiu, 1990). Despite recent advances in neonatal intensive 
care, the clinical outcome of infants born with oligohydramnios-related 
pulmonary hypoplasia is frequently poor; contemporary mortality rates range 
from 30-40% (Everest, Jacobs, Davis, Begg, & Rogerson, 2008; Kemper & Mueller-
Wiefel, 2007; Mehler et al., 2011). In an attempt to relieve antenatal urinary 
obstruction and restore amniotic fluid volume necessary for pulmonary 
development, novel fetal surgical techniques were pioneered in animal models 
and successfully translated into humans: fetuses with oligohydramnios and 
dilated urinary system indicating bladder outlet obstruction (e.g. posterior 
urethral valves), can undergo a procedure whereby a catheter is inserted 
between the fetal bladder and amniotic cavity, via the mother’s abdominal wall, 
so called vesicoamniotic shunting (Harrison, Golbus, & Filly, 1982; Harrison, 
Nakayama, Noall, & De Lorimier, 1982). In selected, severely afflicted cases, 
there are indications this technique may improve perinatal survival: firm 
conclusions are precluded by a lack of high quality evidence and results of 
randomised controlled trials are awaited (Clark et al., 2003). 
These two contrasting aetiological examples illustrate how different prenatal 
events result in similar pulmonary hypoplasia, with consequent profound effects 
on infant health and survival. They also exemplify how inter-related 
biomechanical and biochemical factors regulate pulmonary organogenesis, 
factors that have been targeted in the development of novel therapeutics. 
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1.1.2 Lung disease in the premature infant 
Prematurity is the most common cause of respiratory failure in the newborn. 
Respiratory distress syndrome (RDS, also known as hyaline membrane disease) 
affects approximately 1% of all infants and is the leading cause of death in those 
born prematurely (Rodriguez, Martin, & Fanaroff, 2002). Its incidence is 
inversely proportional to gestation: infants born prior to 29 weeks gestation have 
a 60% chance of developing RDS, whilst the risk for those born around term 
approaches zero (Robertson et al., 1992). Given that premature birth is common 
and may be increasing in incidence, RDS is a major global public health problem: 
not only does it account for significant infant mortality, but RDS also predisposes 
to bronchopulmonary dysplasia (BPD), a form of chronic lung disease (Northway 
Jr, Rosan, & Porter, 1967). BPD occurs in around 20% of very low birth weight 
infants (<1500 g) and is responsible for significant long-term pulmonary 
morbidity, including obstructive symptoms such as wheeze, a susceptibility to 
infection, long-term oxygen dependency and reduced pulmonary function, 
manifest for example, as impaired exercise tolerance (Baraldi & Filippone, 2007; 
Lemons et al., 2001). RDS therefore results in both significant acute mortality 
and chronic morbidity, placing a high burden on the child, family and healthcare 
provider.  
Recognition that RDS involved distinct defects in pulmonary development began 
with early observations at autopsy of ‘hyaline membranes’ in lungs of infants 
who died shortly after birth, but not in stillborns (Hochheim, 1903). In the 
1920s, von Neergaard investigated surface tension in isolated lungs, eventually 
postulating the existence of a substance in the lung that reduces this tension, 
allowing airways to open (v. Neergaard, 1929). Further work in the 1950s led to 
the discovery by Avery and Mead that hyaline membrane disease of the newborn 
was due to surfactant deficiency (Avery & Mead, 1959; Clements, 1957; Macklin, 
1954; Pattle, 1955). Experiments of surfactant replacement in animal models 
demonstrated its benefit in prematurity and led to the first human study in 
1980: 10 premature infants were given modified bovine surfactant, resulting in 
significant improvements to clinical and radiological parameters (Enhorning & 
Robertson, 1972; Fujiwara et al., 1980) Subsequently, a host of trials have 
investigated multiple natural and synthetic surfactants and have confirmed their 
benefit in reducing mortality and morbidity: surfactant therapy has 
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revolutionised the care of premature infants, resulting in up to 50% decrease in 
neonatal mortality and pulmonary air leaks when reviewed at meta-analysis and 
significantly reducing the burden of chronic morbidity (Soll, 2000a, 2000b). RDS 
is an elegant example of how increased understanding of pulmonary 
development transformed medical care and ensured survival and future health 
for generations of infants.  
1.1.3 Developmental origins of lung disease in later life 
For certain diseases, the role of an individual’s genetic predisposition has long 
been apparent. In contrast, many common adult lung diseases were thought to 
arise due to environmental factors e.g. tobacco smoking, industrial pollutants or 
infectious organisms. However, the importance of genetic contributions for 
these multifactorial adult lung diseases is being studied more closely. Genetic 
variations can now be associated with adult outcomes, such as particular lung 
diseases or overall lung function. Unsurprisingly, a number of these associations 
occur where the relevant genes play key roles in lung development. Therefore, 
two particularly common, chronic respiratory diseases are now discussed in the 
context of potential developmental origins. 
Chronic obstructive pulmonary disease (COPD) incorporates emphysema and 
chronic bronchitis and is known as a disease of ageing tobacco smokers. 
Emphysema is the abnormal, permanent enlargement of air­spaces distal to 
terminal bronchioles, accompanied by destruction of their walls and without 
obvious fibrosis: chronic bronchitis is defined clinically, as the presence of a 
chronic productive cough, not attributable to other lung disease, present for an 
extended period of time, e.g. greater than half the time for two successive 
years (British Thoracic Society and others, 1997; Snider, 1989). Although the 
pathogenesis of COPD is somewhat complex and can vary between patients, the 
principal common factor is airway obstruction, which is largely irreversible; this 
obstruction causes impairment of lung function, disability and death. COPD has 
been described as a global epidemic and in 2004 was the fourth leading cause of 
death worldwide, accounting for 5% of all deaths: by 2030, COPD mortality is 
predicted to exceed that from HIV and TB (World Health Organization, 2008). 
Interestingly, only around 20% of smokers develop emphysema and non-smokers 
can, albeit rarely, also develop COPD, indicating variable genetic susceptibility 
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to this disease (Sethi & Rochester, 2000). Knockout studies have implicated a 
number of genes in the developmental origin of COPD, e.g. (i) Smad3 null 
mutant mice display early onset emphysema which is also accelerated by smoke 
exposure; and (ii) targeted knockdown of CCAAT/enhancer binding protein α 
(C/EBPα), results in a COPD-like phenotype of chronic bronchial inflammation, 
excess mucous production and emphysema (H. Chen et al., 2005; Didon, Roos, 
Elmberger, Gonzalez, & Nord, 2010; Farkas et al., 2011). Further review of these 
genetic candidates demonstrates roles in early pulmonary development and their 
dysregulation in COPD. Smad3 is a key effector in the TGF-β signalling pathway; 
null-mutants display impaired alveolarisation and failure of extracellular matrix 
organisation in the lung, as well as increased metalloproteinase (MMP) activity, 
indicating that correct matrix assembly may protect against proteolytic 
degradation of alveoli seen in emphysema: polymorphisms in other TGF-β 
pathway and MMP genes are found in COPD sufferers, further implicating these 
mechanisms in its pathogenesis (H. Chen et al., 2005; Hersh et al., 2006; Joos et 
al., 2002). C/EBPs are a group of transcription factors known to regulate gene 
expression in the lung; they are essential for normal early lung development, 
with C/EBPα loss of function resulting in pulmonary immaturity and surfactant 
deficiency in newborn mice, a phenotype similar to that of BPD: activity of these 
factors is impaired in COPD sufferers when compared to healthy smokers (Cassel 
& Nord, 2003; Didon, Qvarfordt, Andersson, Nord, & Riise, 2005; Martis et al., 
2006). Collectively, these studies demonstrate that factors responsible for early 
lung development are implicated in the pathogenesis of COPD.  
Asthma is another chronic respiratory disorder that has been characterised as a 
global epidemic: it is estimated that 300 million people suffer from asthma 
worldwide (Masoli, Fabian, Holt, & Beasley, 2004). Asthma afflicts both children 
and adults, usually presenting with wheeze, cough, difficulty breathing and 
chest tightness (Douglas et al., 2008). Sufferers frequently depend on long-term 
drug therapies, often have restricted exercise capacity and may require 
recurrent hospital admissions: asthma causes 250,000 deaths each year globally 
(Masoli et al., 2004). It is characterised by obstruction of the conducting 
airways, smooth muscle hyper-responsiveness and chronic mucosal 
inflammation, with oedema and excess mucous production (Stephen T. Holgate, 
2008). Remodelling of the airway wall occurs as an injury response and includes 
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ASM hypertrophy, hyperplasia and ectopic spreading (Bousquet et al., 1992). In 
addition, several pieces of evidence indicate that airway remodelling may play a 
role in early development and this could be an essential precursor to the onset 
of asthma: (i) infants who later develop asthma, but are asymptomatic at point 
of investigation, already display airway inflammation and remodelling; (ii) 
asthmatics may continue to express developmental genes abnormally; (iii) 
molecular regulation is similar for both airway epithelial differentiation during 
ontogenesis and remodelling/repair; and (iv) the epithelial–mesenchymal trophic 
units active in asthma remodelling and repair, share signalling with lung 
development; this is supported by upregulation of morphogens such as EGFR and 
persistence of high TGFβ levels, despite effective anti-inflammatory treatment 
(Baldwin & Roche, 2002; Bousquet, Yssel, & Vignola, 2000; Dizier et al., 2000; S. 
T. Holgate et al., 2001; Kasper & Fehrenbach, 2000; Nakao, 2001; Puddicombe 
et al., 2000; Warner, Marguet, Rao, Roche, & Pohunek, 1998). A large, 
prospective cohort study recently demonstrated that children who go on to 
develop asthma by age 7, have lung function deficits and increased bronchial 
responsiveness in the neonatal period, strongly indicating fetal and early-life 
origins for the disease (Bisgaard, Jensen, & Bonnelykke, 2012). Further support 
for an underlying, non-immune basis for asthma, is provided by a number of 
trials that have demonstrated prolonged treatment with inhaled corticosteroids 
in children of asthmatic and atopic parents, does not influence the natural 
history of the subsequent asthmatic phenotype: if airway inflammation was the 
sole initiator of asthma, it would be expected that its prevention during disease 
onset should alter disease outcome (Bisgaard, Hermansen, Loland, Halkjaer, & 
Buchvald, 2006; Guilbert et al., 2006; Murray, Woodcock, Langley, Morris, & 
Custovic, 2006). In summary, there is a significant body of evidence to suggest 
that the pathogenesis of asthma involves a pre-programmed, developmental 
component and this may be independent of more traditional, immunological 
mechanisms (inflammation and allergy), also known to be extremely important 
in the disease process. Shifting the paradigm of asthma pathogenesis away from 
one solely based on inflammation has allowed the development of novel 
therapeutics, targeting areas such as growth factor signalling (e.g. EGF) and 
airway smooth muscle dysfunction (bronchial thermoplasty) (Cox, Miller, 
Mitzner, & Leff, 2004; Ingram & Bonner, 2006; Jesudason, 2009). 
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1.2 Normal Lung Development 
Having discussed the importance of lung disease to human health, and the 
developmental origins for such problems, we should next review the principal 
components of lung organogenesis.  
1.2.1 Developmental anatomy, embryology and histology 
Lung development starts at 4-5 weeks gestation in humans and continues until 
around seven years of age with alveolarisation: key stages in this process are 
illustrated in Figure 1.2 and summarised below [reviewed in (Cardoso & Lu, 
2006; Warburton et al., 2010)]. The respiratory tract arises from primitive 
foregut endoderm, which also contributes alimentary structures e.g. the 
oesophagus and stomach: initial pulmonary development must therefore begin 
with establishment of respiratory cell fate. Following this, epithelial tubes 
undergo iterative branching events, forming the ‘tree-like’ structure of the 
airways; later they undergo alveolarisation, the process whereby most of the gas 
exchange epithelial surfaces are formed: in humans, this branched system of 
airways is divided into three lobes on the right and two on the left (Figure 1.2). 
Foregut endoderm differentiates into numerous types of epithelial cells, which 
line the inner surface of the lung and trachea: pulmonary mesenchyme, derived 
from the lateral plate mesoderm, is also essential; it gives rise to numerous 
components of the lung, including airway smooth muscle, connective tissue, 
tracheal cartilage and pleural mesothelium. In addition to airway branching 
morphogenesis and alveolarisation, development of a pulmonary vasculature is 
integral to the lung’s structure and function: occurring through a combination of 
angiogenesis (migration of blood vessels from the aortic arches and left atrium) 
and vasculogenesis (blood vessels develop de novo in the pulmonary 
mesenchyme, near epithelial end-buds), a rudimentary capillary network forms 
and later connects to larger vessels, giving rise to the lung vasculature. 
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Figure 1.2 Stages of Pulmonary Organogenesis 
Schematic diagram illustrating the key elements of lung development. A: The lung first emerges 
from the ventral surface of the primitive foregut (PF) as the laryngotracheal groove (LTG) at 4-6 
weeks of human gestation. B: The primitive trachea (T) separates dorsoventrally from the primitive 
oesophagus (O). C: Progenitor cells in the distal trachea give rise to the left and right main bronchi 
(LMB and RMB). D: The lobar bronchi branch from the two primary bronchi at around 7 weeks 
gestation. E: There are 16 highly stereotyped airway branches that form by 16 weeks gestation.  
Between 16 and 24 weeks, further branching is not stereotyped. The process of alveolar formation 
starts at around 20 weeks gestation and continues until around 7 years of age. (Illustration adapted 
from Warburton et al. Lung organogenesis. Curr Top Dev Biol. 2010; 90: 73-158) 
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Histologically, pulmonary development is often divided into four stages: (i) 
pseudoglandular (5-17 weeks gestation): epithelial tubes lined with cuboidal 
epithelium undergo branching and resemble an exocrine gland: at this stage the 
tubes are fluid filled and do not function as a respiratory organ; (ii) canalicular 
(16-25 weeks): increases in length and diameter of the respiratory tree are 
accompanied by vasculogenesis and angiogenesis; there is a great increase in 
capillary number; terminal bronchioles divide into respiratory bronchioles and 
alveolar ducts; airway epithelial cells differentiate into squamous cells distally 
and cuboidal cells proximally; (iii) terminal saccular (24 weeks to late fetal 
period): the pulmonary interstitium become much thinner; alveolar epithelial 
cells clearly differentiate into squamous type I pneumocytes (for gas exchange) 
and secretory type II pneumocytes (for surfactant production); capillary growth 
in mesenchyme surrounding the saccules, forms a network of closely aligned, 
thin walled air spaces and blood vessels for gas exchange: later in this stage the 
lung can function sufficiently to sustain life e.g. infants born prematurely; and 
(iv) alveolar (late fetal period to around 7 years of age): in this period, alveoli, 
alveolar ducts and terminal saccules all expand in number and hence increase 
the lung’s capacity for gas exchange. 
1.2.2 Biochemical regulation of pulmonary morphogenesis 
Partly driven by a search for novel therapeutic targets, a great deal of 
endeavour has been devoted to understanding the molecular basis of lung 
development; this has revolutionised our understanding of the genetic and 
epigenetic pathways required to build such a complex structure and vast array of 
differentiated cell types. Reviewing the biochemical regulation of lung 
organogenesis in its entirety is beyond the scope of this thesis: here, an 
overview of key aspects is given and further, more detailed discussion of 
selected candidates provided in Chapter 3.  
Pioneering experiments in the 1960s demonstrated that transplanted pulmonary 
mesenchyme was capable of inducing ectopic branches of the trachea; this led 
to the concept of epithelial-mesenchymal signalling (crosstalk), now known to be 
fundamental to lung development (Alescio & Cassini, 1962). It is this signalling 
that directs morphogenetic patterning, e.g. branch position; dictates cell 
differentiation and stimulates cell growth and migration in the developing lung 
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(Shannon & Hyatt, 2004). These epithelial-mesenchymal interactions are 
mediated by a host of diffusible factors, tightly controlled in their spatial and 
temporal expression. For the purpose of this overview, biochemical factors 
involved in such processes are grouped into: (i) transcription factors; (ii) peptide 
growth factors; and (iii) other biochemical factors, as per a recent 
comprehensive review (Warburton et al., 2010). Examples of key lung 
transcription factors include, the zinc finger Gli and GATA families, 
homeodomain transcription factors (e.g. Nkx2.1 and Hox family) and the 
forkhead box family (e.g. Foxa1&2 and HFH4&8): spatial and temporal changes 
in the activity or expression level of such transcription factors, differentially 
activates target gene expression through specific binding to promoter regions 
(Costa, Kalinichenko, & Lim, 2001). Peptide growth factors are critical effectors 
of lung development; their closely regulated expression controls cell growth, 
migration and differentiation in the branching lung buds, developing 
mesenchyme and vasculature: key examples include, fibroblast growth factors 
(FGFs), sonic hedgehog (Shh), Wnt Genes and β-Catenin, bone morphogenetic 
proteins (BMPs) and other transforming growth factor (TGF) family members, 
epidermal growth factors (EGFs) and vascular endothelial growth factors (VEGFs) 
[reviewed in (Cardoso & Lu, 2006; Warburton et al., 2010)]. These factors may 
mediate both autocrine and paracrine signals, serving to directly affect cellular 
processes, but also control each other’s spatio-temporal expression patterns. 
Further discussion of individual growth factors and their regulation is provided in 
Chapter 3. Examples of other biochemical factors involved in lung development 
include: (i) retinoic acid signalling, which is critical for primary lung bud 
initiation, airway maturation and alveolarisation; and (ii) extracellular matrix 
components (ECMs, e.g. laminins), which mediate cell-cell and cell-ECM 
interaction: ECMs provide structural support, appear to modulate cell 
proliferation and differentiation, and define barriers and reservoirs for growth 
factors (Cardoso et al., 1995; Dickman, Thaller, & Smith, 1997; Hilfer, 1996; 
Lwebuga-Mukasa, 1991; McGowan et al., 2000). 
1.2.3  Biomechanical regulation of pulmonary morphogenesis 
Evidence for mechanical factors playing fundamental roles in pulmonary 
development derives from naturally occurring birth defects and in utero animal 
studies: (i) abolishing fetal breathing movements by transection of the phrenic 
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nerve induces pulmonary hypoplasia; (ii) loss of lung liquid e.g. from fetal 
tracheostomy results in similar impairments in lung development; (iii) 
intrathoracic pressure effects e.g. from a mass or surgically created fetal 
diaphragmatic hernia, impairs lung development; and (iv) fetal laryngeal or 
tracheal occlusion (either congenital or iatrogenic e.g. FETO) results in 
pulmonary overgrowth and distension, as discussed above (Fewell, Hislop, 
Kitterman, & Johnson, 1983; Miller, Hooper, & Harding, 1993; Starrett & de 
Lorimier, 1975; Wilson et al., 1993). These observations confirm that careful 
regulation of prenatal airway and intrathoracic mechanics, including 
maintenance of lung liquid homeostasis, is critical to normal lung development.  
A further area of interest in prenatal pulmonary mechanics is airway peristalsis 
(AP); this spontaneous, phasic contractility of prenatal airway smooth muscle 
(ASM), is conserved from birds to mammals: increasing in frequency through 
gestation, AP propels lung liquid to the distal airways, causing cycles of stretch 
and relaxation at the growing, terminal end buds (Figure 1.3) (Schittny, 
Miserocchi, & Sparrow, 2000). AP waves have been shown to arise from a right-
sided pulmonary pacemaker and appear coupled to lung growth (increases or 
decreases in AP frequency result in parallel changes in growth and vice versa); 
they are underpinned by spontaneous, propagating intracellular Ca2+ waves that 
depend on Ca2+ stores and gap junctions (N. C. Featherstone et al., 2005; 
Jesudason et al., 2005). Quite why the developing fetus expends significant 
energy on AP, and also why ASM has been evolutionarily conserved, despite its 
role in asthma, remains unclear, but it has been hypothesised that both have key 
roles in normal lung development; there is also evidence to suggest ASM 
dysfunction in disease states, such as experimentally induced pulmonary 
hypoplasia (N. C. Featherstone et al., 2006; Jesudason, 2009). Continued 
investigation into ASM and AP is seen as a priority and may yield novel 
therapeutic targets with which to both rescue inadequate prenatal lung growth 
and treat common respiratory disorders, e.g. it has been hypothesised that 
bronchial thermoplasty, already used to treat refractory asthma, may mediate 
its effects via ablation of pulmonary pacemaker cells, rather than by reducing 
ASM mass as previously suggested (Cox et al., 2004; Jesudason, 2009). 
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Figure 1.3 Waves of airway peristalsis (AP) in the developing lung occlude the airway 
proximally and distend it distally  
Sequential photomicrographs of cultured embryonic lung: arrows demonstrate the proximal airways 
that are open in the left panel but occluded by contraction in the right. Effects of AP on the distal 
airway are shown in a terminal lung bud, which increases in size with contraction (the ovoid outline 
is the same size in both images). These effects are repeated with each wave of AP. (Illustration 
courtesy of E.C. Jesudason) 
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1.2.4 Pulmonary progenitor and stem cells 
The regeneration of damaged tissues involves cellular mechanisms that include 
compensatory hyperplasia, dedifferentiation of mature cells to produce stem 
cells and the activation of resident adult stem cells (Stocum, 2008). Attempts to 
exploit stem cells for exogenous application, in order to repair diseased human 
tissues, has been at the forefront of modern medical research for many years. 
Successes such as the transplantation of a human stem cell derived main 
bronchus have provided hope that such approaches could ultimately provide 
solutions to other more complex and refractory lung disease (Macchiarini et al., 
2008). Mammalian lung contains distinct, regional pools of lineage-restricted 
progenitor cells; these have been shown to display some of the properties 
inherent to stem cells and are capable of giving rise to specific lung structures 
through differentiation into at least one other cell type; these progenitors have 
been found in both epithelial and mesenchymal niches (Lama et al., 2007; 
Rawlins & Hogan, 2006). It has been thought that regional progenitors rather 
than multipotent stem cells are responsible for endogenous regeneration 
capacity. However, Kajstura et al isolated a population of c-kit positive cells 
from adult human lung, which appeared to differentiate into multiple cell types 
(both endodermal and mesodermal) in vitro and when they were grafted into 
cryo-injured murine lung in-vivo (Kajstura et al., 2011). Other groups have yet to 
replicate these findings and they have been the source of some controversy 
(Stripp, Hogan, & Thannickal, 2011).   
Although trials of cell based therapies for the lung are underway (including the 
infusion of mesenchymal stem cells to treat COPD, BPD, and asthma), animal 
studies indicate any benefits are largely due to paracrine or immunomodulatory 
roles in the lung: lung regeneration may not be the best way to describe these 
trials (Kotton, 2012; Weiss et al., 2011). The application of endogenous lung 
progenitors or pluripotent cells (e.g. embryonic stem (ES) or induced pluripotent 
stem (iPS) cells) for ‘true regeneration’ continues to be explored though and 
organ recellularisation may be an alternative approach: recellualrised lungs have 
already been implanted briefly in rodents (Ott et al., 2010; Petersen et al., 
2010). The pitfalls for clinical translation however, are widely described and 
further understanding of the stem cell biology has been called for (Kotton, 2012; 
Weiss et al., 2011). Finally, patient-specific or disease-specific iPS cells from 
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humans with lung diseases and the subsequent correction of their disease-
causing gene mutations via zinc finger nuclease–mediated gene repair is an 
alluring idea (Kotton, 2012; Urnov, Rebar, Holmes, Zhang, & Gregory, 2010). iPS 
cells generated from patients with α1-antitrypsin deficiency have undergone 
gene correction in vitro using this technology and have subsequently been 
transplanted into rodent livers: an obvious potential application for this 
technique could be the correction of the ΔF508 CFTR mutation in the lungs of 
cystic fibrosis sufferers (Kotton, 2012; Weiss et al., 2011; Yusa et al., 2011). 
In this section, the normal development of the lung has been described and 
some biochemical, biomechanical and stem/progenitor cell factors briefly 
discussed with regard to their roles in regulating development and tissue 
regeneration or repair. The burden of pulmonary disease described earlier 
mandates that further research into such factors is required. In this thesis, the 
role of an intracellular Ca2+ ATPase pump, SERCA, is investigated in this very 
context. 
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1.3 Sarco-Endoplasmic Reticulum Calcium ATPase 
(SERCA) 
Given the diverse yet fundamental roles that Ca2+ signalling plays in almost every 
aspect of biology, close spatio-temporal regulation of Ca2+ is paramount to 
normal cellular function (Berridge, Lipp, & Bootman, 2000). This depends upon 
an array of intra and extra-cellular proteins, ranging from sensor/adaptor 
proteins e.g. calmodulin, to membrane spanning channels e.g. IP3R and ATPase 
pumps e.g. PMCA. One key effector of intracellular Ca2+ homeostasis is the Ca2+ 
ATPase pump, SERCA; this protein will now be considered in some detail and the 
rationale for this thesis explained. 
1.3.1 SERCA genetics  
Vertebrates have evolved three SERCA paralogues (ATP2A 1–3) and each may 
have numerous mRNAs (from alternative splicing): ATP2A 1-3 therefore encode 
the SERCA1a/b, SERCA2a/b and SERCA3a-e protein isoforms, each showing 76 - 
84% amino acid sequence identity with each other in humans (Wuytack, 
Raeymaekers, & Missiaen, 2002). SERCA is found specifically in membranes of 
the endoplasmic reticulum (ER) or in specialised ER-derived sub-compartments, 
such as the sarcoplasmic reticulum (SR) in muscle: tissue expression of different 
SERCA isoforms varies significantly though, with SERCA1, the most specialised 
form, being largely confined to fast-twitch skeletal muscle; SERCA2a is 
restricted to cardiac and slow-twitch skeletal muscle, whereas SERCA2b is 
expressed fairly ubiquitously; finally, SERCA3 isoforms are expressed in a diverse 
but limited range of non-muscle tissues and appear to co-express with SERCA2b 
(Anger et al., 1993; Brandl, Green, Korczak, & MacLennan, 1986; Lytton & 
MacLennan, 1988; MacLennan, Brandl, Korczak, & Green, 1985). Despite these 
disparate expression patterns, the biochemical functions of individual SERCA 
isoforms are thought to be largely the same, as supported by conservation of key 
functional residues (e.g. Ca2+ and ATP binding sites) and effects of their 
mutagenesis (Lytton, Westlin, Burk, Shull, & MacLennan, 1992). 
1.3.2 SERCA protein structure  
SERCA is a P-type ATPase: first discovered in 1957 by Skou, P-type ATPases are 
defined by their function as catalysts for self-phosphorylation of a conserved 
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aspartate residue within their cytoplasmic domain; they most frequently 
transport cations but are also known to move phospholipids (Skou, 1957). 
SERCA’s structure consists of four distinct domains, defined by the folding of a 
single polypeptide chain; these include the 10 alpha-helical transmembrane (M) 
domain and three cytosolic domains, the actuator (A), the phosphorylation (P) 
and the nucleotide-binding (N) domains (Figure 1.4); links between the A and M, 
as well as N and P domains are thought to be flexible, permitting conformational 
change upon ATP and Ca2+ binding (Toyoshima, Nakasako, Nomura, & Ogawa, 
2000; Toyoshima & Nomura, 2002). SERCA has two Ca2+ binding sites within the M 
domain and these alternate between two states: (i) a high Ca2+ affinity state 
when they face the cytosol (known as E1); and (ii) a low Ca2+ affinity state when 
they face the lumen of the membrane (E2). An accepted model for SERCA 
mediated Ca2+ transport based on crystal structures involves the following series 
of events (Figure 1.4): SERCA in an E1 state binds two cytosolic Ca2+ ions and 
ATP; phosphorylation and ATP hydrolysis then produce a high energy phospho-
intermediate and bound Ca2+ is occluded; transformation to a low energy state 
results in significant conformational change to E2, whereby the Ca2+ binding sites 
move to face the lumen and have low affinity; the cycle is completed by release 
of Ca2+ into the lumen and return to E1 (Toyoshima et al., 2000; Toyoshima & 
Nomura, 2002; Wuytack et al., 2002).  
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Figure 1.4 Schematic diagram of the reaction cycle of SERCA  
During the cycle, two Ca2+ ions are moved from the cytoplasm into the lumen of the endoplasmic 
reticulum (ER) or ER variant; there is exchange for two protons and hydrolysis of a single molecule 
of ATP. The four domains of SERCA’s structure are labelled: the transmembrane (M), the actuator 
(A), the phosphorylation (P) and the nucleotide-binding (N). Conformational changes in SERCA’s 
structure are also highlighted. (Illustration adapted from Toyoshima C. J Gen Physiol 2005; 126(1): 
cover image) 
 
This text box is where the unabridged thesis included the following third 
party copyrighted material: 
 
Toyoshima C. (2005). Cover picture: Cartoon of the reaction cycle of 
SERCA Ca2+-ATPase, based on crystal structures of its four principal 
conformations: during a complete cycle, two cytoplasmic Ca2+ ions are 
extruded into the lumen of the sarcoplasmic reticulum in exchange for 
two protons, at the expense of hydrolysis of a single molecule of ATP. 
The Journal of General Physiology, 126(1), cover. 
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1.3.3 SERCA function 
The principal function of SERCA is to pump Ca2+ ions from the cytoplasm to the 
lumen of the ER and other specialised compartments, such as the SR and Golgi: 
SERCA is therefore responsible for both returning cytosolic free Ca2+ 
concentration back to its resting level following cell activation and also 
maintaining high concentrations of Ca2+ in organellar lumens, therefore creating 
Ca2+ gradients across the cell, environments which are critical for a number of 
cellular functions. 
Reviewing the results of SERCA knockout in mice provides further insight into its 
important roles in normal cellular physiology. SERCA1-null mutants are initially 
viable but die soon after birth from respiratory failure; this is presumed to be 
due to a lack of SERCA1 in muscles of the diaphragm and chest wall (where it 
would normally be expressed in abundance) and consequent impaired muscular 
function (Pan et al., 2003). SERCA2-null mutants are non-viable, indicating that 
SERCA2 plays a fundamental role in the functioning of numerous cell types, 
rather than one confined to muscle physiology: further evidence of a more 
general, ‘house-keeping’ type role for SERCA is provided by the ubiquitous 
nature of SERCA2b expression and strong phylogenetic conservation of SERCA’s 
amino acid sequence (Periasamy et al., 1999; Wuytack et al., 2002). 
Interestingly, SERCA3 deficient mice do not display an apparently abnormal 
phenotype: in contrast to SERCA2, SERCA3 therefore does not appear to play key 
roles during embryogenesis, nor serve an essential housekeeping function (Lynne 
H. Liu et al., 1997). Possible explanations for this apparently diminished role in 
Ca2+ homeostasis may incorporate SERCA3’s reduced affinity for Ca2+ and altered 
pH dependence when compared to other isoforms: an alternative explanation 
may include functional redundancy between isoforms, for which there is some 
evidence e.g. SERCA1a has been shown to functionally substitute SERCA2a in the 
hearts of transgenic mice (Ji, Loukianov, Loukianova, Jones, & Periasamy, 1999; 
Lytton et al., 1992).  
1.3.4 SERCA in human disease 
Mutations in SERCA paralogues have been implicated in a number of human 
diseases and SERCA manipulation has also been explored for a host of 
therapeutic goals. Brody’s disease is characterised by exercise-induced, 
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progressive impairment of skeletal muscle relaxation, causing cramps, stiffness 
and muscle pain; it is most frequently due to autosomal recessive inheritance of 
a mutation in ATP2A 1 (SERCA1) and consequent reduction in Ca2+ uptake into 
the SR of skeletal muscle cells (Brody, 1969; Odermatt et al., 1996). Darier 
disease is an autosomal dominant condition due to a mutation in ATP2A 2 
(SERCA2); almost exclusively limited to the skin, it is characterised by defects in 
keratinocyte adhesion and aberrant epidermal keratinisation: quite why this 
mutation appears to solely manifest in the skin (with the exception of occasional 
neuropsychiatric involvement) is unclear, but the affected cell type is somewhat 
in-keeping with high rates of squamous cell carcinoma seen in SERCA2 deficient 
mice (L. H. Liu, Boivin, Prasad, Periasamy, & Shull, 2001; Sakuntabhai et al., 
1999). Interestingly, patients with Darier disease do not display defects in 
cardiac function, indicating that one copy of ATP2A 2 is sufficient to maintain 
SERCA2a function in cardiac myocytes (where it is known to play essential roles 
in cardiac physiology), a similar picture to that seen in mice heterozygous for a 
SERCA2 mutation (Tavadia, Tait, McDonagh, & Munro, 2001). SERCA3 is 
expressed in pancreatic β-cells and mutations in ATP2A 3 have been found in 
humans with type II diabetes; furthermore, SERCA3 expression is reduced in a 
murine model of diabetes and Ca2+ signalling is perturbed in SERCA3 deficient β-
cells (Arredouani et al., 2002; Levy, Zhu, & Dunbar, 1998; Varadi et al., 1999). 
Collectively, these observations of naturally occurring SERCA mutations indicate 
a broad role for this protein in human physiology, ranging from excitation 
contraction coupling in muscle, to cell adhesion and intracellular signalling. 
There has been a great deal of interest in the role of SERCA dysfunction in 
human heart failure: SERCA mRNA and protein levels are decreased in end-stage 
heart failure and are closely related to the degree of SR Ca2+ uptake and 
measures of myocardial function, as demonstrated by the analysis of tissue from 
patients undergoing cardiac transplant (Arai, Alpert, Maclennan, Barton, & 
Periasamy, 1993; Hasenfuss et al., 1994; Mercadier et al., 1990). It is postulated 
that these findings may explain abnormalities in Ca2+ handling and myocardial 
relaxation seen in cardiac failure, by a mechanism of reduced SERCA dependent 
Ca2+ uptake to the SR. Given these reproducible findings, investigators have 
explored the use of gene therapy to restore SERCA expression levels in-vitro and 
in-vivo with the aim of rescuing myocardial function in animal models of heart 
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failure: results of these efforts are promising, with adenoviral delivered gene 
transfer resulting in improvements in SERCA protein levels, SR Ca2+ uptake, 
myocardial function and animal survival (del Monte et al., 1999; del Monte et 
al., 2001; Miyamoto et al., 2000). These discoveries have now been translated 
into humans and there are at least two clinical trials of SERCA2 gene therapy 
ongoing: preliminary reports have demonstrated the safety of this intervention 
and suggest efficacy; results of larger, long-term studies are eagerly awaited 
(Jaski et al., 2009; Jessup et al., 2011). 
SERCA’s role in proliferative disease has also been investigated: in-vitro data in 
prostate cancer cell lines shows SERCA inhibition with RNAi or thapsigargin 
inhibits growth and prevents growth factor stimulation of cell proliferation; 
furthermore, SERCA is upregulated during stimulated cell proliferation and 
reciprocally downregulated when proliferation is reduced (Crepin et al., 2007; 
Humez et al., 2004; Legrand et al., 2001). Given the potential for clinical 
translation of these findings, investigators have explored the application of anti-
SERCA agents for use as cytotoxic therapies in proliferative diseases; one of the 
most notable examples is the use of thapsigargin-derived drugs. Thapsigargin is a 
natural product originally discovered in the 1970s by Rasmussen et al from the 
umbelliferous plant Thapsia garganica, based on its ability to liberate histamine 
from mast cells of the skin: thapsigargin is a potent and selective inhibitor of 
SERCA function through its strong binding to the protein (Rasmussen, Broogger 
Christensen, & Sandberg, 1978; Sagara & Inesi, 1991; Thastrup, Cullen, Drobak, 
Hanley, & Dawson, 1990). Exposing cancer cell lines (e.g. prostate or liver) to 
thapsigargin results in their apoptosis; the mechanism of this cytotoxicity is 
widely regarded to be due to thapsigargin’s dose-dependent ability to elevate 
intracellular Ca2+ sufficiently to activate programmed cell death (Furuya, 
Lundmo, Short, Gill, & Isaacs, 1994; Kaneko & Tsukamoto, 1994). Thapsigargin’s 
cytotoxic action, whilst apparently effective at inducing cell death in cancer, is 
not cell-specific and would therefore likely result in considerable side-effects if 
used systemically in humans: thapsigargin’s effects have been exploited 
clinically by specifically targeting it to cancer cells e.g. by coupling to a peptide 
carrier through chemical modification, to produce a prodrug that is activated 
only at deposits of tumour cells (Denmeade et al., 2003). A thapsigargin prodrug, 
G-202 has been produced to target prostate specific membrane antigen (PSMA), 
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a type II membrane carboxypeptidase which is over-expressed in prostate cancer 
cells and the neovasculature of most other solid tumours: G-202 is currently 
being evaluated in a clinical trial of patients with advanced solid tumours (trial 
protocol available at http://clinicaltrials.gov/ct2/show/NCT01056029  
(Ghantous, Gali-Muhtasib, Vuorela, Saliba, & Darwiche, 2010). This translation of 
basic science to clinical medicine provides a further example of how discoveries 
of SERCA’s roles in cell biology can be applied to the treatment of common and 
frequently debilitating medical problems. Further discussion of SERCA’s apparent 
roles in pulmonary health and disease will now be considered and form the basis 
for this thesis. 
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1.4 SERCA and the Lung 
SERCA has been implicated in diseases of the lung including asthma and cystic 
fibrosis; this, combined with recent evidence suggesting an essential role for 
SERCA in normal pulmonary development, indicates that further investigation 
into SERCA’s role in the lung is warranted.  
1.4.1 SERCA deficiency in the pathogenesis of asthma  
Abnormal Ca2+ handling has been proposed to underpin airway hyper-
responsiveness in asthma, since Ca2+ is a key regulator of ASM contractility 
(Parameswaran, Janssen, & O'Byrne, 2002; Triggle, 1983). Ca2+ reuptake into the 
SR is critical for ASM function; given that SERCA is a key regulator of Ca2+ 
reuptake, it is likely that SERCA activity is essential for ASM functions: this inter-
relationship of ASM function and SERCA derived SR Ca2+ reuptake, as well as pro-
inflammatory cytokine mediated repression of SERCA in ASM has led to SERCA 
being explored as a novel asthma target (Hirota, Helli, & Janssen, 2007; Sathish 
et al., 2009). Mahn et al demonstrated that SERCA2 mRNA and protein 
expression is reduced in ASM of patients with asthma; this reduction correlates 
with disease severity and is associated with corresponding changes in Ca2+ 
homeostasis, such as attenuation in response of intracellular Ca2+ to thapsigargin 
stimulation (Mahn et al., 2009). Interestingly, ASM taken from asthmatics, or 
healthy subjects then subjected to siRNA mediated SERCA knockdown, displayed 
increased cell proliferation, cell-spreading and cytokine secretion, effects 
similar to those known to underpin the asthmatic ASM phenotype. The authors 
conclude that an underlying SERCA2 deficiency in ASM may induce these cellular 
effects that contribute to ASM remodelling, a mechanism central to the 
pathogenesis of asthma: restoration of SERCA2 function is hence proposed as a 
novel therapeutic target in asthma. 
1.4.2 SERCA as a treatment target in cystic fibrosis 
Cystic fibrosis, a relatively common (incidence 1:2500 live births), lethal 
autosomal recessive disease, is most frequently caused by a mutation of the 
cystic fibrosis transmembrane regulator (CFTR) gene, known as ΔF508, which 
prevents it functioning as a cAMP-dependent Cl- ion channel. This mutation 
results in a CFTR protein that is retained in the ER; retention is dependent upon 
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chaperone proteins, many of which require high Ca2+ concentrations for optimal 
activity (S. H. Cheng et al., 1990). Given in vitro evidence that mutant ΔF508-
CFTR protein can function as a Cl- ion channel if permitted to reach the cell 
surface, a landmark study aimed to create conditions that would enable CFTR 
protein to exit the ER, by depleting ER Ca2+ stores and hence inhibit the action of 
chaperone proteins retaining the CFTR (Dalemans et al., 1991; Egan et al., 2002; 
Rubenstein, Egan, & Zeitlin, 1997). In order to deplete ER Ca2+, the SERCA 
inhibitor thapsigargin was administered to CFTR cell lines and also in vivo to 
ΔF508 mutant mice via aerosol: thapsigargin treatment released ER-retained 
ΔF508-CFTR to the plasma membrane, where it functioned effectively as a Cl- 
channel; furthermore, it reversed the nasal epithelial potential difference 
defect observed in the CF mouse model (Egan et al., 2002). In view of the 
potential implications of these data for CF pharmacotherapeutics, a host of 
studies have investigated the use SERCA pump inhibitors (thapsigargin, curcumin 
and cyclopiazonic acid) with the aim of correcting the CF phenotype: although a 
number report highly promising results, with significant improvements in CFTR 
Cl- channel function in vitro and in vivo, others have failed to reproduce these 
findings and controversy persists (Berger et al., 2005; Dragomir, Bj√∂rstad, 
Hjelte, & Roomans, 2004; Egan et al., 2004; Grubb et al., 2006; Loo, Bartlett, & 
Clarke, 2004; Norez, Antigny, Becq, & Vandebrouck, 2006; Seng et al., 2004). 
More recently, work has been carried out to optimise drug delivery and 
nanoparticles have been used to deliver curcumin to CF mice orally, resulting in 
a partial correction of CF defects: SERCA continues to be explored as a 
therapeutic target in CF (Cartiera et al., 2009). 
1.4.3 Evidence for a fundamental role for SERCA in lung 
development 
Initial observations of SERCA’s role in prenatal lung development occurred during 
investigation of AP and the propagating ASM Ca2+ waves that underpin it (N. 
Featherstone et al., 2005; N. C. Featherstone et al., 2005). As discussed above, 
AP waves arise from a right-sided pulmonary pacemaker and appear coupled to 
lung growth (Jesudason et al., 2005). To determine the origin of these Ca2+ 
waves specific pharmacological blockers were used to test the role of 
intracellular Ca2+ stores, extracellular Ca2+ entry and gap-junction connectivity 
(N. C. Featherstone et al., 2005). Cyclopiazonic acid (CPA), a specific SERCA 
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inhibitor was used on cultured and contracting lung explants to determine if Ca2+ 
stores were required for the AP waves and underlying Ca2+ transients (Seidler, 
Jona, Vegh, & Martonosi, 1989). CPA induced several key effects that might be 
expected from its mode of action: (i) ASM Ca2+ transients were abolished; (ii) 
baseline intracellular Ca2+ concentration was increased; (iii) AP was replaced 
with tonic ASM contraction (Figure 1.5). However, an unexpected finding was 
that branching morphogenesis was halted (Figure 1.6) (N. Featherstone et al., 
2005; N. C. Featherstone et al., 2005). Importantly, these effects were 
reversible, with branching resuming when CPA was removed, thus indicating that 
effects on pulmonary growth were not simply due to toxicity e.g. death of the 
explanted tissue (N. Featherstone et al., 2006). Further investigation revealed 
decreases in lung branching and AP frequency were dependent on CPA dose, 
with higher doses abolishing both (Lansdale, Connell, Featherstone, Midgley, & 
Jesudason, 2010).  
CPA’s effects indicate a fundamental role for SERCA in pulmonary organogenesis. 
Given that: (i) branching morphogenesis and AP have been shown to be coupled 
in vitro, and (ii) SERCA mediated Ca2+ reuptake into the SR is critical for smooth 
muscle function (discussed above), it was necessary to determine if CPA-induced 
abolition of ASM contractility was required for abrogation of branching.  To test 
this, we sought a model of airway branching morphogenesis that occurs in the 
absence of ASM and in which genetic, rather than pharmacological inactivation 
of SERCA can be used. This led us to the Drosophila model discussed later.  
In addition to questions related to SERCA and the interplay of airway branching 
and ASM function, further consideration of the CPA-induced lung explant 
phenotype yields a number of other questions that require wider investigation: 
e.g. (i) what are the cellular mechanisms that underpin the witnessed changes in 
airway branching and peristalsis? (ii) are these changes reproducible in vivo? (iii) 
could off-target effects of CPA (outside of SERCA inhibition) be responsible for 
these changes in development, or can they be reproduced by genetic SERCA 
inhibition? These questions will be considered in detail by this thesis and are 
further discussed below. 
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Figure 1.5 SERCA blockade with cyclopiazonic acid (CPA) reduces both airway branching 
and peristalsis reversibly and dose dependently, whilst reversibly halting Smooth Muscle 
Actin (SMA) expression 
Panel A: photomicrographs of E13 rat lung explants cultured +/- 20 µM CPA (time in culture 
indicated in hours). Panel B: lung bud number vs. time (medians, IQR & range); normal lung (red) 
branches throughout; CPA treatment for all 78 hours (blue) abolishes branching; removal from CPA 
at 30 hours (yellow) and 54 hours (green) restarts branching within 24 hours. Panel C: lung bud 
number (median & IQR) vs. CPA concentration at 0, 30, 54 & 78 hours (n=>25 in all groups). Panel 
D: number of peristaltic waves in 10min (median & IQR) vs. CPA concentration (n=>10 in all 
groups). Difference between CPA concentration groups statistically significant (p<0.05). Panel E: 
SMA immunohistochemistry labelling (green) of proximal ASM in control lung (arrowed, left) with a 
paucity of SMA in CPA-treated lung (middle) and return of SMA (brown, arrowed) in lung rescued 
from CPA >24 hours previously (right). (All data and photomicrograph images courtesy of N.C. 
Featherstone, M.G. Connell and E.C. Jesudason) 
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1.5 Animal models of lung development 
Data presented above indicate that further exploration of SERCA’s role in lung 
development is warranted and could yield novel insights into those translational 
opportunities that have already been explored for SERCA in pulmonary disease. 
Given this potential importance, it seems prudent to review different 
experimental techniques that could be exploited in order to achieve this aim. To 
determine the roles of SERCA in airway development, animal models are 
required and their various strengths and weaknesses are briefly reviewed below. 
1.5.1 Vertebrate models 
The rich history of developmental analysis in the mouse has made it the model 
of choice for studying mammalian development and it remains the principal 
model with which to study the airway: in the past two decades or so, transgenic 
mice have permitted dramatically improved understanding of the cellular 
processes underlying lung development, homeostasis, and repair (discussed 
above) (Cardoso & Lu, 2006; Warburton et al., 2010). Mice have clear 
advantages as a model organism, including the close homology of lung 
development between mammalian species and the ever-increasing availability of 
mutants. Notable examples of murine data advancing the field include, Alescio 
and Cassini’s early work on epithelial-mesenchymal cross-talk (discussed above), 
Metzger et al’s painstakingly detailed cataloguing of the three-dimensional 
branching patterns and lineage of the mouse bronchial tree, and discoveries of 
FGF-10’s key chemotactic role in inducing epithelial lung branching (Alescio & 
Cassini, 1962; Bellusci, Grindley, Emoto, Itoh, & Hogan, 1997; Metzger, Klein, 
Martin, & Krasnow, 2008; Park, Miranda, Lebeche, Hashimoto, & Cardoso, 1998). 
Murine work may involve the assessment of lung tissue (e.g. gross morphology, 
histology or molecular cell biology) from animals post mortem or after in vitro 
culture of explants. Gene expression can be manipulated in these systems with 
an array of techniques, broadly divisible into: (i) in vitro agents e.g. 
pharmacological inhibitors or RNA interference (RNAi); and (ii) in vivo means 
e.g. chemical mutagenesis, site-directed gene knock-out or conditional, lung-
specific transgenesis (such as the Cre-LoxP system) (Paddison et al., 2004; Sauer 
& Henderson, 1988; K. R. Thomas & Capecchi, 1987). Creating novel transgenic 
and mutant mice can be challenging, due to relatively long generation times, 
difficulties in conditional mutant generation to circumvent lethality and also 
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issues such as genetic redundancy and developmental plasticity. For phenotypic 
assessment, an array of imaging techniques have been developed for use in live 
and fixed tissues, including different forms of microscopy (e.g. light, fluorescent 
and confocal), magnetic resonance imaging and bioluminescence. Live imaging 
of the developing mouse embryo is largely reserved to ex utero culture systems: 
in utero imaging of embryogenesis has been described with ultrasound 
backscatter microscopy or optical coherence tomography, but detailed imaging 
of the lung has not been reported (Syed, Larin, Dickinson, & Larina, 2011; 
Turnbull, Bloomfield, Baldwin, Foster, & Joyner, 1995).  
Chick and quail embryos have also been used as a system with which to study 
pulmonary development; key advantages of these models include cost, 
availability, rate of development (which can be mainpulated with changes in 
temperature), ease of manipulation (including ability to perform microsurgery 
on the living organism and transgenesis) and advanced imaging capabilities. 
Important discoveries have been made in the chick embryo, including the 
existence of embryonic germ layers, the neural crest giving rise to the peripheral 
nervous system and the development of left right asymmetry [reviewed in 
(Stern, 2005)]. Novel whole organism (in ovo) live imaging techniques have been 
devised in avian embryos and promise a great deal; one such exciting potential 
use may be live imaging of AP in the developing lung in ovo, although 
practicalities of this, such as minimising artefact from the nearby beating heart 
have yet to be determined (Kulesa, Bailey, Cooper, & Fraser, 2010). 
In this thesis, an established embryonic lung explant culture model is exploited 
that has been successfully used in the past to study both branching 
morphogenesis and AP in the developing lung. 
1.5.2 Drosophila  
Drosophila melanogaster is a classical model organism: used by geneticists and 
developmental biologists since the early 20th century, research in the fruit fly 
has channelled modern biology. A number of properties lend Drosophila to this 
role, for example: (i) they generate prolifically, are cheap to maintain, easily 
transportable and simple to culture; (ii) they are highly relevant to biomedical 
research, given that an estimated 75% of 1378 human disease loci detected at 
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genome wide association studies have fly counterparts; (iii) vast libraries of 
experimental resources e.g. transgenic fly lines, are held at large collaborative 
laboratories and are available to researchers relatively cheaply; and (iv) 
Drosophila offer an unparalleled, powerful genetic tool kit to researchers. 
Examples of these tools include, the bipartite GAL4/UAS system that permits 
inducible overexpression of genes, site-specific recombination and mosaic 
analysis systems e.g. mosaic analysis with a repressible cell marker (MARCM), 
and an almost genome wide library of inducible in vivo RNA interference (RNAi) 
lines for gene silencing: many of these tools will be discussed prior to their use 
later in this thesis (Brand & Perrimon, 1993; Dietzl et al., 2007; Lasko, 2002; T. 
Lee & Luo, 1999). 
1.5.3 Development of the Drosophila respiratory organ 
Looking at respiratory organogenesis, the fly offers a comparatively simple, 
highly stereotyped, branched tracheal system to study, but one that remains 
directly homologous to mammalian lung development, owing to conservation of 
key genetic pathways through evolution. It is a network of tubes that fulfils 
respiratory demands of the fly by allowing air to enter through specialised 
openings, called spiracles and then be transported through the network to blind-
ended capillaries that facilitate gas exchange with target tissues. For effective 
function, it is critical that (i) tracheal branches find their way to all tissues in 
the fly; and (ii) trachea have the correct dimensions for optimal gas flow. The 
complex genetic regulation of these events has largely been discovered and 
provides a fascinating insight into the similar regulation of mammalian lung 
development. Classically, the tracheal system of Drosophila embryos has been 
used as a model with which to explore these pathways and it is this that will now 
be discussed in some detail. Less well studied and more variable in nature, 
Drosophila larvae also have a branched network of respiratory tubes and related 
appendages; these will be reviewed when investigated in Chapter 7.  
Embryonic tracheal morphogenesis occurs through a series of iterative branching 
events that result in an elaborate network of single-cell thick epithelial tubes 
with cuticular lining: originating from 10 pairs of metameric tracheal sacs, 
comprising around 80 cells each, the network is built without further cell 
division by orientated cell migration, changes in cell shape, selective growth of 
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the apical cell membrane and intracellular lumen formation (Figure 1.6) 
(Manning & Krasnow, 1993; Samakovlis, Hacohen et al., 1996; A. Uv, Cantera, & 
Samakovlis, 2003). The 20 tracheal sacs form by invagination of planar 
ectodermal cells in the embryo, a process brought about by expression of the 
transcription factor trachealess and its interaction with its cofactor tango. The 
first branching event occurs when this sac develops six stereotyped primary 
branches (Figure 1.6B), events that are induced by a member of the fibroblast 
growth factor family, Branchless (Bnl): bnl is ‘turned-on’ in patches of 
mesenchyme around each sac and promotes branch migration towards its source 
through activation of Breathless (Btl), the receptor tyrosine kinase expressed in 
the tracheal epithelium (Klambt, Glazer, & Shilo, 1992; Sutherland, Samakovlis, 
& Krasnow, 1996). The dynamic, differential expression of bnl controls the 
patterning of branch outgrowth. bnl expression is therefore a key factor in 
determining tracheal system structure: misexpression of bnl in novel locations 
induces ectopic branch formation (Sutherland et al., 1996). The intracellular 
protein Downstream-of-FGF-receptor, encoded for by dof (stumps) is specifically 
required for FGF signal transduction; in stumps mutants, tracheal cells fail to 
move out from the epithelial sacs and only rudimentary tracheal branches form 
(Imam, Sutherland, Huang, & Krasnow, 1999). Primary branch growth entails 
three major cellular events: extension of actin filaments (filipodia) towards the 
source of Bnl; movement of the nucleus and cell body in the same direction; and 
enlargement of the apical cell surfaces to accommodate the growing lumen (A. 
Uv et al., 2003). Early patterning genes induce the specific, regional identities of 
the primary branches shown in Figure 1.6B: (i) cells exposed to Decapentaplegic 
(Dpp) signalling maintain expression of two early tracheal transcription factors, 
Knirps (Kni) and Knirps-related (Knrl) and will migrate either dorsally to populate 
the dorsal branch (DB) or ventrally to populate the lateral trunk branches (LTa & 
LTp/GB); (ii) activation of EGF by Rhomboid (Rho) in a central subset of tracheal 
cells is required for development of the dorsal trunk (DT) and visceral branch 
(VB); and (iii) the differentiation between DT and VB cells is mediated by 
Wingless (Wg) signalling which induces DT cell fates (Chihara & Hayashi, 2000; 
Llimargas, 2000; Llimargas & Casanova, 1999; Wappner, Gabay, & Shilo, 1997). 
Given that EGF and Wg promote the transcription factor Spalt, which is 
repressed by Kni and Knrl, a clear system of regional specification of primary 
branch migration is apparent (C. K. Chen et al., 1998). 
   
 49 
 
   
 50 
Figure 1.6 Development of the Drosophila embryonic tracheal system 
Panels A-C: confocal micrographs of the embryonic tracheal system labelled with GFP (Btl-GAL4, 
UAS-act5c.GFP). Panel A: stage 11 embryo demonstrating the 10 paired metameric tracheal sacs, 
the earliest tracheal structure (arrowed in white) which is evident approximately 6 hours after 
embryo laying (AEL). Panel B: the 6 primary tracheal branches of a single sac are shown and 
labelled: dorsal branch (DB), dorsal trunk (DT), transverse connective (TC), visceral branch (VB), 
spiracular branch (SB) and lateral trunk (LT). The DT and LT branches have paired anterior (a) and 
posterior (p) elements. Panel C: tracheal system at stage 13 (approximately 10 hours AEL): the 
dorsal trunk branches in neighbouring metameres have fused together (arrowed in white) to form 
the dorsal trunk (DT), the main airway of the embryo. Panel D: 3D projection of confocal Z-stacks 
of an embryo with fully developed tracheal system (stage 16/17). The tracheal system is labelled 
with the 2A12 antibody (DSHB, University of Iowa) and pseudo-coloured to illustrate depth of its 
structure. Panel E: Schematic diagram of the fully formed tracheal system. The 10 metameric units 
are illustrated (Tr1-Tr10) and standard branch names indicated at Tr6: DT, DB, dorsal anastamosis 
(DA), VB, SB, fat body branch (FB), lateral trunk (LT) and ganglionic branch (GB). Some 
specialised branches of Tr1: ventral anastamosis (VA); ventral cephalic branch (VC); 
cerebropharyngeal branch (CP); cerebral branch (CB); anterior spiracular branch (ASP) and Tr10: 
lateroposterior branch (LP); caudal-hindgut branch (CH) and posterior spiracular branch (PSP) are 
also illustrated. The lateral aspect of the embryo is shown in each case (anterior to the left, ventral 
uppermost).  
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Secondary tracheal branches form a number of hours after primary ones bud: in 
this process, cells nearest the end of each primary branch form either: (i) fusion 
cells, that join neighbouring tracheal metameres or the paired tracheal hemi-
segments; or (ii) terminal cells, the blind-ended tracheoles that directly contact 
target tissues for gas exchange (Samakovlis, Hacohen et al., 1996). This cell-fate 
determination requires the ETS-family transcription factor Pointed (Pnt) and 
again relies on iterative Bnl-Btl, Dpp and Wg signalling: furthermore, activation 
of Delta-Notch signalling plays a role in refining fusion/terminal cell fate, 
possibly by restricting the fate of neighbouring tracheal cells (Notch mutants 
display both an increased number of fusion and terminal cells) (Ikeya & Hayashi, 
1999; Llimargas, 1999; Scholz, Deatrick, Klaes, & Klambt, 1993; Steneberg, 
Hemphala, & Samakovlis, 1999). There are five fusion cells in each tracheal 
metamere: one at the end of the DB, which connects with the DB fusion cell of 
the contralateral hemi-segment, and one each at the anterior and posterior ends 
of the DT and LT, which contact the fusion cells of the DT and LT in the adjacent 
tracheal metameres (Figure 1.6). Fusion cells express the transcription factor 
Escargot, which is required for deposition of the adhesion protein E-cadherin at 
the contact site between the two adjoining fusion cells (Tanaka-Matakatsu, 
Uemura, Oda, Takeichi, & Hayashi, 1996). Nineteen of the approximate 80 cells 
of each tracheal metamere become terminal cells; each terminal branch 
comprises one cell and targets distinct tissues in the embryo to facilitate gas 
exchange. Embryonic terminal branches have a fixed path and follow 
developmental cues, in contrast to those in larvae that are also guided by 
hypoxia. Two key genes involved in this terminal branching are: (i) sprouty, 
which encodes a cytoplasmic factor activated in response to high-level Btl-
signalling at the primary branch tips and functions to antagonize the pathway in 
neighbouring cells to limit the number of cells that take on a terminal cell fate; 
and (ii) pruned, which encodes Drosophila serum response factor (DSRF), a 
transcription factor required for the establishment of cytoplasmic extensions: 
DSRF activity must be controlled to prevent ectopic branching and limit the 
invasion of tracheoles into tissues normally supplied by other tracheal cells 
(Guillemin et al., 1996; Hacohen, Kramer, Sutherland, Hiromi, & Krasnow, 
1998). 
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The above events, comprising highly stereotyped cell migration, changes in cell 
shape, selective growth of the apical membrane and intracellular lumen 
formation (rather than cell proliferation), are sufficient to build the final, 
complex network of embryonic tracheae (shown in Figure 1.6) by approximately 
16 hours AEL (Manning & Krasnow, 1993; Samakovlis, Hacohen et al., 1996). 
Further to this and prior to embryonic hatching, the tracheal structure 
undergoes various maturation events and ultimately fills with air to become 
functional in its role as a respiratory organ: further discussion of tracheal 
maturation is provided in Chapter 6.  
Among tubular organs, the Drosophila trachea has emerged as the premier 
system for understanding the molecular and cellular underpinnings of tube 
formation (Maruyama & Andrew, 2012). For the purpose of this thesis, 
Drosophila provides a genetically tractable model of airway development where 
existing genetic tools allow the elegant spatial and temporal manipulation of 
SERCA function and in vivo study of airway morphogenesis.  
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1.6 Introductory summary and aims of the thesis 
Disordered lung development results in death and disease in the young and old: 
development of novel therapies to target these conditions requires new insights 
into pulmonary development. SERCA, already explored as a treatment target in 
asthma and CF, appears to play a key role in regulating aspects of early 
pulmonary organogenesis: further investigation of this role may be achieved 
using murine and fly models of airway development. 
In view of the striking effects of SERCA inhibition presented above, this thesis 
aims to further explore this CPA-induced embryonic lung phenotype by assaying 
changes in gene expression and cell proliferation. In addition, given the coupling 
of Ca2+ dependent AP and branching morphogenesis, it is necessary to separate 
these two phenomena to ascertain whether SERCA function regulates airway 
branching morphogenesis itself or whether effects of SERCA inhibition are 
mediated through changes in airway contractility. By exploiting a Drosophila 
model, this thesis aims to determine the effects of genetic perturbation of 
SERCA function in vivo on airway branching morphogenesis, in the absence of 
airway contractility. 
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Chapter 2 
 
MATERIALS AND METHODS 
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2.1 Bioinformatics  
2.1.1 Analysis of SERCA 
SERCA genomic and protein data were obtained from the National Center for 
Biotechnology (NCBI, available at http://www.ncbi.nlm.nih.gov) and Flybase 
(available at http://flybase.org/) databases. Sequence comparisons against a 
variety of databases were performed using BLAST (NCBI, available at 
http://blast.ncbi.nlm.nih.gov/Blast.cgi) which matches short sequence 
fragments and identifies the best local alignment between unknown sequences 
and the database. BLASTP was used to align protein sequences with other known 
SERCA paralogues and splice variants, for a number of model organisms and 
subsequently retrieve their protein sequences. Multiple alignments of protein 
sequences were obtained using ClustalW2 at the European Bioinformatics 
Institute (available at http://www.ebi.ac.uk/Tools/msa/clustalw2/).  
2.1.2 RNA interference (RNAi) construct assessment 
RNA interference (RNAi) constructs were analysed by aligning the construct’s 
DNA sequence (obtained from the supplier) with the cDNA sequence of the gene 
of interest, using the BLAST (NCBI) software and assessing the start and end 
points of the alignment. When the supplier did not provide the DNA sequence, 
the specified forward and reverse primers were similarly aligned with BLAST. 
The start point of the forward and end point of the reverse primer was then 
recorded and used to obtain the predicted DNA sequence of the RNAi construct.  
Each RNAi construct was checked for predicted off-target effects by inputting 
the sequence into dsCheck (available at http://dscheck.rnai.jp/) (Naito et al., 
2005). This software predicts genes that the RNAi could potentially interfere 
with, other than the gene intended for knockdown. It 'dices' the input sequence 
into 19 nucleotide lengths of small interfering RNA (siRNA) and performs 
exhaustive scans for each 'diced siRNA' to find off-target gene candidates, 
simulating the biochemical process of dsRNA-mediated RNAi in vivo. The 
software then provides the number of hits with a complete match, one mismatch 
and two mismatches for every off-target gene candidate individually.  
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2.1.3 Oligonucleotide primer design 
In order to design oligonucleotide primers for RT-PCR, the cDNA sequence of the 
gene of interest was inputted into Primer3Plus software (available at 
http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi). The 
software’s parameters were specified to provide a primer size of between 18 
and 25 bases, a product size of less than 400 base pairs and predicted melting 
points of both primers within 3°C. The advanced parameters were set to provide 
a maximum poly-X of 3 bases, maximum number of unknown bases of 0, 
maximum self-complementarity score of 8 and maximum 3’ self-
complementarity score of 0. The oligonucleotide primers were then reviewed 
using BLAST (NCBI). FGF-10 primer sequences were taken from Unbekandt et al’s 
publication where they had been successfully used for PCR analysis (Unbekandt 
et al., 2008). Primer sequences used in PCR experiments are detailed in Tables 
2.1 and 2.2. 
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Table 2.1 Oligonucleotide primer sequences used in murine PCR 
 
 Gene Forward Primer Reverse Primer 
Product 
Size 
18S TCCGATAACGAACGAGACTC CAGGGACTTAATCAACGCAA 315 
Fgf-9 CGGCACCAGAAATTTACACA ATAAGAACCCACCGCATGAA 161 
Fgf-10 CACATTGTGCCTCAGCCTTTCC CCTGCCATTGTGCTGCCAGTTAA 506 
Shh GGAAAACACTGGAGCAGACC CCACGGAGTTCTCTGCTTTC 308 
SM-MHC AGGAAACACCAAGGTCAAGC CCCTGACATGGTGTCCAATC 324 
Spry2 TTGTGGTTTGCAGTGAGAGG TCTTCGCCTAGGAGTGTTGG 200 
Vegfa ATGTGACAAGCCAAGGCGGTG TGGCGATTTAGCAGCCAGATA 298 
 
Table 2.2 Oligonucleotide primer sequences used in Drosophila PCR 
 
Gene Forward Primer Reverse Primer 
Product 
Size 
18S CGCAAGATCGTTATATTGGTTG GCTGCCTTCCTTAGATGTGG 203 
Ca-P60A CGATATCCGTATCACCCACA CTCACCGAACTCGTCCAGTT 292 
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2.2 Murine Experiments 
2.2.1 Preparation of murine embryonic lung explants 
In accordance with Schedule 1 of the UK Animals Act, embryos from timed-
pregnant mice (Charles River Ltd, Margate, UK) were harvested on Day 11.5 of 
gestation (vaginal plug positive = Day 0) by caesarean section. Upon retrieval, 
embryos were transferred to an isotonic saline bath cooled on ice. Micro-
dissected from their extra-embryonic membranes, embryos were secured in a 
lateral position using cranial and caudal entomology pins (Figure 2.1). Using a 
Leica MZ6 (Leica Microsystems Ltd., Milton Keynes, UK) stereomicroscope and 
microsurgical instruments, a thoracic incision was performed to expose the 
embryonic heart and lungs. The heart was teased from the lung rudiments 
before the oesophagus was freed carefully from the primitive carina. The 
trachea was then sectioned and the pulmonary complex transferred by pipette 
into serum-free culture medium (DMEM/F12 1:1, Gibco; Invitrogen Life 
Technologies, Paisley, UK).  
 
 
Figure 2.1 Micro-dissection steps used to isolate lung explants from E11.5 mouse embryos 
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2.2.2 Embryonic lung explant culture 
Lung rudiments were positioned on translucent polytetrafluorethylene 
membrane culture-dish inserts (Millicell; Millipore Corp., Bedford, MA) with 
serum-free culture media incorporating penicillin (100 IU/ml) and streptomycin 
(100 µg/ml; Gibco). Cyclopiazonic acid (CPA) (Sigma-Aldrich Company Ltd., 
Dorset, UK) was filter sterilised and added to the medium at final concentrations 
of 4 – 20 µM. Lung primordia were incubated at 37°C in 5 % CO2 for periods up to 
78 hours. Using brightfield microscopy, specimens were inspected daily for 
histologic integrity and viability, and photographed. The culture medium was 
changed every 48 hours. Lung cultures were either homogenised for RNA 
extraction or fixed and mounted for histology.  
2.2.3 Embryonic lung explant RNA extraction 
For each culture condition, lung explants were collected and snap frozen in a 
micro-centrifuge tube with liquid nitrogen. They were homogenised with a 
pestle in a micro-centrifuge tube containing 350 µL Buffer RLT (Qiagen Ltd., 
Crawley, UK) with β-mercaptoethanol (10 µL per 1 ml). The suspension was then 
passed 10 times through a 22-gauge needle fitted to a 1 ml RNase-free syringe. 
The suspension was then transferred to a QIAshredder spin column (Qiagen) and 
centrifuged at 8,000 x g for 2 min. RNA was extracted from the subsequent 
lysate using an RNeasy Mini Kit (Qiagen) according to the handbook protocol. 
Briefly, 1 volume of 70 % ethanol was added to the lysate, mixed by pipetting 
and the mixture transferred to an RNeasy spin column, which was centrifuged 
for 15 sec at 8000 x g. After washing the column with 350 µl Buffer RW1 and 
centrifuging for 15 s at 8000 x g, an on-column DNase digestion was performed, 
to eliminate genomic DNA contamination.  10 µl DNase I solution (1500 Kunitz 
units in 550 µl) were added to the spin column membrane along with 70 µL 
Buffer RDD (Qiagen) and incubated at 25 for 15 minutes. The spin column 
membrane was further washed with 350 µl Buffer RW1 and then twice with 500 
µl Buffer RPE, with the column being centrifuged after each step. Finally, the 
RNA was eluted from the spin column membrane by adding 50 µl nuclease-free 
H2O and then centrifuging for 1 min at 8000 x g. The concentration of extracted 
RNA was determined at 260  nm using a NanoDrop ND-1000 spectrophotometer. 
The A260/A280 ratio was assessed as an indicator of RNA purity. The RNA was 
then stored at -80°C. 
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2.2.4 Embryonic lung explants fixation and mounting 
Cultured lungs were preserved in 4 % paraformaldehyde in PBS, rinsed in PBS, 
cryoprotected with 20 % (wt/vol) sucrose, gelatine embedded (7.5% [wt/vol] 
gelatin, 15 % [wt/vol] sucrose in PBS), before being covered in Cryo-M-Bed 
(Bright, Huntingdon, UK), and snap-frozen at -30°C. Lung frozen sections were 
taken at 7 µm using a microtome and mounted on slides for storage at -30°C. 
2.2.5 Lung explant immuno-histo-chemistry 
Frozen sections were allowed to thaw at room temperature and then circled 
with a hydrophobic pen (Dako UK Ltd., Ely, UK). All subsequent steps were 
carried out with a drop of solution within each hydrophobic circle. Specimens 
were first blocked for 30 minutes with 20% goat serum in PBS. Incubation with 
anti-phospho-Histone H3 (Ser10, Rabbit, Cell Signalling Technologies, Danvers, 
MA, USA) diluted 1:500 with PBS was carried out at 4°C overnight. Washes used 
coplin jars and comprised 3 x 10 minute washes in PBS. Alexa Fluor® 555 anti-
rabbit (Invitrogen, 1:500 in PBS) secondary antibody and DAPI (1:5000) were 
incubated with the sample in the dark for 2 hours at room temperature. Washes 
were carried out as previously stated. The sections were mounted by applying a 
coverslip over aqueous mountant (Dako). 
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2.3 Drosophila Experiments 
2.3.1 Growth and maintenance of Drosophila 
Fly stocks were maintained at 18°C, 25°C or 29°C with a 12 hour light/dark 
photo cycle, on Drosophila yeast/glucose medium (Table 2.3). Adult flies were 
anaesthetised with CO2 gas using an Ultimate Flypad (Genesee Scientific, San 
Diego, CA, USA) and examined using a Nikon SMZ-645 stereoscopic zoom 
microscope (Nikon UK Limited, Kingston Upon Thames, UK) and Photonics PL3000 
light source (Photonic Optics, Vienna, Austria). Flies were manipulated using a 
fine artist’s paintbrush. 
Table 2.3 Drosophila Food Recipe 
 
Mass / Volume Reagent 
6 L H2O 
72 g Agar 
510 g Sucrose 
120 g Dried yeast 
360 g Organic maize 
150 ml 
 
10% Nipagen solution  
(in 70% ethanol) 
18 ml Propionic acid 
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2.3.2 Drosophila stocks and genotypes 
Standard markers and chromosomes were as described by Lindsley and Zimm 
(Lindsley & Zimm, 1992). Stocks were obtained from the Bloomington Drosophila 
Stock Centre (Indiana University, USA), the Vienna Drosophila RNAi Centre 
(Institute of Molecular Biotechnology and Research Institute of Molecular 
Pathology, Vienna, Austria) and the Drosophila Genetic Resource Centre (Kyoto 
Institute of Technology, Japan). Others were requested from the individual 
researchers, Daimark Bennett (University of Liverpool, UK), Deborah Andrew 
(The Johns Hopkins University, USA), Andrea Brand (University of Cambridge, 
UK), Sanyal Subhabrata (University of Arizona, USA), Dirk Bohmann (University of 
Rochester, USA), Christos Samakovlis (Unversity of Stockholm, Sweden) and 
Martin Barron (University of Manchester), as indicated in Table 2.4. 
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Table 2.4 Fly stocks used or generated 
 
Genotype Brief Description Source 
w1118 white eyed mini-gene Bennett 
w*; Tft/CyO 2nd chromosome balancer Bennett 
w*; Tft/CyO; MKRS/TM6B 2nd and 3rd chromosome balancer Bennett 
w*; +/ CyO, twi>GFP Fluorescently tagged CyO balancer Bennett 
w*; Tft/CyO, twi>GFP; 
MKRS/TM6B 
As above but fluorescently labelled 2nd 
chromosome balancer 
Generated  
w*; His2Av-mRFP1 
Expresses histone:mRFP fusion 
protein ubiquitously 
Bloomington 
w*; UAS-histone-YFP 
Expresses histone:YFP fusion protein 
under UAS control 
Brand 
w*; UAS-dsRednls 19A 
Expresses dsRed nuclear localisation 
signal under UAS control 
Andrew 
w*; UAS-Act5C.mRFP 
Expresses actin:mRFP fusion protein 
under UAS control 
Bloomington 
w*; btl-GAL4, UAS-
Act5C.GFP 
Expresses actin:GFP fusion protein in 
breathless expressing (tracheal) cells 
Bloomington 
w; btl-GAL4, UAS-histone. 
YFP, UAS-act.RFP/CyO 
Expresses actin.mRFP and 
histone.YFP in tracheal cells 
Generated 
w; Btl-GAL4, UAS-dsRed 
NLS, UAS-act:GFP/CyO 
Expresses actin.GFP and dsRedNLS 
in tracheal cells 
Generated 
w1118; UAS-Cameleon.2.1 
Expresses Cameleon 2.1 calcium 
sensor under UAS control 
Bloomington 
w1118; UAS-Dcr-2.D Expresses Dicer-2 under UAS control Bennett 
y1, w67c23, btl-GAL4 
Expresses GAL4 in breathless 
expressing (tracheal) cells 
DGRC, Kyoto 
w*; bnl-GAL4 / TM3, Sb1 
Ser1 
Expresses GAL4 in branchless 
expressing cells 
DGRC, Kyoto 
w*; ; da.G32-GAL4 Expresses GAL4 ubiquitously Bennett 
w1118/Dp(2;Y)G, w+mC=hs-
hidY; wgSp-1/CyO 
Virginiser strain with 2nd chromosome 
balancer 
Bloomington 
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w1118/Dp(2;Y)G, w+mC=hs-
hidY; MKRS/TM2, y+ 
Virginiser strain with 3rd chromosome 
balancer 
Bloomington 
Ca-P60AKum170/CyO 
Conditional, dominant negative 
mutant form of SERCA  
Subhabrata 
Ca-P60AKum170/CyO-
twi>GFP 
Conditional, dominant negative 
mutant form of SERCA with 
fluorescent balancer 
Generated 
w*; Ca-P60AKum(295)/CyO-
MHC-LacZ 
Conditional, dominant negative 
mutant form of SERCA 
Subhabrata 
w*; Ca-P60AKum(295)/CyO-
twi>GFP 
Conditional, dominant negative 
mutant form of SERCA with 
fluorescent balancer 
Generated 
y*; w*; Ca-
P60AKum170.Scer\UAS/CyO; Ca-
P60AKum170.Scer\UAS 
Conditional, dominant negative 
mutant form of SERCA under UAS 
control 
Subhabrata 
w; Ca-P60AKum170, btl-GAL4, 
UAS-act:GFP/CyO 
Conditional mutant form of SERCA 
and GFP under btl-GAL4 control 
Generated 
w118; P{KK107371}v107446 
SERCA RNAi construct under UAS 
control 
VDRC 
w1118; P{GD436}v4474 
SERCA RNAi construct under UAS 
control 
VDRC 
w118; P{GD436}v4474, 
P{KK107371}v107446 
Above 2 RNAi constructs recombined 
on the 2nd chromosome 
Generated 
w1118; P{GD436}v4474, 
UAS-dicer 
SERCA RNAi construct recombined 
with Dicer-2 on the 2nd chromosome 
under UAS control 
Generated 
w*; nocSco/CyO; tubP-
GAL80ts 
Temperature-sensitive GAL80 under 
control of alphaTub84B promoter 
Bloomington 
w*; btl-GAL4, UAS-
Act5C:GFP; tubGAL80ts 
Expresses actin:GFP fusion protein in 
breathless expressing (tracheal) cells 
and  temperature sensitive GAL80 
Generated 
btl-GAL4, UAS-GFP, 
tubGAL80ts, esg-LacZ 
Expresses actin:GFP fusion protein in 
tracheal cells and LacZ under control 
of escargot promotor 
Bohmann 
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hsFlp; act>y>GAL4, UAS-
GFP; btl-mRFPmoe 
Flippase recombinase under control of 
heat shock promotor; GAL4 under 
control of actin promotor (with yellow 
cassette); GFP under UAS control 
and moesin.RFP fusion protein under 
control of breathless promotor 
Bohmann 
hsFlp122; Tft/CyO; 
TM2/TM6B 
Flippase recombinase (122 allele) 
under control of heat shock promotor 
and 2nd/3rd chromome balancers 
Bennett 
y1, w*; FRT42D, 
tubGAL80/CyO 
GAL80 under control of tubulin 
promoter with FRT site 
Bloomington 
w*; +/CyO; Act>CD2>GAL4, 
UAS-GFP/MKRS 
GAL4 under control of actin promotor 
(with CD2 cassette) and GFP under 
UAS control 
Bennett 
w*; FRT42D, tubGAL80; 
Act>CD2>GAL4, UAS-GFP 
Elements from above 2 stocks 
combined on 2nd/3rd chromosomes 
Generated 
yd2, w1118; FRT42D, Ca-
P60Ak08308ab / CyO 
Dominant negative SERCA mutant 
with FRT site 
DGRC Kyoto 
hsFlp122; FRT42D,  
Ca-P60Ak08308ab / CyO; 
Btl>mRFPmoes 
Dominant negative SERCA mutant 
with FRT site, combined with heat 
shock flippase and moesin.RFP fusion 
protein under control of breathless 
promotor 
Generated 
w1118; FRT42D, white-un1 FRT site for making control clones Bloomington 
hsFLP122; FRT42D, white-
un1/CyO; 
Btl>mRFPmoes/TM6B 
FRT site for making control clones 
and moesin.RFP fusion protein under 
control of breathless promotor 
Generated 
Btl-GAL4, UAS-
GcaMP3/CyO 
Expresses genetic calcium sensor in 
breathless expressing (tracheal) cells 
Samakovolis 
UAS-deltex/CyO-GFP Expresses deltex under UAS control Barron 
w; FRT/CyO; UAS-rasV12 Oncogenic ras under UAS Bennett 
ptc-GAL4, UAS-GFP/CyO 
Expresses GAL4 in patch expressing 
cells and GFP under UAS control 
Bennett 
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2.3.3 Embryo collection 
Embryos were collected on apple juice agar plates (Table 2.5) smeared with a 
small amount of yeast paste and placed at the bottom of fly cages. Firstly a pre-
lay collection was performed to encourage females to deposit retained eggs and 
synchronise subsequent egg collections. Embryo collections were carried out 
over relatively short periods of time (1-4 hours) to ensure embryos were of a 
similar developmental stage. Embryos were then aged on the agar plates at 25°C 
to reach the desired stage of development. Embryos were removed from the 
plates by washing with distilled water through a fine mesh sieve (Sefar Nitex 120 
µM mesh, Sefar Ltd., Bury, UK). The chorion was removed by placing the sieve 
into thin household bleach for 1-2 mins. The bleach was drained off and the 
embryos were washed with copious distilled water. The mesh was then dried by 
blotting on paper towels. The embryos were removed with a damp, fine artist’s 
paintbrush and either placed in fixative, mounted for live imaging or dissociated 
for RNA extraction or calcium imaging. 
Table 2.5 Apple Juice Agar Recipe 
 
Mass / Volume Reagent 
335 ml H2O 
165 ml Apple Juice 
30 g Agar 
8 g Sucrose 
2 ml 
10% Nipagen solution  
(in 70% ethanol) 
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2.3.4 Staging embryo development 
In order to obtain a number of embryos at the same, known developmental 
stage, collections were performed over short time windows (as described above) 
and carefully aged according to standard Bownes stage numbers, using accepted 
time periods described by Campos-Ortega and Hartenstein (Bownes, 1975; 
Campos-Ortega & Hartenstein, 1985). For accurate, reproducible assessment of 
tracheal phenotype, early stage 16 (16.1) was chosen in most cases: at this stage 
the large majority of the tracheal system has formed and importantly, it is 
readily identifiable from gut morphology. The onset of stage 16 is characterised 
by three circular midgut constrictions that subdivide the midgut into four 
chambers (Figure 2.2), customarily numbered 1-4 antero-posteriorly. These 
characteristics are identifiable in dechorionated embryos inspected under light 
or transmitted-light confocal microscopy. Later in stage 16, all four chambers 
constrict further, resulting in the long, highly convoluted tube that is evident as 
the larval midgut. Development of the embryonic alimentary tract is complete 
by stage 17. 
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Figure 2.2 Selecting early stage 16 embryos based on gut morphology 
Transmitted light confocal micrograph of a number of early stage 16 (16.1) embryos. The midgut is 
subdivided by 3 circular constrictions (labelled with arrows), leading to the characteristic 
appearance of parallel chambers of gut that appear ‘stacked’ antero-posteriorly. The most posterior 
chamber is often more difficult to visualise, but can be clearly seen in the upper left embryo. Scale 
bar indicates 200 µm. 
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2.3.5 Determination of developmental stage of lethality 
Embryos were collected on apple juice agar plates as described above and then 
counted using light microscopy (Nikon SMZ-645 stereoscopic zoom microscope 
and Photonic PL3000 light source). The embryos were then inspected at 12 hour 
intervals to assess development. Larval developmental stage was determined 
according to the 3 instars. 
2.3.6 Determination of tracheal gas filling 
Embryos were selected for stage 16.1 and correct genotype (if necessary) using 
fluorescent and light microscopy (described above, using Leica MZ10F stereo 
microscope and EL6000 light source). Embryos were then mounted on double-
sided sticky tape on a microscopic slide and covered in halocarbon oil. They 
were then inspected at 22 hours AEL for tracheal gas filling.  
2.3.7 Drosophila embryo RNA extraction 
For each genotype, twenty embryos were collected as described above and snap 
frozen in a micro-centrifuge tube with liquid nitrogen. They were homogenised 
with a pestle in a micro-centrifuge tube containing 350 µL Buffer RLT (Qiagen) 
with β-mercaptoethanol (10 µL per 1 ml). The suspension was then passed 10 
times through a 22-gauge needle fitted to a 1 ml RNase-free syringe. The 
suspension was then transferred to a QIAshredder spin column (Qiagen) and 
centrifuged at 8,000 x g for 2 min. RNA was extracted from the subsequent 
lysate using an RNeasy Mini Kit (Qiagen) according to the handbook protocol sd 
described above. The concentration of extracted RNA was determined at 260  nm 
using a NanoDrop ND-1000 spectrophotometer. The A260/A280 ratio was 
assessed as an indicator of RNA purity. The RNA was then stored at -80°C. 
2.3.8 Embryo fixation 
Embryos were transferred to a small glass jar containing 5ml heptane, in order 
to puncture the vitelline membrane and 5 ml fixative solution (0.1 M Hepes, pH 
6.9, 2 mM MgSO4, 3.7 % formaldehyde) and left for 45 minutes with gentle 
agitation. The embryos settled at the interface of the heptane and 
formaldehyde layers. In order to remove the vitelline membrane, the lower 
aqueous phase was removed using a fine glass Pasteur pipette and 5 ml methanol 
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was added. The jar was shaken vigorously for around 30 seconds so the 
devitellinised embryos fall to the bottom of the methanol. They were then 
transferred to a fresh tube and washed with fresh methanol 4 times. These can 
then be stored at 4°C in methanol. Embryos were rehydrated with serially 
decreasing solutions of methanol (80 %, 60 %, 40 %, 20 %, 0 %) in PBS and 0.1 % 
Triton X-100. For certain immunofluorescent experiments, a short fixation 
procedure was required. This involved the same steps described above, but the 
fixative solution contained 33% formaldehyde in 500 mM EGTA (pH 7.5) and the 
duration of fixation was 5 mins.  
2.3.9 Immunofluorescent staining of Drosophila embryos 
Staining was carried out in micro-centrifuge tubes and a rotator was used to 
gently agitate the embryos in all steps. A blocking step was performed whereby 
rehydrated embryos were placed in a solution of PBS, 0.1 % Triton X-100 and 0.5 
% BSA for 30 minutes at 25°C and this step was repeated a further time. Primary 
antibodies were used as in Table 2.6 and diluted in PBST (PBS and 0.1 % Triton X-
100) to the stated working concentrations. Incubation was carried out for either 
6 hours at 25°C, or overnight at 4°C. Embryos were then washed in PBST for the 
following time periods and frequencies: 2 x 30 seconds, 2 x 5 minutes and finally 
2 x 30 minutes. Secondary antibodies used are given in Table 2.7 and incubation 
was for 2 - 4 hours at 25°C or overnight at 4°C. Washes were then carried out 
with PBST for the durations described above. When red-fluorescent BODIPY® TR-
X thapsigargin (Invitrogen) was used, rehydrated embryos were incubated with 
the fluorophore at a concentration of 5 µM for 2 hours at 25°C and then washes 
were carried out as above. Embryos were mounted on microscopy slides with 
VECTASHIELD® Mounting Medium (Vector Laboratories, Peterborough, UK). To 
avoid crushing the embryos, coverslips were applied in a system where they 
were raised by 2 further coverslips stuck to the slide with clear nail-polish. Clear 
nail-polish was also used to seal the edges of the coverslip. 
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Table 2.6 Primary Antibodies used for Embryo Staining 
 
Antibody Dilution Host Supplier 
2A12 1:10 Mouse DSHB, Iowa, USA 
Muscle-myosin 1:250 Rabbit Kiehart, Duke University, USA 
Non-sarcomeric Myosin 1:250 Rabbit Kiehart, Duke University, USA 
 
 
 
Table 2.7 Secondary Antibodies used for Embryo Staining 
 
Antibody Dilution Host Species Against Supplier 
Alexa Fluor® 488 1:500 Goat Mouse, Rabbit Invitrogen 
Alexa Fluor® 555 1:500 Goat Mouse, Rabbit,  Invitrogen 
 
2.3.10 Calcium imaging of embryonic cells 
For live calcium imaging of embryonic cells, a system was designed using 
features of a protocol for Drosophila primary embryonic cell culture (Bai, Sepp, 
& Perrimon, 2009). Embryos were collected and dechorionated as described 
above. 100-200 embryos were placed in a micro-centrifuge tube containing 800 
µL of GIBCO™ Schneider’s Drosophila medium (Invitrogen) and dissociated using a 
sterile pestle. The suspension was then centrifuged at 40 x g for 5 minutes and 
the process repeated. The cell suspension was then diluted to 1200 µL with 
further medium. 300 µL of this cell suspension was loaded into each chamber of 
a 4-well Lab-Tek™ II Chambered Coverglass (Nunc, Thermo Fisher Scientific, 
Rochester, NY, USA) that had been pre-coated with Poly-L-Lysine (Sigma-Aldrich) 
for 1 hour and washed off with sterile water. 
Cells were then loaded with Fluo-4 (Invitrogen) at a concentration of 1 µM for 1 
hour, thus also allowing them to adhere to the coverglass. Imaging was 
performed with confocal microscopy as described below. When required for 
stimulation experiments, thapsigargin (Sigma-Aldrich) was added to give a final 
concentration of 2 µM.  
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2.3.11 Collection of larvae 
Embryos were collected over 4 – 8 hour periods of time on apple juice agar 
plates as described above, or in large vials containing fly food. Embryos were 
allowed to hatch and develop into the required stage of larval development at 
25°C. When the temperature sensitive GAL80 construct was used to repress 
GAL4 mediated expression, a permissive (to GAL80) temperature of 18°C and 
restrictive temperature of 29°C were used.  
2.3.12 Generation of flip-out and mitotic clones 
For clonal analysis, embryos were kept at 25°C until late L2 larval stage. Vials 
containing the larvae were then placed in a 37°C water bath for between 15 
minutes and 1 hour in order to activate the flippase (FLP) recombinase which is 
under the control of a heat-shock promoter (hs). The larvae were then returned 
to 25°C until the late L3 stage when they were dissected. The presence or 
absence of clones within the imaginal discs was deduced by inspecting the larvae 
under fluorescence microscopy (as above). 
2.3.13 Larval micro-dissection 
Larvae at the correct stage of development were first washed and then 
dissected in ice cold PBS. In order to dissect the imaginal wing disc, larvae were 
transected at the level of the abdomen and inverted over forceps. The wing disc 
was then carefully dissected away from the thoracic trachea using fine forceps 
and transferred to cold PBS. Care was taken to ensure that the tracheal system 
and air sac were not damaged by excessive traction. 
2.3.14 Fixation and fluorescent staining of imaginal discs 
Fixation and staining were carried out in ‘watch-glass’ type glass containers. 
Wing discs were fixed in 4% paraformaldehyde in PBS for 20 minutes at 25°C. 
The discs were then washed twice in PBS for 20 minutes. A blocking step was 
carried out for 2 hours at 25°C using PBST containing 5% fetal calf serum. 
Primary antibodies were used as in Table 2.8 and diluted in the blocking solution 
to the specified concentration. Discs were incubated in the primary antibody 
overnight at 4°C. Four 20 minute washes were carried out with PBST before 
incubation with the secondary antibody. Secondary antibodies (Table 2.9) were 
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diluted in blocking solution and incubated for 2 hours at 25°C in the dark. The 
final wash steps included 20 minutes washes in PBST repeated 4 times in total 
and then a final wash of 20 minutes in PBS to remove the detergent. Wing discs 
were mounted on microscopy slides with VECTASHIELD® Mounting Medium 
(Vector Laboratories). Slides were kept in the dark at 4°C to reduce fading of 
the fluorophores. 
When MAP Kinase (Diphosphorylated ERK-1&2) staining was carried out, the 
concentration of fixative was increased to 8 %. When Notch intracellular domain 
staining was carried out, a protocol adapted from Mark Fortini (Thomas 
Jefferson University, Philadelphia, USA) was used. This comprised a PLP fixation 
step (2% paraformaldehyde, 75 mM lysine, 37 mM sodium phosphate, 10 mM 
periodate) for 40 minutes on ice. Washes prior to primary and secondary 
antibody incubation were carried out with PBS-DT (1 X PBS, 0.3 % Na-
deoxycholate, 0.3% Triton X-100). The antibody dilution, incubation and final 
wash steps were as above.  
Table 2.8 Primary Antibodies and Dyes used for Imaginal Disc Staining 
 
Antibody Dilution Host  Supplier 
Anti-phospho-Histone H3 
(Ser10) 
1:500 Rabbit Cell Signalling  
17.9C6 Anti-notch ICD 1:100 Mouse DSHB 
2B10 Anti-cut protein 1:100 Mouse DSHB 
Anti-β-Galactosidase 1:1000 Rabbit Promega 
Activated Caspase-3 1:100 Rabbit Cell Signalling  
Anti-MAP Kinase, Activated 
(Diphosphorylated ERK-1&2) 
1:100 Mouse Sigma 
4F3 Anti-discs large 1:100 Mouse DSHB 
TOPRO-3 1:1000 N/A Invitrogen 
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Table 2.9 Secondary Antibodies used for Imaginal Disc Staining 
 
Antibody Dilution Against Host  Supplier 
Alexa Fluor®  555  1:500 Mouse or Rabbit Goat Invitrogen 
Alexa Fluor®  633  1:500 Mouse or Rabbit Goat Invitrogen 
 
2.3.15 Preparation for live imaging 
Live embryos at the correct developmental stage were dechorionated and 
washed with distilled water as above. Individual embryos were mounted with a 
damp; extra fine artist’s paint brush, with most of the bristles removed. 
Embryos for confocal imaging using an inverted microscope, were placed on the 
coverglass of a 4-well Lab-Tek™ II Chambered Coverglass (Nunc, Thermo Fisher 
Scientific). These dishes have borosilicate glass and embryos loosely adhere to 
them, whilst still allowing manipulation with a brush to gain the correct 
orientation for imaging. Once embryos had been mounted, 600 µL of PBS was 
carefully added to the well. Embryos for live fluorescent, wide-field imaging on 
an upright microscope were mounted on a gas-permeable membrane stretched 
over two silicon bars on top of a slide and covered with halocarbon oil to prevent 
desiccation. 
In order to image live imaginal discs, a modified version of the protocol 
published by Aldaz et al was adopted (Aldaz, Escudero, & Freeman, 2010). 
Shields and Shang M3 insectum medium (Sigma-Aldrich) was supplemented with 
2 % fetal calf serum and 0.5 % penicillin-streptomycin. (Invitrogen) In order to 
make the medium viscous for live imaging, methyl-cellulose (Sigma-Aldrich) was 
added at a concentration of 2.5% wt/vol. The methyl-cellulose was added to the 
medium and stirred until dissolved, then left overnight at 4°C to remove 
bubbles. Aliquots were then stored at -20°C. Late third instar larvae were 
dissected as stated earlier, except the above culture medium (without 
methylcellulose) was used in place of PBS. Care was taken to ensure that 
imaginal discs were undamaged. 300 µL of the viscous medium was placed in a 
chamber of a 4-well Lab-Tek™ II Chambered Coverglass (Nunc, Thermo Fisher 
Scientific) and dissected discs carefully transferred to this. Each disc was 
orientated with it’s columnar epithelium facing downwards and peripodial 
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membrane upwards. The disc was encouraged to sink down in the media and 
then gently placed against the glass coverslip (previously coated in Poly-L-
Lysine, as above).  
2.4 Imaging 
2.4.1 Confocal microscopy 
Slides were imaged using a Zeiss LSM 710 (Carl Zeiss Ltd, Hertfordshire, UK) laser 
scanning confocal system with an inverted Axio Observer.Z1 microscope. Zeiss 
Fluor 20x/0,75 air and 40x/1,3 oil immersion objectives were used. An X-CITE® 
120PC Q (Lumen Dynamics Group Inc., Ontario, Canada) light source was use for 
fluorescent microscopy. For live imaging experiments, a cooled stage (Lauda Dr. 
R, Lauda-Königshofen, Germany) was kept at 25°C. 
GFP fusion proteins and Alexa Fluor 488 dyes were excited at 488 nm, using an 
Argon laser and detected maximally at 509 nm and 519 nm respectively. YFP 
fusion proteins were excited at 514 nm using an Argon laser and detected 
maximally at 527 nm. mRFP and DsRed fusion proteins and Alexa Fluor 555 were 
excited at 543 nm using a GHe/Ne laser and detected maximally at 607, 583 and 
565 nm respectively. Alexa Fluor 633 dyes were excited at 633 nm using a 
GHe/Ne laser and detected maximally at 647 nm. Images were captured using 
Zen 2010 (Zeiss) software. 
The pinhole was usually set at around 1 airy unit (AU) to give optimal signal to 
noise ratios. When Z-stacks of tissues were taken, the optimal slice thickness for 
1 AU, as specified by the software was used (usually between 0.5 – 2 µm).  
2.4.2 Calcium imaging 
When live imaging of cells loaded with Fluo-4 (Invitrogen) was carried out, a 
system was used whereby thapsigargin could be added to the dish during imaging 
with minimal disruption to the solution and cells. A fine, 22G needle, connected 
to a syringe by fine plastic tubing, was carefully inserted into the well of the 
dish and the correct amount of thapsigargin infused. In order to collect real-time 
data during stimulation experiments, the LSM 710 was set-up to scan at 
maximum speed without averaging. The 20x objective was used to gain good 
depth of field for a number of cells imaged simultaneously. 
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2.4.3 Fluorescent Resonance Energy Transfer (FRET)  
Confocal spectral scanning microscopy was used to image the genetically 
encoded calcium indicator cameleon 2.1. This involved using the lambda mode 
of the Zeiss 710 microscope and Zen 2010 software. Cameleon YC.2.1 was 
excited at 458 nm using an Argon laser and the emission captured with 13 photo-
detectors (at specific wavelengths of 469, 479, 488, 498, 508, 581, 527, 537, 
547, 557, 566, 576 and 586 nm). FRET was indicated by the presence of 2 peaks 
of maximal emission at 485 nm (corresponding to cyan fluorescent protein [CFP]) 
and 535 nm (corresponding to yellow fluorescent protein [YFP]). In order to 
confirm FRET, acceptor photo-bleaching was carried out and the recovery in CFP 
emission observed in the bleached region (Karpova et al., 2003). The Zen 
software bleach function was used to carry out bleaching of a defined region of 
interest (ROI) of YFP. The 514 nm laser is used at high power in order to do this. 
An internal control for the bleaching experiment was established by assessing 
changes in emission of an unbleached region in parallel (Karpova et al., 2003). 
The software was used to unmix the spectral channel emission data by 
extracting the mean intensity for two wavelength ranges, corresponding to CFP 
and YFP emission (473-493 nm and 522-541 nm respectively). Since background 
(outside of imaged cells or tissues) pixel fluorescence was low (<10% of signal), 
background subtraction was not performed in order to minimise data 
manipulation (Karpova et al., 2003). 
2.4.4 Assessment of cameleon FRET System 
In order to assess the approximate dynamic range of the cameleon 2.1 system in 
Drosophila embryonic cells in vitro, embryos ubiquitously expressing cameleon 
YC2.1 were collected and dechorionated as described above. 100-200 embryos 
were then placed in a micro-centrifuge tube containing 800 µL of GIBCO™ 
Schneider’s Drosophila medium (Invitrogen) and dissociated using a sterile 
pestle. The suspension was then centrifuged at 40 x g for 5 minutes and the 
process repeated. 400 µL of this cell suspension was loaded into each chamber 
of a 4-well Lab-Tek™ II Chambered Coverglass (Nunc, Thermo Fisher Scientific) 
that had been pre-coated with Poly-L-Lysine for 1 hour. The cells were allowed 
to adhere to the coverglass for 1 hour and then the medium replaced with S2 
Ringer’s Solution (150 mM NaCl, 5 mM KCl, 2 mM CaCl2, 4 mM MgCl2 and 10mM 
HEPES, pH 7.2) or Ca2+ free Ringer’s solution (150 mM NaCl, 5 mM KCl, 6 mM 
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MgCl2, 1 mM EGTA and 10mM HEPES, pH 7.2) (Zhang et al., 2006). Calibration 
steps were adapted from Palmer et al’s protocol (Palmer & Tsien, 2006). In 
order to assess the maximum YFP/CFP ratio, conditions of high calcium 
concentration were created by adding CaCl2 (final concentration 10 mM) and 
ionomycin (final concentration 10 µM) to the well. For assessing the minimum 
ratio, calcium was chelated by adding EGTA (final concentration 5 mM) and 
ionomycin 10 µM). Imaging was carried out for at least 15 minutes post addition 
in order to achieve a steady state. 
2.4.5 Live Fluorescent Imaging  
For wide-field live imaging, dechorionated embryos were mounted on a gas-
permeable membrane stretched over two silicon bars on the top of a slide and 
covered with halocarbon oil to prevent desiccation. Embryos were imaged on a 
Zeiss Axio Observer.Z1 microscope, Colibri LED light source and high speed 
AxioCam CCD camera, controlled by AxioVision software 4.5. Objectives used 
were Zeiss 20x/0,5  Plan-Neofluar or 63x/1,3 C-Apochromat water-immersion 
lenses.  
2.4.6 Image Processing 
Images were exported from Zen 2010 in Tagged Image File Format (TIFF) and 
edited in Adobe Photoshop CS5 (Adobe Systems Europe Ltd, Maidenhead, UK). 
When Z-stacks were produced, images are presented as single slices, unless a 
projection is specified. When a 3-dimensional (3D) projection was required, 
stacks were rendered using Zen 2010 software (Zeiss). If image brightness 
required changing in order to achieve satisfactory colour reproduction for 
publication, this change was standardised between groups to allow valid 
comparison. 
When pixel intensity was quantified in a defined region of interest (for example 
during single cell calcium imaging), the mean intensity for that region, at 
individual time points was determined in the Zen software and exported as 
numerical data. These data were processed and plotted as graphs using SPSS 
Statistics 18.0 (IBM®). 
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2.5 Polymerase Chain Reaction (PCR) Experiments 
2.5.1 Reverse Transcriptase 
First-strand cDNA synthesis was initiated from 0.2  µg total RNA. The 
oligonucleotide primer was annealed to the RNA by adding 1 µl random hexamers 
(0.5 µg/µl Promega, Madison, WI, USA) and nuclease-free H2O to a total volume 
of 15 µl in a micro-centrifuge tube. The mixture was then incubated at 70°C for 
5 mins and then put on ice. For the reverse transcriptase reaction, 1 µl Moloney 
Murine Leukemia Virus (M-MLV) reverse transcriptase, 5 µl 5x M-MLV reverse 
transcriptase buffer, 0.5 µl ribonuclease inhibitor (all from Promega), 1.25 µl 
nucleotides (10 mM ATP, CTP, GTP, UTP) and 2.25 µl nuclease-free H2O were 
added to the RNA and oligonucleotide mixture and incubated at 42°C for 1 hour. 
The cDNA was then diluted to a volume of 100 µl with nuclease-free H2O and 
stored at -30°C. 
2.5.2 Polymerase Chain Reaction 
Oligonucleotide primers were used at a concentration of 10 µM (DST, Sigma-
Aldrich). For the PCR reaction, 5 µl cDNA were added to 1 µl forward primer, 1 
µl reverse primer, 18 µl nuclease-free H2O and 25 µl PAQ5000 2X PCR Master Mix 
(Agilent Technologies UK Ltd, Edinburgh, UK). The PCR conditions were 94°C for 
2 min, 94°C for 30 seconds, 58°C for 30 seconds (oligonucleotide annealing) and 
72°C for 1 min (primer extension). The last 3 steps were repeated for 25 cycles. 
The final step was 72°C for 5 min and then the samples were removed and 
placed on ice. 18 µl PCR product was combined with 2 µl loading buffer and 
loaded on a 1% agarose electrophoresis gel in 1 x TAE buffer, along with a 50 
base pair DNA ladder (New England BioLabs, Hitchin, UK). The gel was run at 110 
volts for 30 min and analysed using a InGenius (Syngene UK, Cambridge, UK) gel 
documentation system with GeneSnap (Syngene) software .  
2.5.3 Quantitative Polymerase Chain Reaction (qPCR) 
For the qPCR reaction, 5 µl cDNA were added to 0.75 µl forward primer, 0.75 µl 
reverse primer, 6 µl nuclease-free H2O and 12.5 µl Brilliant SYBR Green 2X QPCR 
Master Mix (Agilent). PCR conditions were 95°C for 10 min in order to activate 
the DNA polymerase and then 40 cycles of: 95°C for 15 seconds and 58°C for 1 
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minute. A further step of 90°C for 15 seconds, 55°C for 30 seconds and 95°C for 
30 seconds was used to generate a dissociation (melting) curve.  
An MX3000P® Multiplex Quantitative QPCR System (Agilent) was used for all 
reactions and corresponding MxPro software for analysis. Transcripts were 
quantified using the relative standard curve method (Applied Biosystems, 1997). 
Although this method does not permit absolute quantification of the target gene, 
it negates the requirement for the absolute quantity of the standard to already 
be known (as required by an absolute standard curve method) (Agilent 
Technologies, 2009; Applied Biosystems, 1997). It also has advantages over the 
ΔCT relative quantification method, of not requiring the reference 
(housekeeping) gene to uninfluenced by the experimental situation and not 
relying on the amplification efficiencies of reference and target genes to be 
broadly the same (Ginzinger, 2002). A standard (calibrator) was produced by 
pooling cDNA from a large number of samples and this was used as the standard 
for all experiments. 1:1, 1:2, 1:5, 1:10 and 1:20 dilutions of this standard were 
used to produce the standard curve for each target gene. An arbitrary value of 
1000 copies was assigned to the 1:1 standard for all experiments. All reactions 
were run in either duplicate or triplicate. 18S expression was monitored as an 
internal standard on the cDNA template; mRNA expression for each target gene 
was normalised to this internal standard.  
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2.6 Statistical Analyses 
Data were analysed using SPSS Statistics 18.0 (IBM®). Fisher’s exact test was 
used to compare categorical data. Continuous data were analysed for normality 
using Kolmogorov-Smirnov and Shapiro-Wilk tests and homogeneity of variance 
using Levene’s test. Normally distributed data with similar variance between 
groups were compared using an unpaired student t-test. Non-parametric data 
were compared using the Mann-Whitney U test. Statistical significance was 
defined as p<0.05. 
Boxplots were plotted in SPSS using the package’s standard algorithm. The 
median and IQR are displayed as a thick line and box respectively. Values that 
are between one and a half and three box lengths from either end of the box, 
are known as ‘outliers’ and denoted by dots. Values that are more than three 
box lengths from either end of the box are labelled ‘extreme’ values and 
denoted by asterisks.  
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Chapter 3 
 
SERCA REGULATES GENE EXPRESSION AND 
CELL PROLIFERATION IN THE DEVELOPING 
LUNG IN VITRO 
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3.1 Introduction and aims 
SERCA inhibition in the embryonic lung in vitro has been shown to have striking 
effects (discussed in Chapter 1). When rodent lung explants are cultured with 
the specific SERCA inhibitor, cyclopiazonic acid (CPA), there is a dramatic loss of 
branching morphogenesis, pulmonary myogenesis and airway peristalsis (AP) (N. 
Featherstone et al., 2005; N. C. Featherstone et al., 2005; Seidler et al., 1989). 
Furthermore, these effects are: (i) reversible, when CPA is removed from the 
culture medium, branching morphogenesis, myogenesis and AP resume; and (ii) 
dose dependent, with higher doses of CPA resulting in a more marked effect 
(Lansdale, Connell et al., 2010).  
The reversibility of the effect is significant: it implies the abrogation of 
development is not simply due to cellular toxicity from CPA. If CPA treatment 
was profoundly toxic and resulted in extensive necrosis or apoptosis, it could be 
expected that that the lung explant would indeed fail to branch and develop 
normally. However, if this was the case, it is likely the lung explant would 
reduce in size with time, normal architecture would be lost and branching 
morphogenesis would fail to restart on removal of the CPA: this pattern is not 
seen. Since branching morphogenesis and airway peristalsis are complex 
processes, necessitating cell growth, patterning, migration and proliferation, it 
seems reasonable to hypothesise that CPA is having a reversible and specific 
effect on the control of one or more of these. Given the likelihood of changes to 
these fundamental cellular processes, we hypothesised that CPA’s effect on the 
developing lung was mediated by changes in gene expression and / or cell 
proliferation and aimed to determine: 
(i) How is gene expression in the developing lung affected by SERCA inhibition 
with CPA? 
(ii) What are the effects on cell proliferation from SERCA inhibition with CPA? 
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3.2 SERCA regulates gene expression in key 
morphogenic pathways  
3.2.1 Selecting genetic pathway candidates  
Lung organogenesis involves the interplay of a number of biochemical and 
biomechanical factors [reviewed in (Warburton et al., 2010)]. These factors are 
regulated by a complex set of genetic signalling pathways. Much of our 
understanding of these molecular pathways comes from studies using transgenic 
mouse technology, where the effects of gene knock out and over-expression on 
lung organogenesis have been meticulously catalogued (Cardoso & Lu, 2006).  
To assess the effect of SERCA inhibition on these genetic pathways, broadly 
speaking, two approaches could be instigated: (i) a high-dimensional screen of a 
large number of genes, using so called multiplex techniques; or (ii) a candidate 
gene approach, where key pathways are focussed on. Given the dramatic 
changes witnessed upon CPA treatment in the developing lung, and prior to 
embarking on a more costly and less focussed screening approach, we selected a 
candidate approach to ascertain whether any key pathways were affected by 
this treatment. Having observed the abrogation of branching morphogenesis in 
embryonic lung explants, specific elements of the branching programme were 
interrogated. Similarly, because CPA treatment also resulted in a cessation of 
airway smooth muscle (ASM) function, elements of pulmonary myogenesis were 
also assessed: the specific roles of the selected genes are briefly discussed 
below. 
Fibroblast growth factor (FGF) family members have been shown to play a 
conserved role in respiratory organ development from Drosophila to mammals 
(Sutherland et al., 1996). There are 23 subgroups of mammalian FGFs, with 4 
types of cognate, transmembrane protein tyrosine kinase receptors (FGFRs) 
(Ornitz & Itoh, 2001). During development, FGFs are known to play key roles in 
the processes of cell proliferation, migration and differentiation. Within the 
lung, FGF10 is the most well studied member and is expressed in the peripheral 
lung mesenchyme in E11-12 mouse lung (the stage of development studied in our 
culture model) (Bellusci, Grindley et al., 1997). What is more, the pattern of 
FGF10 expression changes dynamically and appears to occur at the site of lung 
bud formation (Bellusci, Grindley et al., 1997). FGF10 signals via adjacent 
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FGFR2IIIb, which is expressed in the distal lung epithelium. This mesenchyme to 
epithelial, FGF10-FGR signalling pathway is critical for lung formation: Fgf10 null 
mutant mice lack lung distal to the trachea, whilst loss of its receptor, Fgfr2IIIb 
also results in severe lung defects (De Moerlooze et al., 2000; Min et al., 1998; 
Sekine et al., 1999). In vitro studies have shown that FGF10 has a chemo-
attractant effect on neighbouring lung bud epithelium, inducing it to proliferate 
and migrate towards the source of FGF10 (Park et al., 1998; Weaver, Dunn, & 
Hogan, 2000). FGF10 also induces differentiation of the growing epithelium 
through its effects on other genes such as Bmp4 and Sp-C (Hyatt, Shangguan, & 
Shannon, 2002). FGF10 is itself regulated by genes such as Sonic Hedgehog (Shh) 
and Sprouty (Spry2), which were also investigated (discussed later).  
The Sprouty (Spry) family, coded for by four genes (Spry1-4) in mammals, are 
key regulators of the size and shape of developing lung buds through their 
control of FGF signalling. Spry2 is expressed in the distal epithelium of the 
embryonic lung and is down regulated in clefts between new lung buds (Mailleux 
et al., 2001). This expression is adjacent to Fgf10 expression in the neighbouring 
mesenchyme and is spatially and temporally dynamic. Induced soon after Fgf10 
expression, Spry2 acts as an Fgf10-dependent inhibitor of Fgfr2b activity, 
limiting the proliferation and migration of lung epithelial cells during branching 
morphogenesis (Mailleux et al., 2001; Tefft et al., 2002). Consistent with these 
observations, decreasing Spry2 activity in vitro results in increased lung 
branching, whilst over-expression severely impairs branching (Mailleux et al., 
2001; Tefft et al., 2002). 
Sonic hedgehog (SHH) signalling plays important roles in embryonic development 
through its regulation of epithelial to mesenchyme interactions (Bitgood & 
McMahon, 1995). SHH in the epithelium, binds to the transmembrane protein, 
Patched 1 (Ptch1) in the adjacent sub-epithelial mesenchyme and results in 
activation of the Gli transcription factors (van Tuyl & Post, 2000). In the lung, 
Shh is expressed at low levels throughout the epithelium, but particularly high 
levels are found at the growing tip (Bellusci, Furuta et al., 1997). Shh null 
mutants display hypoplastic lungs and a failure of the oesophagus and trachea to 
separate (Pepicelli, Lewis, & McMahon, 1998). Shh over-expression in the lung 
results in increased proliferation of the mesenchyme and epithelium, but leads 
to a failure of alveolarisation (Bellusci, Furuta et al., 1997). SHH is proposed to 
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regulate epithelial branching pattern by spatially suppressing Fgf10 in the distal 
mesenchyme and upregulating Fgf7 (Lebeche, Malpel, & Cardoso, 1999; Pepicelli 
et al., 1998). 
FGF9 is another FGF family member that plays an important role in regulating 
branching morphogenesis of the developing lung. FGF9 is expressed in the 
mesothelium (visceral pleura) of the early embryonic lung (again around the 
stage of our culture model) (J. S. Colvin, Feldman, Nadeau, Goldfarb, & Ornitz, 
1999). Fgf9 null mice display lungs with reduced airway branching and 
interestingly, reduced pulmonary mesenchyme (J. S. Colvin, White, Pratt, & 
Ornitz, 2001). This reduction in mesenchyme has a knock-on effect of reducing 
Fgf10 expression. FGF9’s other effects on the mesenchyme include the 
repression of peribronchiolar smooth muscle differentiation and stimulation of 
vascular development in vivo (White et al., 2006).  
Airway smooth muscle (ASM) is evident from early in the pseudoglandular stage 
of development (E11 in the mouse), closely following the emergence of the 
definitive lung bud (Sparrow, Warwick, & Everett, 1995; Tollet, Everett, & 
Sparrow, 2001). Prenatal pulmonary myogenesis is thought to play an intimate 
role in regulating overall organogenesis, both biochemically, through ASM 
progenitor mediated FGF-10 production, and mechanically, through contraction 
and maintenance of tone (Harding & Hooper, 1996; Jesudason, 2009; Mailleux et 
al., 2005). ASM prenatal phasic contractility (airway peristalsis) propels lung 
liquid, distending the distal bud (where growth is centred) and maintains airway 
tone, thus permitting stretch-induced signals that are implicated in lung growth 
(Jesudason et al., 2005; Schittny et al., 2000). Airway peristaltic waves are 
preceded by spontaneous propagating Ca2+ waves in ASM cells and SERCA 
inhibition with CPA abolishes these Ca2+ transients, resulting in airways 
peristalsis being replaced by tonic contraction (N. C. Featherstone et al., 2005). 
It therefore appears that SERCA has a key role in ASM function and this may be 
linked to the effects on morphogenesis seen upon its inhibition with CPA. As a 
result, we chose to test the impact of SERCA inhibition on ASM gene expression 
by assessing levels of the smooth muscle variant of myosin heavy chain (smMHC), 
a gene that has been detected at E10.5 in the mouse lung (Jostarndt-Fogen, 
Djonov, & Draeger, 1998).  
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In addition to the branched network of airways in the lung, efficacious gas 
exchange requires the development of a patterned pulmonary vascular network 
that is intimately related to those airways. Vascular endothelial growth factors 
(VEGFs) regulate vascular development by promoting endothelial cell viability; 
cell proliferation and directing cell motility via their signalling with the tyrosine 
kinase receptors, Flk-1 and Flt-1 (Larrivee & Karsan, 2000). VEGF isoforms are 
expressed from E11.5 in the developing lung epithelium and mesenchyme 
(Greenberg et al., 2002). VEGF mutants display abnormal pulmonary vasculature 
and rats treated with VEGF receptor inhibitors, display a pruned pulmonary 
arterial tree and decreased alveolarisation (Kasahara et al., 2000; Ng, Rohan, 
Sunday, Demello, & D'Amore, 2001). 
3.2.2 Gross morphology of lung explants for assessment 
Before assessing gene expression in CPA-treated lung explants, we first 
reproduced the observation that CPA halts branching morphogenesis in these 
explants as reported by Featherstone et al (Figure 3.1) (N. Featherstone et al., 
2005; N. C. Featherstone et al., 2005). E11.5 murine lung explants were cultured 
on polytetrafluorethylene membranes at the air/fluid interface +/- 20 µM CPA, 
using an established model and photographed at 24 hour intervals up to 78 hours 
(Figure 3.1) (Jesudason et al., 2000). There was an abolishment of epithelial 
branching in the CPA group and this effect occurred soon after commencement 
of culture, given that no branching occurred between 0 and 30 hours. In 
addition, pulmonary mesenchyme was seen to expand in size relative to 
neighbouring epithelium, compared to controls (Figure 3.1). These findings 
therefore reproduce the previously discovered phenotype and confirm the 
samples are appropriate for gene expression analysis. 
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Figure 3.1 Gross morphology of lung explants for assessment  
Photomicrographs of whole E11.5 murine lung primordia in organ culture +/- 20 µM CPA at 0 – 78 
hours. The trachea is seen superiorly. At 78 hours, whole lungs were homogenised for RNA 
extraction or fixed for immunohistochemistry 
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3.2.3 Measuring changes in gene expression in the developing 
embryonic lung using quantitative RT-PCR 
To make a quantitative assessment of gene expression, quantitative RT-PCR 
(qRT-PCR) was used to measure whole lung mRNA levels of candidate genes 
outlined above. Real-time qRT-PCR is a sensitive and reliable method with which 
to quantify mRNA in a sample (Schmittgen et al., 2000). It uses specific 
technology (such as TaqMan® probes or SYBR Green I dyes) to measure PCR 
product accumulation in real-time, through continuous detection of generated 
fluorescence (Heid, Stevens, Livak, & Williams, 1996; Wittwer, Herrmann, Moss, 
& Rasmussen, 1997). In the case of SYBR Green I (the method of choice in this 
thesis), the dye binds to double stranded DNA (dsDNA) with a high affinity 
(compared to single stranded), resulting in approximately 1000-fold increase in 
fluorescence, thus making it a sensitive indicator of dsDNA quantity (Agilent 
Technologies, 2009). During the exponential phase of the PCR reaction, a 
fluorescent signal threshold is determined at which point all samples can be 
compared (Ginzinger, 2002). The number of PCR cycles required to generate this 
fluorescent signal is defined as the cycle threshold (Ct). This Ct value is directly 
proportional to the amount of starting template for the target gene and is the 
basis for calculating mRNA expression levels.  
RNA was extracted from whole lung explants cultured +/- 20 µM CPA, as above. 
Extracted RNA concentration was higher from control explants (Table 3.1). This 
difference was standardised during reverse transcriptase when first-strand cDNA 
synthesis was initiated from a total of 0.2  µg RNA for each sample. The A260/A280 
absorbance ratio for extracted RNA was within the frequently quoted range of 
1.8 - 2.0 (Table 3.1): RNA purity therefore appeared reasonable (Fleige & 
Pfaffl).  
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Table 3.1 Median (IQR) concentration and A260/A280 absorbance ratio of extracted RNA 
 
Condition RNA Conc. (ng/uL) A260/A280 
Control 44.5 (17.9) 2.01 (0.06) 
CPA 18.3 (5.2) 1.84 (0.12) 
 
 
A relative standard curve method of qRT-PCR was used for quantification of the 
initial template (Applied Biosystems, 1997). This relies on high quality standard 
curve production (through accurate serial dilution), but not absolute PCR 
efficiency, thus contrasting with the ΔCt method (Applied Biosystems, 1997; 
Ginzinger, 2002). When reviewing standard curve characteristics, R2 is an 
indicator of quality of fit of the curve; slope is directly related to average 
amplification efficiency.  Here, R2 is >0.989 for all but one target genes, 
indicating good quality of fit and curve accuracy (Table. 3.2).  
Table 3.2 Standard curve characteristics for qRT-PCR experiments 
 
Gene R2 Slope Efficiency (%) 
18S 0.995 3.06 112 
FGF-9 0.998 3.55 91 
FGF-10 0.935 3.03 114 
SHH 0.997 3.92 80 
smMHC 0.999 4.22 73 
SPRY2 0.996 3.29 101 
VEGF 0.989 3.06 112 
 
 
The amplification curves (Figure 3.2) for each experiment were inspected to 
ensure that: (i) the fluorescent threshold was set within the exponential phase 
of the PCR reaction; (ii) the curve continued to rise and the reaction was 
therefore not limited by reagent availability; and (iii) the non-template control 
(NTC) did not show fluorescence (and hence product formation). The 
dissociation (melting) curves (Figure 3.2) were inspected to ensure PCR product 
specificity, as indicated by a single, tall peak at a melting temperature above 
80°C (Agilent Technologies, 2009). These criteria were fulfilled in each case.
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Figure 3.2 Amplification and dissociation curves for qRT-PCR experiments 
Top panel: representative amplification curve for relative quantification of genes of interest. Curves 
indicate the increase in fluorescence with increasing cycle number for each reaction. The horizontal 
line indicates the threshold fluorescence. The point at which the amplification curve intersects the 
horizontal line indicates the cycle threshold (Ct) value. Lower panel: representative dissociation 
(melting) curve produced to confirm specificity of PCR. The first derivative of the fluorescence 
reading multiplied by –1 (–R´(T)) is plotted against temperature to demonstrate the loss in 
fluorescence when double stranded DNA product is melted to single stranded DNA. 
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3.2.4 SERCA inhibition regulates key candidate genes in vitro 
SERCA inhibition with CPA had the effect of up or down regulating mRNA levels 
of target genes, normalised to the reference gene (18S ribosomal RNA) (Figure 
3.3). These effects were consistent across biological replicates, as indicated by 
the relatively small variance of these ratios when compared to effect size (data 
are presented as mean +/- SEM). Normalised Fgf10 mRNA expression was 
significantly lower in lung explants in the CPA group, although this difference 
was relatively modest, being around 3-fold in magnitude (p=0.001). In contrast, 
the other FGF member, Fgf9 was expressed at significantly higher levels in the 
CPA treated group and the size of the difference was greater, approaching 9 fold 
(p=0.006). Normalised Shh mRNA expression was significantly lower in CPA 
treated lungs, following a similar pattern to that of Fgf10, with a fold difference 
of approximately 6 (p=0.001). Similarly, smMHC mRNA was significantly 
downregulated, with a fold change in the order of 9 (p=0.001). Spry2 mRNA 
expression was significantly higher in the CPA treated group, being nearly 10 
times greater (p=0.004). Finally, Vegfa was upregulated in CPA treated lungs, 
with a fold change approaching 7 (p=0.001).  
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Figure 3.3 SERCA inhibition both up and down regulates candidate genes in vitro 
Quantitative RT-PCR of whole cultured embryonic murine lungs (E11.5). Fibroblast-growth-factor-
10 (FGF-10), Fibroblast-growth-factor-9 (FGF-9), Sonic-hedgehog (SHH), smooth-muscle-Myosin-
Heavy-Chain (SM-MHC), Sprouty-2 (SPRY2) and Vascular-endothelial-growth-factor-A (VEGF) 
mRNA expression levels in CPA treated & control lung cultures at 78h. Levels normalised to 18S 
mRNA expression. Error bars indicate +/- SEM. (n≥8 individual embryos in all groups, except for 
FGF-9 and SPRY2 when n≥5). Difference between CPA treated & control groups significant 
(p<0.05) for all genes.  
 
   
 93 
3.3 SERCA inhibition reduces cell proliferation dose-
dependently  
3.3.1 Quantifying mitosis in CPA treated lung explants 
To test the effect of SERCA inhibition on pulmonary cell proliferation in vitro, 
mitotic activity was assessed in CPA and control groups using established 
methods. Embryonic lung explants were cultured +/- differing concentrations of 
CPA (4, 10 and 20 µm), as previously described. Immunohistochemistry of lung 
frozen sections was carried out for Phospho-Histone-H3, serine 10 (PH3). 
Histone-H3 is one of four core histone proteins (H2A, H2B, H3, and H4) that 
undergo various post-translational modifications at their N-termini, as part of 
their structural and functional roles (Hansen, Tse, & Wolffe, 1998). 
Phosphorylation at serine 10 is a specific and highly conserved modification that 
occurs during chromosome condensation, during mitosis (Hendzel et al., 1997). 
PH3 immuno-staining is therefore widely used to detect mitotic cells. 
Once the labelled sections of lung explants had been imaged with confocal 
microscopy, mitotic activity was quantified with nuclear counting (carried out by 
MG Connell). Mitotic nuclei (labelled with anti-PH3 and fluorescent secondary 
antibody) were counted in the pulmonary epithelium and mesenchyme 
independently, as were the other nuclei (labelled with DAPI). Mitotic activity 
was therefore quantified as the percentage of total nuclei that were PH3 
positive, for the epithelium and mesenchyme alike. 
3.3.2 SERCA inhibition with CPA reduces cell proliferation dose-
dependently, in vitro 
SERCA inhibition with CPA reduced levels of pulmonary cell mitosis (Figure 3.4). 
The lowest concentration of CPA (4 µM) was sufficient to induce a significant 
reduction in proliferation compared to controls (0 µM CPA). Reduction in mitosis 
was seen in both the epithelium and the mesenchyme of lung explants. Cell 
proliferation reduced further with higher concentration of CPA (10 µM), but no 
further, significant reduction was witnessed when CPA concentration was raised 
to 20 µM (p<0.05 between all groups, except 10 and 20 µM). These data indicate 
there is a dose dependent reduction in mitosis until a threshold concentration of 
CPA is reached at around 10 µM. Reviewing the separate components of 
epithelium and mesenchyme, there appeared to be a more marked decrease in 
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mesenchymal cell proliferation at the lower dose of 4 µM CPA, when compared 
to the epithelium, where a higher dose was required for such a magnitude of 
effect (Figure 3.4). 
 
 
Figure 3.4 SERCA inhibition with CPA reduces cell proliferation does-dependently, in vitro 
Percentage of PH3+ve nuclei (median & IQR) vs. CPA concentration for epithelial and 
mesenchymal cells (n=>24 in all groups). E11.5 murine lung explants cultured +/- CPA (4, 10 and 
20 µM) for 78 hours. Mitotic cells labelled with Phospho-Histone-H3, serine 10 (PH3) 
immunohistochemistry and expressed as a percentage of total nuclei (labelled with DAPI) in the 
epithelium and mesenchyme separately. Difference between CPA concentration groups statistically 
significant for each cell type (p<0.05), with the exception of 10 and 20 µM. Cell counting performed 
by MG Connell. 
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3.4 Discussion 
3.4.1 SERCA as a regulator of pulmonary gene expression 
These data demonstrate that the reversible loss of branching, airway 
contractility and Smooth Muscle Actin expression that are mediated by CPA 
inhibition of SERCA function are associated with altered gene expression in key 
pathways that regulate airway branching, ASM formation, as well as other 
aspects of lung epithelial and endothelial development (Chapter 1 and Figure 
3.3). Given the importance of these closely regulated genetic pathways in 
dictating normal prenatal development (discussed above), the significant 
disruption in expression levels witnessed upon SERCA inhibition with CPA is likely 
to result in consequent changes to essential developmental processes. Whether 
such changes could explain the striking phenotype remains unclear: given the 
complexity and frequent interdependency of these genetic pathways, this is 
likely to be challenging to deduce experimentally in murine knockout studies. 
The above findings remain important, as the up and down regulation of key 
candidate genes lends further support (in addition to reversibility and dose-
dependency) to the postulate that SERCA plays an important role in pulmonary 
development, rather than CPA simply inducing global toxicity or cellular 
quiescence (Figure 3.3). Together, these observations justify further exploration 
of SERCA’s role in airway development and provide a rationale for investigations 
in this thesis. 
Given the paramount importance of the FGF-FGFR-Sprouty axis in airway 
organogenesis, our observed alterations in this pathway are of particular interest 
(Figure 3.3). Conservation of airway FGF-FGFR-Sprouty signalling from 
Drosophila to mammals allow us, in the rest of the thesis, to define the role of 
SERCA in airway development genetically using Drosophila (with its single SERCA 
gene rather than three in mammals; see also Chapter 1) (Sutherland et al., 
1996).  
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3.4.2 SERCA: a link between Ca2+ driven airway smooth muscle 
(ASM) peristalsis and branching morphogenesis? 
Propagating Ca2+ waves in ASM cells precede waves of airway peristalsis in the 
prenatal lung (discussed in Chapter 1): SERCA inhibition with CPA abolishes these 
transients and results in tonic ASM contraction (N. C. Featherstone et al., 2005). 
A number of roles for these largely unexplained Ca2+ waves have been proposed 
in regulating lung development: (i) a mechanical role, where they drive ASM 
contraction and induce rhythmic stretch of the airway epithelium; and (ii) a 
biochemical role, by triggering epithelial Ca2+-activated chloride release and 
hence lung liquid production (N. C. Featherstone et al., 2005; Jesudason, 2009). 
Prenatal ASM contraction and lung liquid are intimately related: airway 
peristalsis induces lung fluid flux, causing phasic distension and relaxation of the 
growing lung end buds (Jesudason et al., 2005; Schittny et al., 2000). This 
mechanical stretch, along with the maintenance of airway tone by ASM, are 
proposed to induce signals that regulate key morphogenic events (Unbekandt et 
al., 2008; Yang, Beqaj, Kemp, Ariel, & Schuger, 2000). Given ASM peristalsis is 
coupled to branching morphogenesis in vitro, and underpinned by SERCA 
dependent Ca2+ transients, it was important to tease apart, as far as possible, 
the roles SERCA plays in peristalsis and branching (N. C. Featherstone et al., 
2005; Jesudason et al., 2005)? 
Data presented here and from others, demonstrate that SERCA inhibition in the 
lung in vitro, has striking effects on: (i) propagating Ca2+ waves; (ii) myogenic 
gene expression and ASM contraction; (iii) morphogenic gene expression and; (iv) 
branching morphogenesis (N. C. Featherstone et al., 2005; Lansdale, Connell et 
al., 2010). In addition, these effects on airway peristalsis and branching share a 
similar dose-response range. One suggestion is that these phenomena are linked 
by the function of SERCA dependent pulmonary pacemaker cells: SERCA function 
is essential for pacemaker activity in other tissues (Dixon et al., 2011; Jesudason 
et al., 2005; Sanyal, Jennings, Dowse, & Ramaswami, 2006). 
3.4.3 SERCA as a cell cycle regulator 
SERCA also has a role(s) in controlling specific elements of the cell cycle. Cheng 
et al knocked-down SERCA in cell lines, detected slower cell growth and found a 
delay in the transition from G1 to S phase, with SERCA deficient cells less likely 
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to enter DNA synthesis (G. Cheng, Liu, Yu, Diglio, & Kuo, 1996). Similarly, Simon 
et al inhibited SERCA pharmacologically using thapsigargin, and reported cells 
having a prolonged G1 phase (Simon & Moran, 2001). These effects could not be 
recreated by altering cytosolic Ca2+ alone and cells expressing thapsigargin-
resistant SERCA progressed normally through the cell cycle, thus indicating that 
cell cycle effects were SERCA specific. Other studies have reported similar 
effects, finding decreased proliferation and cells reversibly entering a quiescent, 
G0-like state upon SERCA inhibition (Legrand et al., 2001; Waldron, Short, 
Meadows, Ghosh, & Gill, 1994).  
These observations may go some way towards explaining the abrogation of 
branching in the present study. If embryonic lung explant cells were to enter a 
quiescent (G0 like) state upon CPA treatment, then cell proliferation would be 
reduced and it is conceivable that normal branching morphogenesis would halt. 
Indeed, this may also account for the reversibility of the effect on 
morphogenesis. What is not explained by this hypothesis, however, is the 
continued increase in size of the pulmonary mesenchyme relative to the 
epithelium following CPA treatment, indicating there are ongoing changes in cell 
size or number in this tissue. The upregulation of key morphogenic genes, 
discussed earlier, also indicates that all cells were not simply quiescent. In 
addition, studies report contradictory results, with SERCA inhibition actually 
stimulating cell proliferation and overexpression inducing apoptosis, with cell-
cycle arrest in the G2/M phase (Charlesworth & Rozengurt, 1994; Ma, Mann, Lee, 
& Gallinghouse, 1999). It therefore seems likely that effects of SERCA inhibition 
on the cell cycle are complex and may be dependent on the intra and extra-
cellular environment; the in vitro nature of these studies limit the conclusions 
that may be drawn and may also explain the variation in the published findings. 
To determine this matter, we undertake in vivo investigation of SERCA’s role in 
airway cell proliferation in Chapter 7.  
3.4.4 Limits of pharmacological SERCA manipulation 
The principal limitation of the murine system here is the reliance on CPA as a 
specific SERCA inhibitor (Seidler et al., 1989). It is widely known that 
pharmacological agents may induce off-target effects and these may be occult 
(MacDonald et al., 2006). CPA is reported to inhibit the SERCA Ca2+-ATPase pump 
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specifically rather than other ATPases: the diverse phenotypes induced by CPA in 
species ranging from rats to pigs indicate either SERCA has pleiotropic, 
fundamental roles in cell signalling and / or that CPA may harbour off-target 
effects yet to be identified (Cullen, Wilson, Hagler, Ort, & Cole, 1988; Lomax, 
Cole, & Dorner, 1984; Purchase, 1971).  
Genetic models would provide some reassurance about the effects seen with 
CPA. However, mammals have three SERCA paralogues (ATP2A 1-3) each of 
which may produce numerous mRNAs by alternative splicing: complete SERCA 
knockout in a mammalian system would therefore be challenging (Wuytack et 
al., 2002). This task is compounded by the essential developmental requirement 
for SERCA1&2 (SERCA2-null mice are non-viable, SERCA1-null die as newborns): a 
tissue specific and / or conditional mutagenesis approach would be required 
with attention to the problems of redundancy too (Pan et al., 2003; Periasamy 
et al., 1999). As a simple and elegant alternative, we have studied genetic 
manipulation of SERCA during Drosophila airway development. 
3.4.5 Genetic inhibition of airway epithelial SERCA in vivo 
Invertebrates including Caenorhabditis elegans and Drosophila melanogaster 
have one SERCA gene, permitting simpler genetic manipulation than for 
vertebrates (Cho, Bandyopadhyay, Lee, Park, & Ahnn, 2000; Magyar, Bakos, & 
Varadi, 1995). Drosophila affords powerful tools to control gene expression 
spatially and temporally during respiratory organogenesis, with well-
characterised genetic homology to mammals (discussed in Chapters 1, 4 and 7) 
(Sean E. McGuire, Roman, & Davis, 2004; Metzger & Krasnow, 1999). 
3.4.6 SERCA Phylogeny 
FlyBase (available at http://flybase.org) reports the Drosophila SERCA gene, Ca-
P60A to have eight different mRNAs (A-H) from alternative splicing: when the 
predicted translations are aligned, isoforms B–H have identical protein sequences 
(Appendix I) (Tweedie et al., 2009). It therefore appears Drosophila has two 
protein isoforms (A with 1002 residues and B with 1020), differing only at the 
final 27 residues (9 of the short isoform) at the C terminus. Multiple protein 
sequence alignments were undertaken between various paralogues and splice 
variants of SERCA, in principal model organisms and humans (Appendix I)
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proteins are highly conserved across species, from Drosophila to humans: 
differences in amino acid sequence are few and largely grouped at the C 
terminus. This high conservation between species of protein sequence, and 
hence also protein function, indicates that findings from Drosophila are likely to 
be directly applicable to mammals. 
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3.5 Other potential future directions 
The data presented do not provide a proven mechanism linking CPA’s effects on 
gene expression, cell proliferation, pulmonary morphogenesis and ASM 
contractility: reviewing the data with existing literature provides hypotheses for 
future testing.  
Pulmonary development relies on signalling between lung mesothelium, 
mesenchyme and epithelium: given SERCA modulates receptor-mediated Ca2+ 
signals in the pancreas and arterial endothelium, it is plausible that SERCA 
inhibition dysregulates interactions between these pulmonary compartments too 
(Arredouani et al., 2002; Lynne H. Liu et al., 1997; Warburton et al., 2010; 
Zhao, Shin, Liu, Shull, & Muallem, 2001)? This could underpin parallel changes in 
gene expression across these histological compartments, e.g. (i) mesothelial 
Fgf9 positively regulates mesenchymal Vegf: both were upregulated here; and 
(ii) epithelial Spry2, upregulated here, is a key inducible repressor of 
mesenchymal Fgf10, appropriately downregulated here (Figure 3.3).  
Another explanation for CPA’s widespread effects is SERCA’s role in protein 
chaperoning/trafficking. The endoplasmic reticulum (ER), a site of protein 
synthesis, post-translational modification and folding, is highly sensitive to 
changes in Ca2+ homeostasis: the SERCA inhibitor, thapsigargin is well known to 
induce ER stress (Ellgaard, Molinari, & Helenius, 1999; R. V. Rao et al., 2001). In 
the interest of protein quality control, ER stress results in an accumulation of 
unfolded proteins, triggering the coordinated unfolded protein response (UPR) 
(Kaufman, 1999; Rutkowski & Kaufman, 2004; Stirling, Lundin, & Leroux, 2003). 
The effect of the UPR is to decrease the burden of proteins in the ER, by 
reducing translation and increasing protein efflux (e.g. by facilitating their 
folding through increased chaperone protein synthesis). SERCA is 
transcriptionally upregulated in ER stress and UPR, and this increase is 
independent of ER Ca2+ depletion (Caspersen, Pedersen, & Treiman, 2000; 
Hojmann Larsen, Frandsen, & Treiman, 2001). SERCA may therefore have a role 
in regulating post-translational events such as chaperoning and in keeping with 
this, it has an essential role in trafficking of several proteins, including notch, in 
Drosophila (Periz & Fortini, 1999). Whether through these or other mechanisms, 
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SERCA appears critical for development since is it is highly conserved, widely 
expressed and essential for viability (as shown by SERCA2-null mice) (Periasamy 
et al., 1999; Wuytack et al., 2002). 
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Chapter 4 
 
TECHNIQUES TO STUDY THE EFFECTS OF 
SERCA INHIBITION ON THE DROSOPHILA 
RESPIRATORY ORGAN 
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4.1 Introduction 
The development of the Drosophila respiratory organ can be broadly divided into 
3 stages: (i) in the embryonic period, a network of tubes develops from 10 pairs 
of tracheal sacs (each composed of approximately 80 cells), initially formed 
from the invagination of epidermal epithelial cells: development of this 
complex, highly stereotyped structure is entirely controlled by genetically 
determined branching and tube expansion events; (ii) at the end of 
embryogenesis and through much of the larval period, respiratory tubes grow 
and subdivide into finer, more random, often terminal branches in response to 
oxygen demands of target tissues; (iii) during metamorphosis, clusters of 
imaginal and ‘de-differentiated’ larval tracheoblasts proliferate and spread, 
replacing the larval tracheal epithelium and reconfiguring most branches (Guha, 
Lin, & Kornberg, 2008; Manning & Krasnow, 1993; Sato, Kitada, & Tabata, 2008; 
Weaver & Krasnow, 2008). Most early studies that set out to elucidate the 
genetic programming of these events focussed on the first stage, since 
embryonic tracheal morphogenesis is highly stereotyped (Affolter et al., 1994; 
Glazer & Shilo, 1991; Samakovlis, Hacohen et al., 1996). More recently, progress 
has been made in determining the mechanisms behind later events, in larvae 
and pupae (Cabernard & Affolter, 2005; Pitsouli & Perrimon, 2010; Sato & 
Kornberg, 2002). In all cases, the study of trachea and its derivatives is 
dependent on an accurate demonstration of its structure. Non-gas-filled viscera 
are not readily visualised with light microscopy and hence investigators have 
used a variety of experimental techniques with which to demonstrate the 
tracheal system: antibodies (e.g. to tracheal lumenal proteins, such as 2A12), 
enhancer traps (e.g. trachealess-lacZ) and fluorescent proteins (e.g. actin.GFP 
or moesin.mRFP) (Lin, Buff, Perrimon, & Michelson, 1999; Manning & Krasnow, 
1993; Ribeiro, Ebner, & Affolter, 2002; Samakovlis, Hacohen et al., 1996). 
Fluorescent fusion proteins have been targeted to the trachea by cloning them 
downstream of a breathless promoter or using the GAL4-UAS system (discussed 
later) (Brand & Perrimon, 1993; Ribeiro, Neumann, & Affolter, 2004).  
In addition to the advances in imaging techniques that have permitted improved 
demonstration of structure, developmental biology has benefitted from the 
development of functional assays that allow dynamic processes to be studied. 
Examples of such include, live imaging (from single cells to whole organisms), 
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cell markers to allow lineage and fate analysis (e.g. using GFP, luciferase or 
nanoparticles) and molecular reporters (e.g. genetically encoded Ca2+ indicators) 
(Kircher, Gambhir, & Grimm, 2011; Lippincott-Schwartz & Patterson, 2003; 
Miyawaki et al., 1997). Ca2+ signalling is essential to a vast array of biological 
processes and its study depends on the ability to monitor Ca2+ dynamics: resting 
intracellular free Ca2+ is highly heterogeneous yet changes in concentration are 
key to signalling function (Berridge et al., 2000; Rudolf, Mongillo, Rizzuto, & 
Pozzan, 2003). Sensors that accurately demonstrate spatiotemporal changes in 
Ca2+ are therefore useful. SERCA is a key regulator of intracellular Ca2+; 
understanding its role in airway development would therefore benefit from an 
ability to study airway Ca2+ dynamics in vivo.  
To investigate the effect of SERCA modulation on Drosophila airway, I first 
tested existing research tools to confirm and optimise their efficacy and explore 
new and relevant applications for them. 
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4.2 Testing GAL4 drivers in the embryo 
The GAL4–upstream activating sequences (UAS) system is the most widely used 
system with which to spatially restrict ectopic gene expression in Drosophila 
(Figure 4.1) (Brand & Perrimon, 1993). This system has two elements: the GAL4 
gene, encoding the yeast transcription activator protein Gal4, and UAS - a short 
section of the promoter region, to which, Gal4 specifically binds to activate 
gene transcription. A P element, carrying GAL4 is randomly inserted throughout 
the Drosophila genome, bringing GAL4 expression under the control of a range of 
endogenous, tissue-specific genomic enhancers. Alternatively, the specific 
promoter can be cloned upstream of GAL4 in the P element construct. In order 
to create GAL4-responsive target transgenes, they are cloned downstream of a 
UAS sequence. Target genes are hence expressed in the same tissue-specific 
pattern as the GAL4 activator.  
This study relied upon GAL4 drivers to activate gene transcription of a host of 
transgenes (including fluorescent proteins, RNAi constructs and Ca2+ indicators) 
in specific tissues, at specific stages of embryonic development.  Experimental 
design necessitated expression: (i) ubiquitously, throughout the embryo; (ii) in 
tracheal cells specifically; and, (iii) in cells acting as a source of the FGF 
branching morphogen, branchless. Critically, expression of these transgenes was 
required to be active at the start of tracheal branching (stage 11) and at the 
stage of phenotypic assessment (stage 16).  
Three GAL4 lines were selected for this purpose: daughterless-GAL4 (da-GAL4), 
breathless-GAL4 (btl-GAL4) and branchless-GAL4 (bnl-GAL4). To confirm the 
pattern of expression, these lines were crossed to UAS-histone.YFP, which 
encodes a fusion between histone H3 and Yellow Fluorescent Protein (YFP), 
facilitating rapid visualisation in either fixed samples or by live imaging. 
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Figure 4.1 The GAL4–UAS system is used to spatially restrict ectopic gene expression 
The yeast transcriptional activator Gal4 can be used to regulate gene expression in Drosophila by 
inserting the upstream activating sequence (UAS) to which it binds next to a gene of interest (gene 
X). Large libraries of flies expressing GAL4 in an array of cell-type and tissue-specific patterns are 
available. Expression of the gene of interest (gene X) can be driven in any of these patterns by 
crossing the appropriate GAL4 line to flies that carry the UAS–gene X transgene. Image adapted 
from St Johnston D et al. The art and design of genetic screens: Drosophila melanogaster. Nature 
Reviews Genetics 2002; 3: 176-188. 
This text box is where the unabridged thesis included the following third 
party copyrighted material: 
 
St Johnston D et al. (2002). The art and design of genetic screens: 
Drosophila melanogaster. Nature Reviews Genetics, 3, 176-188. 
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4.2.1 Daughterless-GAL4 drives transgene expression in most 
tissues at stage 11 and throughout the embryo at stage 16 
The da-GAL4 driver was crossed to UAS-histone.YFP and live embryos were 
imaged at stages 11 and 16 (Figure 4.2). At stage 11, YFP expression was present 
in most somatic tissues, in an almost identical distribution to daughterless 
protein distribution at this stage (Vaessin, Brand, Jan, & Jan, 1994). At stage 16, 
there was homogenous YFP expression throughout the embryo. These findings 
confirm the da-GAL4 driver can be used to drive ubiquitous transgene 
expression. 
 
 
Figure 4.2 Daughterless-GAL4 drives transgene expression in most tissues at stage 11 and 
throughout the embryo at stage 16 
Confocal micrographs of stage 11 and stage 16 Drosophila embryos expressing the histone.YFP 
fusion protein under the control of the da-GAL4 driver. 3D projections of z-stacks of the YFP 
channel are provided (upper panels), along with the transmitted light image (lower panels). The 
lateral aspect of the embryo is shown in each case (anterior to the left). Embryos are approximately 
500 µm in antero-posterior length. 
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4.2.2 Breathless-GAL4 drives transgene expression in tracheal 
and midline precursor cells. 
The btl-GAL4 driver was crossed to UAS-histone.YFP and embryos imaged at both 
stages 11 and 16 (Figure 4.3). At stage 11, histone.YFP was expressed in the cells 
of the 10 metameric tracheal pits and also in a strip along the ventral midline, in 
cells known as midline precursors (MLP): this conforms with the distribution of 
breathless mRNA and protein reported at this stage (Glazer & Shilo, 1991). 
Later, YFP was expressed throughout the tracheal system, in major branches 
(the dorsal and lateral trunks, the dorsal, visceral and ganglionic branches, the 
transverse connective and dorsal anastomosis) as well as in specialised branches 
in the first and tenth metameres (Manning & Krasnow, 1993). Hence the btl-
GAL4 driver is suitable for driving transgene expression in tracheal cells. 
However, expression will also occur in glial and neural MLP cells: phenotypic 
effects of btl-GAL4 mediated transgene expression must be interpreted with this 
caveat. 
4.2.3 Branchless-GAL4 driven transgene expression in the 
embryo is not in-keeping with reported branchless mRNA 
expression  
The bnl-GAL4 driver was crossed to UAS-histone.YFP and embryos imaged at 
both stages 11 and 16 (Figure 4.4).  At stage 11, histone.YFP expression is largely 
limited to two central areas in the embryo. The distribution of these areas 
implies they are likely to be the anterior and posterior midgut rudiments but 
may also include parts of the foregut and hindgut mesoderm. At this stage, 
branchless mRNA expression is known to surround the developing tracheal 
system: it would be expected that bnl-GAL4 driven histone.YFP expression would 
be found in 10 metameric patches, around the tracheal pits (Sutherland et al., 
1996). At stage 16, a more widespread, segmental distribution of YFP can be 
seen, with an abundance of signal anteriorly in the embryo. Again, this does not 
appear to correlate with reported branchless mRNA expression that follows the 
pattern of tracheal branches, concentrated more posteriorly than anteriorly in 
the embryo (Sutherland et al., 1996). The commercially available bnl-GAL4 
driver tested in these experiments therefore, does not appear to drive transgene 
expression in branchless expressing cells. 
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Figure 4.3 Breathless-GAL4 drives transgene expression in tracheal and midline precursor 
cells. 
Confocal micrographs of stage 11 and stage 16 Drosophila embryos expressing the histone.YFP 
fusion protein under the control of the btl-GAL4 driver. 3D projections of z-stacks of the YFP 
channel are provided (upper panels) and merged with the transmitted light image (lower panels). 
The lateral and dorsal aspects of the embryo are shown in each case (anterior to the left). Embryos 
are approximately 500 µm in antero-posterior length. 
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Figure 4.4 Branchless-GAL4 driven transgene expression in the embryo is not in keeping 
with reported branchless mRNA expression  
Confocal micrographs of stage 11 and stage 16 Drosophila embryos expressing the histone.YFP 
fusion protein under the control of the bnl-GAL4 driver. 3D projections of z-stacks of the YFP 
channel are provided (upper panels), along with the transmitted light image (lower panels). The 
lateral aspect of the embryo is shown in each case (anterior to the left). Embryos are approximately 
500 µm in antero-posterior length. 
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4.3 Techniques for imaging development of the tracheal                                         
system and embryo 
4.3.1 Live imaging of embryonic development may alter timing of 
events 
Embryos expressing histone.YFP under the control of da-GAL4, were prepared by 
adapting Mavrakis et al’s protocol (Mavrakis, Rikhy, Lilly, & Lippincott-Schwartz, 
2008). Live embryos underwent time-lapse confocal microscopy for up to 13 
hours (Figure 4.5). This system did not grossly interfere with morphological 
development since expected transitions were observed. However their timing 
proceeded faster than expected: stage 6 of embryogenesis begins around 3 h 
after egg lay (AEL) and at 25°C, stage 16 supervenes no sooner than 10 h later 
(Bownes, 1975; Campos-Ortega & Hartenstein, 1985). However, embryos imaged 
from early stage 6 (Figure 4.5) took only 8.5 h to reach stage 16.1 (as confirmed 
by the characteristic gut morphology of four parallel, divided segments). Thus 
live imaging protocols can successfully reproduce aspects of morphological 
development but whilst also altering the rate at which these events occur. 
4.3.2 Live imaging protocols allow real time study of developing 
trachea 
Embryos expressing histone.YFP under the control of btl-GAL4 underwent time 
lapse confocal microscopy from stage 12 to stage 17 (Figure 4.6). Appropriate 
tracheal morphogenesis occurred as development proceeded from stage 12 to 
16.1 in only 240 minutes (Figure 4.6), compared to the 300–420 min expected at 
25°C (Bownes, 1975; Campos-Ortega & Hartenstein, 1985). Again live imaging 
protocols can therefore provide morphological fidelity at the expense of the 
temporal. 
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Figure 4.5 Live imaging protocols can be applied to study embryonic development in real 
time, but rates of development may be altered 
Frames from a movie produced by live confocal imaging of a single embryo expressing the 
histone.YFP fusion protein under the control of the da-GAL4 driver. 3D projections of the YFP 
channel (top panels) and transmitted light image (lower panels). Time from the start of imaging is 
indicated in minutes. The lateral aspect of the embryo is shown in all cases (anterior to the left). 
The embryo is approximately 500 µm in antero-posterior length.  
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Figure 4.5 Continued 
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Figure 4.6 Live imaging protocols can be applied to study the developing tracheal system in 
real time 
Frames from a movie produced by live confocal imaging of a single embryo expressing the 
histone.YFP fusion protein under the control of the btl-GAL4 driver. 3D projections of the YFP 
channel (top panels) and transmitted light image (lower panels). Time from the start of imaging is 
indicated in minutes. The lateral aspect of the embryo is shown in all cases (anterior to the left). 
The embryo is approximately 500 µm in antero-posterior length.  
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4.3.3 Fluorescent proteins afford earlier dynamic imaging of 
embryonic trachea while antibody staining offers better 
spatial resolution and reproducibility 
To test which method of tracheal labelling would best fulfil our different 
requirements, fluorescent proteins targeted to the tracheal system were 
compared to antibody staining. Embryos expressing actin.GFP under the control 
of btl-GAL4 were compared to ones stained with an antibody to the lumenal 
protein, 2A12 (DSHB, Iowa) and a fluorescent secondary antibody (Manning & 
Krasnow, 1993). Confocal imaging was performed at stages of embryo 
development ranging from 11–16. The tracheal system of embryos labelled with 
btl-GAL4, UAS-actin.GFP could be imaged from stage 11, whereas the earliest 
stage of development that could be demonstrated with the antibody was stage 
14 (Figure 4.7). Antibody staining offered greater spatial definition of finer 
tracheal branches (such as the ganglionic, spiracular and lateral branches) at 
stage 16, by which time most embryonic branching events are completed (Figure 
4.7) (Manning & Krasnow, 1993). As demonstrated above, targeted fluorescent 
proteins offer the possibility of dynamic imaging in live embryos, but we found 
staining of the trachea in fixed embryos to be more reproducible and consistent. 
In view of this increased spatial resolution and reproducibility, antibody staining 
was the method of choice for much of this study. 
   
 116 
 
Figure 4.7 Fluorescent proteins offer earlier and dynamic imaging of the embryonic tracheal 
system; antibody staining offers better spatial resolution and reproducibility 
Confocal micrographs (3D projections of z-stacks) of fixed Drosophila embryos at the earliest stage 
that the tracheal system can be imaged with each technique (left panels) and later in 
embryogenesis (right panels). The tracheal system is labelled with Btl-GAL4, UAS-act5c.GFP 
(upper panels) or the 2A12 antibody (lower panels, DSHB, University of Iowa). The lateral aspect of 
the embryo is shown in each case (anterior to the left). Scale bar indicates 100 µm. 
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4.3.4 Fluorescent proteins can be recombined to dual label the 
tracheal system  
To enhance methods for investigating tracheal anatomy, both in embryos and 
late L3 larvae, Drosophila lines with dual labelled tracheal cells /tracheoblasts 
were developed. Fluorescent fusion proteins and the btl-GAL4 driver were 
recombined on the second chromosome, using the crossing scheme given in 
Figure 4.8. Meiotic recombination in female Drosophila was exploited to 
combine the heterozygously carried transgenes (present on homologous second 
chromosomes), onto one chromosome. Individual male recombinants were 
selected based on fluorescence of larvae. Crossing these male recombinants to a 
second chromosome balancer made stable stocks. Using similar approaches, 
stocks of flies were generated that expressed either actin.GFP and DsRedNLS, or 
actin.mRFP and histone.YFP under the control of btl-GAL4. Tracheal cells and 
tracheoblasts therefore had both the nucleus and actin cytoskeleton labelled 
with contrasting red and green fluorescent proteins. (Figure 4.9) These two lines 
offered individual benefits: actin.GFP is significantly brighter than actin.mRFP 
and provided better spatial resolution with which to demonstrate tissue 
architecture; histone.YFP can be used to label nuclei in the embryo (as 
demonstrated above in Figures 4.2 - 4.6), whereas the slow maturation kinetics 
of DsRed make it unsuitable for use in Drosophila embryos (Akimoto, Wada, & 
Hayashi, 2005; Campbell et al., 2002). In addition to making use of these dual-
labelled lines in this study, they have been distributed to other laboratories to 
aid their investigations. 
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Figure 4.8 Genetic crossing scheme demonstrating the recombination of fluorescent 
proteins and btl-GAL4 on the 2nd chromosome,  
Meiotic recombination in females was exploited to combine the heterozygously carried transgenes 
(present on homologous second chromosomes), onto one chromosome. Individual male 
recombinants were selected based on fluorescence. Stable stocks were then made, by crossing 
these male recombinants to a second chromosome balancer. A similar scheme was used combine 
actin.GFP, DsRedNLS and btl-GAL4 on the second chromosome. 
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Figure 4.9 Fluorescent proteins can be recombined to dual label the tracheal system 
Confocal micrographs of the wing disc air sac and associated trachea, from late third instar 
Drosophila larvae. Stocks expressing two fluorescent proteins and the btl-GAL4 driver were used 
as indicated. 3D projections were created from z-stacks taken through the air sac. Scale bar 
represents 50 µm. 
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4.4 Calcium imaging in embryonic trachea in-vivo 
Quantitative assessment of Ca2+ dynamics in living cells traditionally relied upon 
synthetic fluorescent chelators (known as Ca2+ indicators, probes, dyes or 
sensors), applied by intracellular injection or as AM-esters (Tsien, 1980, 1981).  
Advantages of the most recent versions of these indicators are a high sensitivity 
and dynamic range, as well as rapid response kinetics to changes in Ca2+ 
concentration (Palmer & Tsien, 2006; Rudolf et al., 2003). Disadvantages include 
an inability to localise these indicators to specific living cells or tissues, leakage 
of the dye from cells with time and Ca2+ buffering, due to the innate property of 
the dye as a chelator. Genetically encoded Ca2+ indicators (GECIs) offer solutions 
to some of these problems and provide powerful means with which to study Ca2+ 
dynamics in defined regions (from biochemically defined sub-cellular locations to 
tissue specific expression in whole organisms) and over prolonged time-courses 
(Miyawaki et al., 1997; Romoser, Hinkle, & Persechini, 1997).  
GECIs can be broadly divided into two classes, dependent on whether they are 
based upon: (i) a single fluorescent protein (e.g. G-CaMPs, camgaroos or 
pericams), where Ca2+ responsive elements, such as calmodulin, are inserted to 
regulate the protonation state of the chromophore; or, (ii) double fluorescent 
proteins (e.g. cameleons or TN-XL) where Ca2+ responsive elements, such as 
calmodulin or troponin alter the efficiency of fluorescence resonance energy 
transfer (FRET) between the two fluorescent proteins (Baird, Zacharias, & Tsien, 
1999; Mank et al., 2006; Miyawaki et al., 1997; Nagai, Sawano, Eun Sun, & 
Miyawaki, 2001; Nakai, Ohkura, & Imoto, 2001; Palmer & Tsien, 2006). FRET is a 
process in which energy is transferred non-radiatively from an excited ‘donor’ 
fluorophore, to another ‘acceptor’ chromophore. Since FRET efficiency is 
dependent on the inverse-sixth-power of the distance between the donor and 
acceptor, and this distance is dependent on the molecular conformation of the 
FRET construct, FRET efficiency can be used to signal changes in conformation of 
a molecule (Förster, 1965; Ha et al., 1996). In FRET GECIs, the binding of Ca2+ to 
a Ca2+ sensitive component (e.g calmodulin), induces a conformational change 
and hence a change in FRET: FRET efficiency is therefore directly related to Ca2+ 
concentration (Figure 4.10) (Miyawaki et al., 1997). 
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GECIs have been used extensively in neuroscience research in species ranging 
from C. elegans to mice: they have permitted novel in-vivo quantitative 
assessment of Ca2+ transients (Hasan et al., 2004; Kerr et al., 2000). In 
Drosophila, a range of GECIs has been targeted to neurons in adults and larvae, 
using the GAL4-UAS system and successfully used for in-vivo assessment (Brand & 
Perrimon, 1993; Fiala et al., 2002; L. Liu, Yermolaieva, Johnson, Abboud, & 
Welsh, 2003; Reiff et al., 2005; Reiff, Thiel, & Schuster, 2002; J. W. Wang, 
Wong, Flores, Vosshall, & Axel, 2003).  Cameleon 2.1, an improved, FRET based 
GECI, has the benefits of being a ratiometric indicator. It has been successfully 
exploited in Drosophila adults and larvae and is available commercially, under 
UAS control (Figure 4.10) (Diegelmann, Fiala, Leibold, Spall, & Buchner, 2002; 
Fiala et al., 2002; L. Liu et al., 2003; Miyawaki, Griesbeck, Heim, & Tsien, 
1999). Although the cAMP FRET-based reporter, GFP-PKA, has been imaged in 
Drosophila embryos, FRET efficiency was not demonstrated, nor measured: I am 
unable to find any reports of FRET measurement in Drosophila embryos, nor 
reports of cameleon 2.1 expression at this stage (Lissandron et al., 2007).    
In view of the exciting potential of GECIs in the in-vivo study of SERCA, I aimed 
to test: (i) the feasibility of expressing cameleon 2.1 in embryonic trachea and, 
(ii) whether or not FRET occurred in the trachea. Having done this, I proceeded 
to investigate the dynamic range of the construct in conditions of extreme Ca2+ 
concentration, in order to explore its potential usefulness in our investigations. 
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Figure 4.10 Schematic illustration of the cameleon 2.1 FRET construct 
Illustration taken from Diegelmann et al, 2002. Cameleon 2.1 consists of ECFP and EYFP 
molecules fused to calmodulin and the calmodulin target peptide M13. When Ca2+ ions bind, there 
is a conformational change in the protein: this can be detected by a change in emission ratio of 
535/485 nm upon ECFP excitation at 440 nm, due to FRET from ECFP to EYFP. 
This text box is where the unabridged thesis included the following third 
party copyrighted material: 
 
Diegelmann S et al. (2002). Transgenic flies expressing the fluorescence 
calcium sensor Cameleon 2.1 under UAS control. Genesis, 34(1-2), 95-98. 
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4.4.1 The cameleon 2.1 FRET construct can be expressed and 
imaged in the Drosophila embryonic trachea 
Flies carrying UAS-Cameleon2.1 were crossed to those carrying btl-GAL4 in order 
to express cameleon in breathless-expressing tracheal cells. Embryos were 
prepared for live imaging as previously described (Mavrakis et al., 2008). 
Spectral scanning confocal microscopy was used to demonstrate the expression 
of cameleon 2.1 in tracheal cells (Figure 4.11). When a region of interest (ROI) 
was defined within the tracheal system, two emission peaks were evident at 
wavelengths of around 485 nm and 530 nm, approximately equal to the 
wavelengths of maximal emission of the two fluorescent proteins in cameleon 
2.1 (CFP and YFP) (Miyawaki et al., 1999). These findings demonstrate that 
cameleon can be successfully expressed and imaged in the embryonic trachea 
and suggest FRET occurrence between the two fluorophores. Further evidence is 
required in order to confirm ‘true’ FRET taking place. 
4.4.2 FRET occurrence in the cameleon expressing trachea is 
confirmed by acceptor photobleaching  
Reliable analysis of FRET is complicated by factors such as: (i) bleed-through in 
excitation, when a donor is excited by the acceptor's excitation wavelength and 
vice versa; and (ii) cross talk in emission detection, when the emission of a 
donor also contributes to the signal measured in acceptor detection, and vice 
versa (Berney & Danuser, 2003; Gordon, Berry, Liang, Levine, & Herman, 1998). 
Acceptor photobleaching helps to eliminate some of the difficulties in FRET 
analysis and therefore offers benefits over the simple approach of measuring 
acceptor emission upon donor excitation: its principle is that energy transfer is 
eliminated upon bleaching of the acceptor, with a consequent increase in donor 
fluorescence (so called donor recovery). 
Acceptor photobleaching of YFP was carried out in an ROI of the trachea 
expressing cameleon 2.1, using spectral scanning confocal microscopy and a 
single laser (Karpova et al., 2003). Changes in emission at 488 and 537 nm 
(captured using specific detectors) were seen in the bleach ROI, with pixel 
intensity markedly reducing at 537 nm but appearing to increase slightly at 488 
nm (Figure 4.12). Mean emission intensities were extracted from the spectra for 
two wavelength ranges (473-493 nm and 522-541 nm, corresponding to CFP and 
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YFP respectively), at the bleached ROI and in a second, internal control 
(unbleached) ROI. In the bleached ROI, the intensity of YFP emission 
dramatically dropped upon bleaching and there was an accompanying, small 
increase in CFP emission, rising from a mean intensity of 147.9, before the 
bleach, to 164.1 after it (Figure 4.12). The FRET energy transfer efficiency, 
expressed as a percentage, can be calculated at 9.9% using the equation 
(efficiency = change in CFP intensity x 100/CFP intensity after bleach) published 
by Karpova et al: this value is in-keeping with published results (Karpova et al., 
2003). This FRET efficiency is a quantification of the amount of FRET taking 
place, however, caution must be exercised in interpreting the significance of any 
absolute quantification here. It has been recognised that in experiments such as 
this, the use of negative controls is critical, since ‘pseudo’ or ‘false’ FRET has 
been clearly demonstrated to occur in both non-bleached regions and in 
bleached regions of non-FRET constructs (Karpova et al., 2003). In the control 
(unbleached) ROI, YFP emission stayed static during the bleaching process, as 
expected, but interestingly, CFP emission did appear to increase slightly (Figure 
4.12). Mean CFP intensity for the control ROI rose from 125.7 to 132.2 during the 
time course of the bleaching process. This demonstrates occurrence of a largely 
unexplained phenomenon, so-called ‘pseudo FRET,’ in the control ROI, with a 
calculated efficiency of 4.9%. The FRET efficiency in the bleached ROI was 
significantly greater than in the control ROI (9.9 vs. 4.9%) and therefore, using 
published guidance, it is reasonable to conclude that true FRET is occurring in 
the cameleon expressing tracheal cells (Karpova et al., 2003). These data 
highlight the significant difficulties in accurately quantifying ‘true’ FRET.  
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Figure 4.11 The cameleon 2.1 FRET construct can be expressed and imaged in the 
Drosophila embryonic tracheal system 
Top panels: confocal micrographs of stage 15/16 embryos (lateral and dorsal views) expressing 
Cameleon2.1 under the control of btl-GAL4. Microscopy used spectral scanning and images are 
pseudo-coloured by lambda coding using Zen 2010 software (Zeiss).  
Lower panel: Emission spectrum for the region of interest (ROI) illustrated in red on the top left 
panel. Mean intensity for the ROI vs. emission wavelength (nm). 2 peaks of emission are seen, 
corresponding to those wavelengths of CFP at 488 nm at its peak and YFP at 530 nm. 
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Figure 4.12 FRET occurrence in tracheal cameleon is confirmed by acceptor photobleaching  
Confocal spectral scanning micrographs of stage 15/16 Drosophila embryo. Top 4 panels show 
emissions at 488 nm and 537 nm (closest detectors to maximal CFP / YFP emission) before and 
after acceptor photobleaching (red outline demonstrates bleach region). Lambda coded images 
demonstrate a region of interest (ROI) within the bleach region (A, yellow) and internal control ROI 
(B, magenta) The mean emission intensity from these ROIs, between the ranges of 473-493 nm 
(CFP) and 522-541 nm (YFP) over time, are shown in the graphs in the lower panels. 
   
 127 
4.4.3 Cameleon 2.1 in embryonic Drosophila cells responds to 
changes in calcium concentration, but dynamic range is 
narrow 
To determine how FRET from cameleon 2.1 is affected by changes in Ca2+ 
concentration in Drosophila embryos, cells expressing this construct were 
exposed to very high and low Ca2+ concentrations. The vitelline membrane 
precludes in-vivo ‘calibration’ since it impedes passage of Ca2+ and EGTA into 
intact Drosophila embryos. Therefore, embryonic cells were instead dissociated 
in culture conditions, from embryos expressing cameleon 2.1 ubiquitously under 
the da-GAL4 driver. These cells underwent spectral scanning confocal 
microscopy with 10 mM CaCl2 and 10 µM ionomycin, or 5 mM EGTA and 10 µM 
ionomycin, in order to submit them to high and low extremes of Ca2+ 
concentration respectively (Palmer & Tsien, 2006).  
Changes in Ca2+ concentration resulted in a change in the cameleon emission 
spectrum in embryonic cells (Figure 4.13). As concentrations of Ca2+ increased, 
the maximum intensity of the lower wavelength peak (around 480 nm) decreased 
and the intensity of the higher wavelength peak (around 535 nm) increased. 
Although the analysis of FRET using simple quantification of acceptor emission, 
upon donor excitation, may be susceptible to multiple confounding factors 
(discussed earlier), this method was used as a simple way to approximate 
changes in FRET with changes in Ca2+ concentration. The mean intensities were 
extracted for two wavelength ranges, corresponding to CFP and YFP, as above. 
Acceptor (YFP) emission was expressed as a ratio of donor (CFP) emission, as 
published elsewhere for cameleon 2.1 (Miyawaki et al., 1999). At rest, in 
physiological S2 Ringer’s solution, the mean YFP/CFP ratio (+/- SEM) was 1.53 
(+/- 0.04) and rose to 2.21 (+/- 0.09) with addition of CaCl2 and ionomycin. In 
Ca2+ free Ringer’s, the ratio was 1.43 (+/- 0.01) and fell to 1.38 (+/- 0.02) with 
addition of EGTA and ionomycin. The change in ratio from low to high Ca2+ 
concentration was 0.83, a fold change of 1.6. It is acknowledged that these data 
only approximate changes in FRET with changing Ca2+ concentration and are 
susceptible to the influence of factors such as bleed through, cross talk and 
pseudo/false FRET, discussed and demonstrated earlier. Indeed, they are likely 
to overestimate true FRET rather than underestimate it (Karpova et al., 2003). 
However, it appears FRET in cameleon 2.1 changes in response to altered Ca2+ 
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concentration in Drosophila embryonic cells and, though not precisely 
quantified, it does so within a narrow range consistent with other cell types.  
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Figure 4.13 Cameleon 2.1 FRET in Drosophila embryonic cells responds to changes in Ca2+ 
concentration, but dynamic range is narrow 
Upper panels: spectral scanning confocal microscopy of dissociated embryonic cells expressing 
Cameleon 2.1 under the control of da-GAL4. An example ROI of a single cell is shown in magenta 
and the emission spectra are shown for similar cells in differing culture conditions (S2 Ringer’s, 
10mM CaCl2 and 5mM EGTA), in order to achieve the resting, maximum and minimum YFP/CFP 
ratio respectively. Lower panel: Mean YFP/CFP emission ratio (+/- SEM) for each culture condition. 
n=>6 cells for each condition. Difference between highest (10mM CaCl2) and lowest (5mM EGTA) 
Ca2+concentrations is significant, p=0.007. 
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4.5 Concluding remarks 
(i) Commercially available da-GAL4 and btl-GAL4 lines can be used to express 
transgenes in the embryo ubiquitously, or in tracheal cells specifically: however 
bnl-GAL4 driven expression was inconsistent with known branchless mRNA 
expression patterns.  
(ii) Live imaging protocols permit high resolution imaging of embryonic 
morphogenesis albeit at altered rates of development. 
(iii) Fluorescent proteins can be targeted to dual label tracheal cells and offer 
dynamic imaging capabilities throughout development (from early embryonic to 
later larval stage). Antibody staining of the trachea in fixed embryos provides 
superior spatial resolution at later stages. Consequently, in these investigations, 
antibody staining was the method of choice for demonstrating embryonic 
tracheal structure; fluorescent proteins were chosen to demonstrate larval 
trachea and the dorsal air sac primordium. 
(iv) The cameleon 2.1 FRET construct can be expressed in embryonic trachea 
and FRET can be demonstrated. The narrow dynamic range of the cameleon 2.1 
response limits its usefulness for quantitative studies, which are further 
complicated by issues such as pseudo/false FRET. Given these limitations, 
tracheal expression of cameleon 2.1 was not used further.  New generations of 
GECIs are likely to reduce the impact of such limitations, through the offer of 
greatly improved dynamic range, faster kinetics and higher signal to noise ratio: 
improvements have led to one author labelling cameleon 2.1 as ‘obsolete,’ 
despite its continued use (Mank et al., 2006; Palmer et al., 2006; Palmer & 
Tsien, 2006). Cloning of these improved GECIs into vectors such as pUAST will 
permit similar targeted expression in-vivo and may offer future opportunities for 
studying Ca2+ transients in Drosophila trachea. 
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Chapter 5 
 
RNAI MEDIATED SERCA KNOCKDOWN IN 
DROSOPHILA EMBRYONIC TRACHEA  
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5.1 Introduction 
First characterised in Caenorhabditis elegans, RNA interference (RNAi) is a 
sequence-specific gene silencing pathway that occurs naturally in organisms 
ranging from plants to mammals (Elbashir et al., 2001; Fire et al., 1998; van der 
Krol, Mur, Beld, Mol, & Stuitje, 1990). RNAi is triggered by double-stranded RNA 
(dsRNA) helices that have been introduced exogenously into cells as small 
interfering RNAs (siRNAs), or produced endogenously from small, non-coding 
RNAs known as microRNAs (miRNAs) (R. C. Lee, Feinbaum, & Ambros, 1993). The 
RNAi pathway is thought to play a diverse range of roles and has been implicated 
in immunity, development, cell proliferation, haematopoiesis and apoptosis 
(Olivier, 2001; Rana, 2007). There are at least three levels at which RNAi is 
mediated: (i) post-transcriptional gene silencing, the best understood pathway, 
whereby mRNA is degraded in response to siRNA complex binding; (ii) 
suppression of mRNA translation and protein synthesis; and (iii) pre-
transcriptionally, through mechanisms such as chromatin modification (de 
Carvalho et al., 1992; Fire et al., 1998; Pal-Bhadra, Bhadra, & Birchler, 1997; 
Tabara et al., 1999; Wightman, Ha, & Ruvkun, 1993; Zeng, Yi, & Cullen, 2003). 
5.1.1 The siRNA post-transcriptional gene silencing mechanism 
Long dsRNA molecules initiate RNAi when they are cleaved into short, 21-23-
nucleotide siRNAs by the RNAse III-type enzyme, Dicer (Figure 5.1) (Bernstein, 
Caudy, Hammond, & Hannon, 2001; Ketting et al., 2001; Zamore, Tuschl, Sharp, 
& Bartel, 2000). siRNAs specific to the mRNA targeted for silencing are 
incorporated into an RNA-induced silencing complex (RISC), along with proteins 
such as Argonaute-2, the mRNA cleavage enzyme in RISC (J. D. Liu et al., 2004; 
Meister et al., 2004; Miyoshi, Tsukumo, Nagami, Siomi, & Siomi, 2005). This RISC 
nuclease complex is the effector unit of RNAi: it finds its target mRNA and uses 
the antisense nucleotide sequence of the siRNA to guide cleavage of the target 
(Hamilton & Baulcombe, 1999; Hammond, Bernstein, Beach, & Hannon, 2000; 
Zamore et al., 2000). The remarkable specificity of RNAi gene silencing is 
governed by complementarity between the guide strand of the siRNA and the 
target mRNA: since its discovery in the 1990s, the apparent specificity of RNAi 
has prompted a range of applications. 
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Figure 5.1 siRNA post-transcriptional gene silencing 
Schematic diagram of the RNA interference (RNAi) mechanism.  
Image adapted from http://integratedhealthcare.eu/1/en/rna_interference/1498/  
This text box is where the unabridged thesis included the following third 
party copyrighted material: 
 
http://integratedhealthcare.eu/1/en/rna_interference/1498/  
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5.1.2 RNAi has found wide technological application 
The study of gene function in cell culture and model organisms has been 
enhanced by RNAi-mediated gene knockdown (Harborth, Elbashir, Bechert, 
Tuschl, & Weber, 2001; Kennerdell & Carthew, 1998). Generation of RNAi 
libraries permits genome-wide loss-of-function screens for genes associated with 
particular phenotypes (Fraser et al., 2000; Paddison et al., 2004; Varsha Wesley 
et al., 2001). In-planta expression of dsRNA has allowed generation of transgenic 
pest-resistant plants; in opium poppies, morphine can be replaced with a non-
narcotic alkaloid, reticuline (Allen et al., 2004; Baum et al., 2007). Finally, 
clinical use of RNAi is being intensively investigated: the first trials of siRNA have 
shown promise in areas such as macular degeneration and respiratory syncytial 
virus immunity (DeVincenzo et al., 2008; DeVincenzo et al., 2010; Singerman, 
2009) 
5.1.3 RNAi in Drosophila Research 
There are now a number of commercially available RNAi libraries, covering much 
of the Drosophila genome (Dietzl et al., 2007; Ni et al., 2008; NIG-Fly; TRiP). For 
in vivo study, RNAi constructs are commonly cloned to vectors such as pUAST 
and expressed using the GAL4-UAS system (Brand & Perrimon, 1993; Dietzl et 
al., 2007; Ni et al., 2008). This provides powerful tools to induce and control 
gene knockdown: in addition to spatial restriction with GAL4 drivers, RNAi 
expression can be restricted temporally by repressing the transcriptional activity 
of GAL4 with the temperature sensitive GAL80 transgene, the so called TARGET 
(temporal and regional gene expression targeting) system (S. E. McGuire, Le, 
Osborn, Matsumoto, & Davis, 2003; S. E. McGuire, Mao, & Davis, 2004). RNAi can 
also be used to create loss of function mosaics or ‘flip-out’ clones. Heat-shock 
induced FLP-recombinase removes a transcriptional-termination cassette that is 
inserted between a defined promoter and GAL4, or between the UAS sequence 
and RNAi construct (Duffy, Harrison, & Perrimon, 1998; Struhl & Basler, 1993). 
Calcium dynamics in Drosophila have also been investigated with RNAi targeting 
of components of calcium signalling pathways in-vitro and in-vivo (Roos et al., 
2005; Worrell & Levine, 2008). Given the apparent specificity and efficacy of 
RNAi gene silencing, this technique was chosen to determine SERCA’s role in 
Drosophila tracheal morphogenesis.  
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5.2 Aims 
To determine the effect of spatially restricted SERCA inhibition on embryonic 
tracheal branching morphogenesis, the aforementioned RNAi and GAL4-UAS 
techniques were used to: 
(i) Characterise the effects of expressing SERCA RNAi constructs in the tracheal 
system on embryonic branching morphogenesis; 
(ii) Increase the efficacy of RNAi mediated SERCA knockdown, through co-
expression of Dicer2 or additional RNAi constructs; 
(iii) Quantify the effect of RNAi on, SERCA mRNA levels, SERCA protein levels 
and SERCA function in embryonic cells. 
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5.3 RNAi mediated SERCA knockdown in the embryonic 
tracheal system 
5.3.1 Selection of RNAi constructs 
Commercially available RNAi libraries were searched for Drosophila lines 
carrying constructs targeted to the Drosophila SERCA gene, calcium ATPase at 
60A (Ca-P60A). The Vienna Drosophila RNAi Centre (VDRC) had two available 
lines, with transformant ID numbers, 4474 and 107446 (construct GD436 and 
KK107371 respectively) (Dietzl et al., 2007). For ease of reference, these lines 
will be referred to simply as RNAi 4474 or 107446 in future. The DNA sequences 
of these constructs were used to ascertain the start and end point of alignment 
with Ca-P60A transcripts (Figure 5.2). The alignments of both constructs 
corresponded to the fourth coding exon, which is common to all Ca-P60A 
transcripts. Their alignments overlapped for a region of 12 nucleotides. 
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Figure 5.2 Gene map demonstrating the alignment of selected RNAi constructs with Ca-
P60A transcripts 
Created using the Flybase database and GBrowse genome viewer (available at 
http://flybase.org/cgi-bin/gbrowse/dmel/). Alignment of nucleic acids performed with BLAST 
software (National Center for Biotechnology, available at http://blast.ncbi.nlm.nih.gov/Blast.cgi) 
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5.3.2 Potential off-target effects of SERCA RNAi 
The most serious limitation of RNAi technology is ‘off-target’ silencing of 
unrelated genes with (A. L. Jackson et al., 2003; A. L. Jackson & Linsley, 2004). 
Off-target silencing effects are caused by siRNA (introduced directly into cells, 
or produced in vivo from long dsRNA) that has sequence similarities with 
unrelated genes. Therefore the design of RNAi constructs, and interpretation of 
their phenotypic effects, need to be approached with care. 
To check chosen SERCA RNAi constructs for vulnerability to off-target effects, 
we input their cDNA sequences into dsCheck software to predict potentially 
susceptible non-target genes (dsCheck, at http://dscheck.rnai.jp/) (Naito et al., 
2005). This prediction is given by means of the number of hits for a complete 
match (sequence alignment) of 19 nucleotide length siRNAs and the target gene 
mRNA, a mismatch of one nucleotide and a mismatch of two nucleotides. RNAi 
4474 had 267 hits with a complete match for each SERCA transcript: there were 
no hits for other genes with a complete match. With one mismatch, the highest 
number of hits for any gene was only three, and with two mismatches, only 
seven (complete data output in Appendix 2). These data indicate that RNAI 4474 
is likely to be highly specific at targeting SERCA mRNA. RNAi 107446 had 700 hits 
for each SERCA transcript and two hits for transcripts of Secretory Pathway 
Calcium atpase (SPoCk), with a complete match (complete data output in 
Appendix 2). These data indicate that RNAi 107446 may affect another Ca2+ 
ATPase pump, although the vastly reduced number of hits (2 vs. 700) for this off-
target gene implies the effect may be small, relative to that on SERCA mRNA 
knockdown. In view of these findings, RNAi 4474 was selected for use in all 
experiments when a single RNAi construct was utilised: RNAi 107446 was only 
used when dual RNAi expression was required. 
5.3.3 Expression of SERCA RNAi 4474 in tracheal cells does not 
disrupt branching morphogenesis in the embryo 
To determine the effect of SERCA knockdown on tracheal morphogenesis, RNAi 
4474 was expressed in tracheal cells using the btl-GAL4 driver and compared to 
a control (w1118 crossed to btl-GAL4). Embryos were collected over short time 
intervals and aged to stage 16, when they were fixed and stained with an 
antibody to the tracheal lumenal protein, 2A12 (DSHB) (Manning & Krasnow, 
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1993). Confocal microscopy was used to image the tracheal system, using z-
stacks with 3D reconstructions for analysis. Stage 16 was chosen for phenotypic 
assessment, as the vast majority of branching is complete in wild type embyros 
of this stage, the stage is readily identifiable from gut morphology and it 
precedes the stage when embryo immunostaining becomes difficult (Manning & 
Krasnow, 1993).  
RNAi 4474 expressed in the trachea did not affect tracheal branching 
morphogenesis (Figure 5.3). In both btl>RNAi and control embryos, the major 
braches of the tracheal system develop at each appropriate metamere, including 
the dorsal and lateral trunks, the transverse connectives, the dorsal, visceral, 
spiracular and ganglionic branches, the dorsal anastomoses, as well as smaller, 
more variable branches such as the lateral group (Manning & Krasnow, 1993). 
The specialised branches of the first and tenth metamere are also evident in 
both groups. Thus RNAi 4474 expression in tracheal cells does not grossly alter 
embryonic tracheal morphogenesis. 
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Figure 5.3 Targeted expression of SERCA RNAi 4474 in tracheal cells does not disrupt 
branching morphogenesis in the embryo 
Confocal micrographs (3D projections of z-stacks) of representative stage 16 Drosophila embryos 
expressing the SERCA RNAi construct, VDRC 4474 in tracheal cells (btl>RNAi) vs. control 
(w1118). The tracheal system is stained with 2A12 antibody (DSHB, Iowa). Upper panels show the 
lateral aspect of the embryo and lower panels the dorsal aspect (anterior to the left). Scale bar 
indicates 100 µm. 
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5.3.4 Recombining SERCA RNAi 4474 with Dicer2 or RNAi 
107446, induces lethality at an earlier stage 
To try to enhance the RNAi mediated SERCA knockdown, RNAi 4474 was 
recombined with ectopic Dicer2 or RNAi 107446: co-expression of Dicer2 has 
been shown to enhance RNAi potency (Dietzl et al., 2007). Meiotic 
recombination events that occur in females were exploited to combine the 
heterozygously carried transgenes (present on homologous second 
chromosomes), on to one chromosome (Figures 5.4 and 5.5). Potential, 
individual male recombinants were selected for increased intensity of eye 
colour, given that flies carrying the individual transgenes and white mutation 
had a moderate eye colour. Stocks of potential recombinants were made, by 
crossing them to a second chromosome balancer (Figure 5.4 and 5.5). 
Interestingly, recombined lines (RNAi 4474 and Dicer2 or RNAi 107446) were 
recessively lethal, whereas RNAi 4474 is viable when homozygous: this finding is 
most likely to be a consequence of insertional inactivation. In order to test GAL4 
mediated effects, the recombined stocks were crossed to btl-GAL4 and da-GAL4 
drivers and the stage of lethality assessed.  
When RNAi 4474 lines recombined with either Dicer2 or RNAi 107746, were 
crossed to da-GAL4, and hence expressed ubiquitously, the progeny died in the 
embryonic or early L1 stage (Table 5.1). This is compared to RNAi 4474 or 
107446 lines alone, which when crossed to da-GAL4, produced progeny that 
survived until the L2 larval stage. When RNAi 4474 lines recombined with either 
dicer2 or RNAi 107746, were crossed to btl-GAL4, and hence expressed in 
tracheal cells, the progeny died at the L1/L2 larval stage. This is compared to 
RNAi 4474 or 107446 lines alone, which produced viable adult progeny when 
crossed to btl-GAL4. Together, these data demonstrate that recombination of 
RNAi 4474 with either dicer2 or RNAi 107446 induces a more potent phenotype 
and may indicate increased knockdown of SERCA compared to individual RNAi 
constructs used alone. Further evidence of increased SERCA knockdown from this 
recombination is detailed later, when the effects on SERCA mRNA expression are 
reported. 
In addition, the lethality seen when more potent RNAi is driven by btl-GAL4 is 
significant: lethality is induced by highly specific SERCA loss of function in 
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tracheal cells, thus indicating that the effects of this loss of function on these 
cells are such to preclude continued survival of the larvae. Whether this 
phenotype is mediated by a disruption in either tracheal structure or function, 
or is induced by an extra-tracheal effect, remains to be seen and will be 
investigated later. 
Table 5.1 Recombining SERCA RNAi 4474 with Dicer2 or RNAi 107446, induces lethality at 
an earlier stage 
Stages of lethality when 2 commercial RNAi lines (VDRC 4474 and 107446) and 2 recombined 
lines (4474 with dicer2 and 4474 with 107446) are crossed to btl-GAL4 and da-GAL4 drivers. 
  
 btl-GAL4 da-GAL4 
RNAi 4474 Viable Adults L2 Larvae 
RNAi 107446 Viable Adults L2 Larvae 
RNAi 4474, dicer2 L2 Larvae Embryo / L1 
RNAi 4474, 107446 L1/2 Larvae Embryo 
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Figure 5.4 Genetic crossing scheme demonstrating the recombination of VDRC RNAi line 
4474 with Dicer2  
Meiotic recombination in females was made use of to combine the heterozygously carried 
transgenes (present on homologous second chromosomes), onto one chromosome. Potential, 
individual male recombinants were selected based on increased intensity of eye colour, since the 
transgenes had originally been inserted in a white-eyed background. Stable stocks were then 
made, by crossing these male recombinants to a second chromosome balancer.  
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Figure 5.5 Genetic crossing scheme demonstrating the recombination of VDRC RNAi line 
4474 with RNAi line 107446 
Meiotic recombination in females was made use of to combine the heterozygously carried 
transgenes (present on homologous second chromosomes), onto one chromosome. Potential, 
individual male recombinants were selected based on increased intensity of eye colour, since the 
transgenes had originally been inserted in a white-eyed background. Stable stocks were then 
made, by crossing these male recombinants to a second chromosome balancer.  
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5.3.5 SERCA RNAi 4474 recombined with Dicer2 or RNAi 107446 
and expressed in tracheal cells, does not disrupt branching 
morphogenesis in the embryo 
RNAi 4474 recombined with Dicer2 or RNAi 107446 and expressed in tracheal 
cells with btl-GAL4, did not affect gross tracheal morphogenesis (Figure 5.6). In 
both btl>RNAi and control embryos, the major branches of the tracheal system 
develop at each appropriate metamere, as discussed above (Manning & Krasnow, 
1993). The specialised branches of the first and tenth metamere are also evident 
in both groups. Since our assessment of structure used an antibody to a luminal 
protein, the presence of a lumen containing 2A12 may be inferred.  
The normal gross tracheal structure offers little to explain the intriguing larval 
lethality observed. The increased potency RNAi may prejudice larval airway 
structure and/or function and hence survival without affecting embryonic 
tracheal anatomy; alternatively, the impact on survival may be mediated via an 
airway independent mechanism. I explore this later in the thesis in Chapter 7. 
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Figure 5.6 SERCA RNAi 4474 recombined with Dicer2 or RNAi 107446, expressed in tracheal 
cells, does not disrupt branching morphogenesis in the embryo 
Confocal micrographs (3D projections of z-stacks) of representative stage 16 Drosophila embryos 
expressing the SERCA RNAi construct, VDRC 4474 with either Dicer2 or RNAi 107446, in tracheal 
cells (btl>RNAi) vs. control (w1118). The tracheal system is stained with 2A12 antibody (DSHB, 
Iowa). The lateral aspect of the embryo is shown in each case (anterior to the left). Scale bar 
indicates 100 µm. 
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5.4 Effects of RNAi on SERCA mRNA, protein and 
function 
 
5.4.1 RNAi mediated SERCA mRNA knockdown does not occur 
until later in embryogenesis 
To determine the effect of RNAi constructs on embryonic SERCA mRNA levels, 
various SERCA RNAi constructs were ubiquitously expressed using the da-GAL4 
driver and RT-PCR performed for SERCA mRNA. RNA was extracted from 20 
embryos in each group at stage 11 and stage 17 and at least three biological 
replicates used for each condition. After reverse transcriptase, cDNA was used to 
carry out quantitative RT-PCR (qRT-PCR, as described in more detail in Chapters 
2 and 3) for SERCA mRNA and significant differences also confirmed on an 
electrophoresis gel. The effects of the RNAi constructs were compared to a 
control (da-GAL4 crossed to w1118) and results normalised to a reference gene 
(18S mRNA expression).   
At stage 11, there was no significant difference in normalised SERCA mRNA level 
between any of the RNAi constructs and the control (Figure 5.7). At stage 17, 
normalised SERCA mRNA levels were significantly reduced by expression of any 
of the RNAi constructs, compared to the control (p<0.05). Reduced SERCA mRNA 
and unaffected 18S mRNA levels were also confirmed at stage 17 on 
electrophoresis gel (Figure 5.7). These findings indicate that ubiquitously 
expressing RNAi in the embryo does not knockdown SERCA mRNA levels until 
later in embryogenesis.  
At stage 17, normalised mean (+/- SEM) SERCA mRNA levels were reduced in the 
RNAi 4474/Dicer2 and RNAi 4474/107446 groups, compared to RNAi 4474 alone 
(0.33 +/- 0.16 and 0.06 +/- 0.05 vs. 0.68 +/- 0.25 respectively), although this 
difference did not reach statistical significance. Given the biological difference 
in lethality between these lines, the lack of statistical significance may overlook 
a real difference due to small sample size (n=3) and degree of variance relative 
to effect size. It remains plausible that addition of Dicer2 overexpression or an 
extra RNAi construct to RNAi 4474 results in a biologically significant increase in 
SERCA mRNA knockdown at stage 17. 
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Looking at the degree of knockdown, the mean percentage reduction in SERCA 
mRNA, relative to control (w1118) at stage 17, ranged from 71% for RNAi 107446 
alone, to 98% for RNAi 4474/107746 recombined together. RNAi 4474 alone 
resulted in a mean knockdown of 81% and RNAi 4447/dicer2 recombined 
together, a 91% reduction.  
   
 149 
 
Figure 5.7 RNAi mediated SERCA mRNA knockdown does not occur until later in 
embryogenesis 
RT-PCR of stage 11 and 17 embryos expressing the da-Gal4 driver and different RNAi constructs 
+/- dicer2. Upper panel: representative gel image of RT-PCR of SERCA and 18S mRNA at stage 
17. Lower panels: quantitative RT-PCR of mean SERCA mRNA expression relative to 18S at 
stages 11 and 17 (error bars indicate +/- 1 SEM). Genotypes used are as indicated  
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5.4.2 Residual SERCA protein is evident in embryos expressing 
RNAi ubiquitously 
To test the effect of RNAi on SERCA protein levels, RNAi 4474 was expressed 
ubiquitously throughout the embryo using the da-GAL4 driver. RNAi 4474 was 
first balanced over the fluorescent second chromosome balancer, CyO, twi>GFP, 
to generate an easily distinguishable internal control in half of all collected 
embryos. Stage 11 and 16 embryos were fixed and stained with fluorescently 
tagged thapsigargin (BODIPY® TR-X thapsigargin, Invitrogen). Thapsigargin avidly 
and specifically binds SERCA protein and therefore, after excess dye is washed 
away, fluorescent emission correlates with SERCA protein localisation in the 
embryo. Embryos were analysed using confocal microscopy with settings 
standardised between groups. 
Diffuse fluorescent emission from TR-X thapsigargin was evident in RNAi and 
control embryos at both stages 11 and 17 (Figure 5.8). The distribution of the 
fluorescent signal was very similar between groups. The widespread distribution 
of SERCA protein in stage 17 embryos, with little or no regional difference, is in-
keeping with published data in wild-type embryos (Vazquez-Martinez, Canedo-
Merino, Diaz-Munoz, & Riesgo-Escovar, 2003). When Vazquez et al carried out 
similar experiments on embryos pre-treated with unlabelled thapsigargin, to 
saturate SERCA binding, fluorescent signal was abolished (confirming the 
specificity of the dye). Hence, in our study, if SERCA protein had been abolished 
or significantly reduced as a result of RNAi expression, it would be expected that 
fluorescent signal would also be lost or greatly diminished. These data indicate 
that there are significant amounts of residual SERCA protein in embryos 
expressing SERCA RNAi ubiquitously, although this assay only provides a 
qualitative assessment: relative amounts of protein between groups can not be 
determined.  
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Figure 5.8 Residual SERCA protein is evident in embryos expressing RNAi ubiquitously 
Confocal micrographs of stage 11 (upper panels) and stage 16 (lower panels) embryos stained 
with fluorescent thapsigargin (BODIPY® TR-X, Invitrogen) that specifically binds to SERCA protein. 
Embryos genotypes are SERCA RNAi 4474 under the control of da-GAL4 vs. an internal control 
(CyO-twi>GFP / da-GAL4) The lateral aspect of the embryo is shown in each case (anterior to the 
left). Embryos are approximately 500 µm in antero-posterior length.  
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5.4.3 RNAi reduces SERCA function in late embryogenesis 
To test the effect of RNAi on SERCA protein function, an assay was developed to 
assess this in embryonic cells. It is known that when the SERCA pump is inhibited 
with thapsigargin, there is a sharp rise in intracellular Ca2+ concentration, soon 
after addition of the inhibitor to Drosophila S2 cells (Yagodin, Pivovarova, 
Andrews, & Sattelle, 1999). This rise is due to inhibition of Ca2+ re-uptake into 
cellular stores (and hence store depletion) and triggering of capacitative (store 
operated) Ca2+ entry into the cell (Yeromin, Roos, Stauderman, & Cahalan, 
2004). The degree of this rise is known to correlate with the baseline SERCA 
function within a cell: S2 cells treated with dsRNA targeted to knockdown SERCA 
in-vitro, display a significantly reduced, or absent rise in intracellular Ca2+ on 
application of thapsigargin (Raymond-Delpech, Towers, & Sattelle, 2004; Zhang 
et al., 2006). In addition, cells treated with SERCA RNAi have a raised resting 
intra-cellular Ca2+ concentration, compared to controls (Abell, Ahrends, Bandara, 
Park, & Teruel, 2011; Raymond-Delpech et al., 2004; Zhang et al., 2006).  
To apply this system to Drosophila embryos expressing RNAi constructs in-vivo, a 
method was required that would permit accurate quantification of intracellular 
Ca2+ concentration and allow simultaneous cell stimulation with thapsigargin. 
Since the vitelline membrane does not readily permit the passage of molecules 
such as AM-ester Ca2+ indicators into the embryo, an assay was developed where 
embryos expressing RNAi 4474 ubiquitously (using da-GAL4) were dissociated to a 
single cell suspension. These cells were then loaded with the Ca2+ indicator Fluo-
4 (Invitrogen) under culture conditions and treated with thapsigargin as 
previously described. Although an in-vitro assay, SERCA RNAi 4474 was expressed 
in the developing embryo in exactly the same way it had been in other 
experiments and embryos were only dissociated at the developmental stage 
when Fluo-4 loading was required. 
Cells from stage 11 embryos expressing RNAi 4474 ubiquitously, demonstrated 
similar intracellular Ca2+ characteristics as control (w1118) embryo cells (Figure 
5.9). The baseline Ca2+ concentration was comparable, as was the amplitude of 
the thapsigargin-induced rise in concentration. This indicates stage 11 embryos 
expressing RNAi 4474 ubiquitously do not have significantly reduced levels of 
SERCA function and hence RNAi has not induced a functional knockdown. 
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However, at stage 16, the RNAi and control embryonic cells differed markedly: 
RNAi 4474 cells had higher baseline intra-cellular Ca2+ concentration and their 
response to thapsigargin administration was markedly attenuated compared to 
control (Figure 5.9). These characteristics are consistent with those of S2 cells 
treated with SERCA dsRNA in-vitro and confirm RNAi 4474 reduces SERCA 
function by stage 16 of embryogenesis (Zhang et al., 2006). Together these data 
correlate with mRNA knockdown findings detailed above and indicate that RNAi- 
mediated SERCA inhibition is effective only by late embryogenesis. 
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Figure 5.9 RNAi reduces SERCA function in late embryogenesis 
Graphs of mean (+/- SD) fluorescent intensity over time of Fluo-4 (Invitrogen) loaded cells, 
stimulated with thapsigargin at times indicated by the grey bars. SERCA RNAi 4474 was expressed 
ubiquitously in the embryo with the da-GAL4 driver and compared to w1118 controls. Embryos were 
aged to stages 11 and 16, dissociated into a single cell suspension, loaded with Fluo-4 and imaged 
with confocal microscopy. 
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5.5 Discussion 
In Drosophila, RNAi has been used extensively to interrogate gene loss of 
function phenotypes, both in S2 cell lines and in targeted, tissue specific in-vivo 
studies (Caplen, Fleenor, Fire, & Morgan, 2000; Goto, Kadowaki, & Kitagawa, 
2003; Piccin et al., 2001). Genome wide screens have now similarly been carried 
out in both manners, taking advantage of available RNAi libraries (discussed 
above) (Boutros et al., 2004; Cronin et al., 2009; Mummery-Widmer et al., 
2009). Despite early, in-vivo RNAi studies yielding valuable information about 
gene function during embryonic development (through the injection of dsRNA 
into Drosophila embryos), most studies of targeted transgenic knockdown (using 
the GAL4-UAS system), have investigated larval and adult phenotypes 
(Kennerdell & Carthew, 1998; Misquitta & Paterson, 1999). The efficiency of 
GAL4-UAS mediated RNAi knockdown in the embryo has therefore not been well 
defined. Here I present data that demonstrates transgenic RNAi SERCA 
knockdown does not occur until later in embryogenesis: once it does occur 
though, it is considerable, with up to 98% reduction in mRNA and an 
accompanying significant decrease in protein function. One explanation for the 
early inefficiency of RNAi is a maternal contribution of SERCA loading (mRNA 
and/or protein) within the embryo. This hypothesis is supported by RNA-seq and 
in-situ hybridisation data that demonstrate high levels of SERCA mRNA 
throughout embryogenesis (Graveley et al., 2011; Tweedie et al., 2009). 
Critically, in this study, significant SERCA knockdown was not achieved until well 
after tracheal branching morphogenesis commences. Findings of a grossly normal 
tracheal system structure therefore have to be interpreted within the 
constraints of this temporally limited knockdown. Two obvious explanations for 
this are: (i) SERCA function is not required for embryonic tracheal morphogenesis 
or (ii) SERCA function is essential for normal tracheal development, but RNAi 
could not mediate adequate and timely knockdown during the relevant stages of 
development. Clues to which of these prevail can be gained from considering the 
larval phenotype: lethality is seen with btl-GAL4 driven co-expression of RNAi 
4474 and either Dicer2 or RNAi 107446, indicating that SERCA function is 
essential in tracheal cells. What is not clear though, is whether this SERCA 
requirement in tracheal cells, is for embryonic or larval morphogenic events and 
whether it is involved in tracheal system structure, function or both; or whether 
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it is required for tracheal-independent mechanisms. To answer these questions, 
more efficient, earlier SERCA inhibition is required in the embryo, as well as an 
interrogation of tracheal structure at the larval stage in SERCA deficient 
animals: these steps are discussed in later chapters. 
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Chapter 6 
 
EFFECTS OF A CONDITIONAL SERCA MUTATION 
ON DROSOPHILA EMBRYONIC TRACHEAL 
MORPHOGENESIS 
   
 158 
6.1 Introduction 
RNAi mediated SERCA knockdown was demonstrated to be ineffective until later 
stages of embryogenesis in Chapter 5. Given that tracheal branching 
morphogenesis starts at stage 11, a method was sought to inhibit SERCA protein 
function earlier in embryogenesis.  
In addition to being present at high levels in Drosophila brain and muscles, 
SERCA mRNA is expressed at lower constitutive levels throughout the adult body 
(Magyar et al., 1995). RNA-seq and in situ hybridisation data also confirm 
relatively high mRNA expression levels throughout embryogenesis (Graveley et 
al., 2011; Tweedie et al., 2009). Together, these observations suggest an 
important housekeeping role for the encoded protein in all, or most cells. This 
theory is given further credence by demonstration of SERCA playing an essential 
role in trafficking of a number of proteins: SERCA loss of function cells display 
mislocalised transmembrane proteins including Notch (Periz & Fortini, 1999). 
Given this likely housekeeping-type role, strong loss-of-function mutations will 
likely result in severe, global defects in early embryogenic events. 
Correspondingly, it has been reported that homozygous SERCA mutants display 
profoundly abnormal embryo morphology (Sanyal et al., 2005). Significant 
disturbances to early embryogenesis are likely to be unhelpful in this 
investigation, as they will preclude the study of later embryonic events, such as 
tracheal morphogenesis beginning at stage 11. In order to interrogate SERCA’s 
role in tracheal morphogenesis, a conditionally activated, dominant negative 
mutation was exploited to overcome these constraints. 
6.1.1 The conditional SERCA mutant, Kumbhakarna  
Named after an eponymous mythological hero who slept for six months of the 
year, the Kumbhakarna (Kum) mutation was discovered in a screen of ethyl 
methanesulfonate (EMS) induced mutant flies that displayed paralytic behaviour 
upon heat treatment (Sanyal et al., 2005). Two independent, recessively lethal 
lines were detected by the screen, both displaying very similar, reversible 
paralytic phenotypes upon heating to 40°C. Recombination mapping placed the 
two alleles, named Kum170 and Kum295, within the Ca-P60A (Drosophila SERCA 
gene) locus, at 60A11–12, on the right arm of the second chromosome. These 
mutants failed to complement previously described, lethal SERCA mutants, and 
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sequencing revealed that Kum170 carries a single-base substitution in the SERCA 
coding sequence, predicted to cause a Glutamic acid 442-to-Lysine mutation. 
This mutation is located in the hinge domain of the protein and has been 
hypothesised to potentially influence ATP binding or the conformational state of 
the molecule (Sanyal et al., 2005; Toyoshima et al., 2000; Toyoshima & Nomura, 
2002). 
Effects of this mutation on SERCA function were characterised using calcium 
imaging and electrophysiology of presynaptic motor neuron terminals: heated 
Kum170 mutants displayed higher peaks of cytosolic calcium upon nerve 
stimulation, with a more rapid return to baseline compared to wild-type controls 
and unheated Kum170 (Kuromi & Kidokoro, 2002; Sanyal et al., 2005). 
Importantly, this phenocopied the effects of thapsigargin (a potent, specific 
SERCA inhibitor) treatment. Kum170 was therefore confirmed as a conditional, 
dominant loss of-function allele of SERCA. 
6.2 Aims 
The conditional, dominant negative SERCA mutant allele, Kum, was exploited in 
a variety of experimental systems in order to determine the effects of SERCA 
inhibition on: 
(i) embryonic tracheal branching morphogenesis; 
(ii) embryonic tracheal maturation events. 
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6.3 Effects of the Kum mutation on embryonic tracheal 
morphogenesis  
6.3.1 Optimising heat treatment of Kum embryos 
Sanyal et al induced short (3–5 minute) periods of heat treatment to flies, using 
a device labelled as a ‘sushicooker’ by Ramaswami et al (Ramaswami, Rao, van 
der Bliek, Kelly, & Krishnan, 1993; Sanyal et al., 2005). This device comprises a 
smooth glass chamber surrounded by a water jacket to maintain a controlled 
temperature. Active flies are loaded into the top and fall from the bottom when 
paralysed by the effects of the heat. Kum170 adults were shown to paralyse 
within three minutes at 40°C, Kum295 similarly, at 39°C. Kum larvae displayed a 
similar paralytic, contracted phenotype within five minutes (Sanyal et al., 2005). 
The description of an embryonic phenotype was limited to: ‘many homozygous 
Kum295/Kum295 mutant embryos also appeared abnormally contracted inside the 
egg case;’ and  ‘most Kum170/Kum170 animals developed normally and hatched 
into very sluggish first-instar larvae.’ It is unclear whether homozygous or 
heterozygous embryos were heated at all, and if so, how this was achieved. 
Consequently, in order to take advantage of the heat-sensitive, conditional 
characteristic of Kum in embryos, it was necessary to optimise a protocol for 
their heat treatment.  
Wild-type Drosophila embryos exposed to heat-shock conditions (usually 37°C for 
15-30 minutes), where the temperature of the embryo is rapidly increased (e.g. 
by use of liquid incubation medium), have been shown to display a range of 
cellular and molecular abnormalities, dependent on their developmental stage 
at heat-shock (Dura, 1981; Graziosi et al., 1983; Graziosi, Micali, Marzari, de 
Cristini, & Savoini, 1980; Santamaria, 1979). Heat shock has been shown to 
result in dramatic, irreversible changes when instigated early (e.g. pre-
blastoderm), but also induces significant changes later in embryogenesis, such as 
collapse of the intermediate filament cytoskeleton (Walter, Biessmann, & 
Petersen, 1990). Even short heat-shocks of a few minutes decrease normal 
protein synthesis and upregulate heat-shock proteins; they impair development 
and decrease survival (Eberlein & Mitchell, 1987). Initial attempts to apply such 
heat-shock methods to Kum embryos at around stage 11, at temperatures and 
over time periods similar to that described by Sanyal et al, were limited by gross 
morphological abnormalities in the embryo (Sanyal et al., 2005). This was 
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somewhat unsurprising, given the known consequences of heat-shock in embryos 
and a likely increased sensitivity to heat in Kum animals.  
To reduce the induction of such global embryonic defects, a different approach 
was tested, whereby a more gradual increase in temperature was instigated, but 
for longer periods. Embryos were left on apple juice agar plates and placed in 
standard 37°C incubators for up to one hour. To test the effects of this 
treatment on embryo viability, an assay of hatching frequency was employed. 
Embryos collected from Kum170/CyO  or Kum295/CyO stocks were aged to stage 11 
and then submitted to a period of one hour in the 37°C incubator, before being 
returned to 25°C. Heated embryos were significantly less likely to hatch 
compared to their non-heated controls (Tables 6.1 and 6.2). It would be 
expected that 25% of these embryos were homozygous for either the Kum 
mutation or CyO and hence half of all embryos would be recessively lethal at 
some point in development: this is consistent with the observation that 50% of 
embryos failed to hatch in the unheated groups. Given that wild-type embryo 
hatching is largely unaffected by this type of heat regime, the significant 
decrease in hatching induced by heat in Kum embryos, is likely to be related to 
specific activation of the conditional mutation. Gross morphology of these 
embryos was apparently unaffected, when inspected with bright-field and 
confocal microscopy (Figure 6.1) and hence this type of treatment was used in 
future experiments.  
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Table 6.1 Hatching frequency of embryos from Kum170/CyO stocks  
 
p=0.0001 Heated Unheated 
Hatched 9 53 
Un-hatched 111 67 
Total 120 120 
 
Table 6.2 Hatching frequency of embryos from Kum295/CyO stocks 
 
p=0.0001 Heated Unheated 
Hatched 7 26 
Un-hatched 43 24 
Total 50 50 
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Figure 6.1 Confocal micrographs of embryos from Kum/CyO, twi>GFP stocks 
Stage 16.1 embryos  (confirmed by characteristic gut morphology) are displayed that are 
heterozygous or homozygous for the Kum allele (indicated by the presence or absence of 
twi>GFP). Embryos were submitted to heat treatment at stage 11 to activate the conditional 
mutation: gross morphology is apparently normal. Scale bar indicates 200 µm. 
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6.3.2 Embryos homozygous for Kum alleles display grossly 
normal patterns of tracheal branching morphogenesis 
To test the effect of the conditional SERCA mutation Kum, on tracheal branching 
morphogenesis, homozygous embryos were assessed in order to maximise the 
effect of the dominant negative mutation. Embryos were collected over narrow 
time intervals and heat treated at stage 11 (as detailed above) and then fixed at 
stage 16. Homozygous embryos were selected from those laid by stocks of Kum 
flies that had been previously balanced with a fluorescent second chromosome 
balancer (CyO, twi>GFP): selection was based on the absence of GFP (Figure 
6.1). The tracheal system was stained with an antibody to the luminal protein, 
2A12 (DSHB) and embryos imaged with confocal microscopy. Embryos as close as 
possible to stage 16.1 were identified from gut morphology (Figure 6.1), to 
ensure phenotypic comparison between groups was made at equivalent 
developmental stages. 
Embryos homozygous for Kum170 or Kum295 alleles displayed a grossly normal, 
branched tracheal system at stage 16, when compared to similarly heated 
controls (w1118) (Figure 6.2). Major tracheal branches were clearly identified at 
appropriate positions in all groups, including the dorsal and lateral trunks; 
dorsal, visceral and ganglionic branches and transverse connectives. Specialised 
branches of the first and tenth metameres were also present at appropriate 
positions. The often more variable, finer and shorter branches such as the 
spiracular, fat body and lateral group, were demonstrated, however, in the 
Kum295 group, these were less well defined (lower panel, Figure 6.2). Although 
there is evidence that the fundamental cellular events that dictate branch 
formation have occurred in these embryos, the 2A12 antibody has not stained 
these finer branches as well as in control or Kum170 embryos: this may indicate a 
disturbance to the branch lumen, or protein within the lumen, rather than to the 
branching event itself. Elements of tracheal maturation, such as this, will be 
investigated later in this chapter. 
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Figure 6.2 Embryos homozygous for Kum alleles display grossly normal patterns of tracheal 
branching morphogenesis 
Confocal micrographs (3D projections of z-stacks) of stage 16 Drosophila embryos homozygous for 
Kum170 or Kum295 vs. control (w1118), exposed to a 1 hour heat treatment at the start of branching 
morphogenesis (stage 11) . The tracheal system is stained with 2A12 antibody (DSHB, Iowa). The 
lateral aspect of the embryo is shown (anterior to the left). Scale bar indicates 100 µm. 
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6.3.3 Embryonic cells homozygous for Kum170 display 
significantly decreased SERCA function 
In order to test the effect of the Kum170 mutation on SERCA function in 
embryonic cells, a functional assay of protein activity was performed, as 
previously described in Chapters 2 and 5. Briefly, embryos homozygous for the 
Kum170 allele were selected as above, aged to stage 11 and submitted to heat 
treatment as above (thus replicating experimental conditions used for tracheal 
phenotype assessment). Following heat treatment, embryos were dissociated 
into a single cell suspension in culture conditions and loaded with the calcium 
indicator, Fluo-4 AM (Invitrogen). During confocal live imaging, cells were 
stimulated with thapsigargin and changes in intensity of fluorescence monitored. 
Cells from embryos homozygous for the Kum170 allele displayed significantly 
different intracellular Ca2+ characteristics, to controls (Figure 6.3). Baseline Ca2+ 
concentration was significantly higher in the Kum170 group, as indicated by a 
higher Fluo-4 intensity (56.1 vs. 26.5, p=0.001). The response to thapsigargin 
stimulation was also significantly attenuated: a smaller increase in intensity was 
witnessed (147.1 vs. 238.2, p<0.001) and this increase occurred at a slower rate 
(time to maximum intensity, 353.9 vs. 413.7 seconds, p=0.047). 
These changes in intracellular Ca2+ characteristics are in keeping with those in 
studies of Drosophila S2 cells, when SERCA function was inhibited with RNAi 
(Raymond-Delpech et al., 2004; Zhang et al., 2006). They are also comparable to 
the effect of in-vivo RNAi in late embryogenesis, detailed in Chapter 5. 
Collectively, this confirms that embryos homozygous for the Kum170 allele and 
treated with heat, have significantly reduced SERCA protein function at stage 11 
(around the start of tracheal branching morphogenesis), contrasting starkly with 
RNAi mediated SERCA knockdown that is not effective at this stage. Given these 
findings, it seems reasonable to conclude that the dominant negative Kum170 
allele is effective at reducing the function of maternally loaded SERCA, the 
presence of which is strongly suggested by transcriptomics and functional assay 
(Chapter 5) (Graveley et al., 2011; Tweedie et al., 2009). This validation of 
significant functional inhibition, together with findings of normal tracheal 
branching (Figure 6.2), confirms that branching morphogenic events can proceed 
with a considerably decreased level of SERCA function.  
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Importantly however, residual SERCA function is evident at stage 11: it therefore 
remains conceivable that SERCA may be required for tracheal branching, but this 
lower level of activity is sufficient. Further, more potent SERCA knockdown 
globally across the embryo (such as that mediated by the Kum allele) may be 
precluded by an essential requirement of SERCA in normal embryogenesis, 
particularly given its putative housekeeping role in most/all cells. Subsequent 
attempts to increase the potency of SERCA inhibition therefore incorporated an 
element of targeting to tracheal cells. 
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Figure 6.3 Embryonic cells homozygous for Kum170 display significantly decreased SERCA 
function 
Upper panels: Graphs of mean (+/- SD) fluorescent intensity over time of Fluo-4 (Invitrogen) loaded 
cells, stimulated with thapsigargin at times indicated by grey bars. Embryos were homozygous for 
the Kum170 allele and compared to w1118 controls. Embryos were aged to stage 11, dissociated into 
a single cell suspension, loaded with Fluo-4 and imaged with confocal microscopy.  
Lower panel: table of mean (+/- SD) cell fluorescent intensities, along with rates of change for both 
groups.   
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6.4 Effects of the Kum mutation and SERCA RNAi on 
embryonic tracheal morphogenesis 
6.4.1 Combining the effects of the Kum allele and SERCA RNAi  
RNAi mediated SERCA knockdown was ineffective in early embryogenesis: given 
the seemingly plausible hypothesis that this was a result of maternally loaded 
SERCA (mRNA and/or protein), efficacious SERCA inhibition must target this 
maternal contribution. One method used to at least partially achieve this, 
studied embryos homozygous for Kum alleles (discussed above). Residual SERCA 
function was evident though, making it difficult to draw firm conclusions from 
findings of a grossly normal tracheal system. A novel way to increase functional 
inhibition may be to combine the Kum allele with RNAi targeted to tracheal cells 
(btl>RNAi, Chapter 5). In theory, the dominant negative Kum allele should 
inhibit maternal SERCA (if Kum female flies were used in the cross) and RNAi 
would target zygotic SERCA specifically in tracheal cells. In order to achieve 
such a genetic combination, the recessively lethal Kum170 allele was recombined 
on the second chromosome with btl-GAL4, UAS-act.GFP. 
Meiotic recombination events that occur in female Drosophila were exploited to 
combine the heterozygously carried Kum170 allele and btl-GAL4, UAS-act.GFP 
transgenes (present on homologous second chromosomes), onto one chromosome 
(Figure 6.4). Potential, individual male recombinants were firstly selected based 
on the presence of tracheal GFP fluorescence in larvae. These larvae were 
allowed to develop to adults and the presence of the Kum allele determined by 
induction of reversible paralysis with a three minute, 40°C heat-shock. The 
paralysis witnessed was in-keeping with that described by Sanyal et al, 
indicating that the confirmed dominant negative effect of the Kum allele had 
been retained, and combined with btl-GAL4, UAS-act.GFP (Sanyal et al., 2005). 
The presence of the Kum170 allele was further confirmed by a failure of 
complementation of Kum295 (Figure 6.5).  
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Figure 6.4 Genetic crossing scheme demonstrating recombination of the Kum170 allele and 
btl-GAL4, UAS-act.GFP on the 2nd chromosome 
 
 
 
 
 
 
Figure 6.5 Complementation test for the Kum170 allele 
Genetic crossing scheme demonstrating the complementation test used to confirm the presence of 
the Kum170 allele on the 2nd chromosome. An absence of viable straight winged flies confirmed the 
presence of the allele.  
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6.4.2 Embryos with maternally derived Kum170 and expressing 
SERCA RNAi in tracheal cells, display grossly normal 
patterns of branching morphogenesis 
To test inhibition of maternal SERCA, in parallel to the targeting of tracheal, 
zygotic SERCA with RNAi, btl-GAL4, UAS-act.GFP, Kum170 / CyO virgin female 
flies were crossed to homozygous RNAi 4474 males. Given the Kum allele was 
heterozygous in these embryos, it was postulated that a stronger heat-shock 
might be tolerated, without inducing global defects in embryogenesis. Stage 11 
embryos were therefore placed on moist nylon mesh in a ventilated PCR 
microcentrifuge tube and a PCR thermocycler used to induce a 37°C heat-shock 
for 30-60 minutes: a method described by Vanario-Alonso et al (Vanario-Alonso, 
O'Hara, McGinnis, & Pick, 1995). Embryos were fixed at stage 16 and stained 
with an antibody to the tracheal luminal protein, 2A12 (DSHB, Iowa). Embryos of 
genotype btl-GAL4, UAS-act.GFP, Kum170 /RNAi 4474 were distinguished from 
internal controls (RNAi 4474 /CyO) based on the presence of tracheal GFP 
(Figure 6.6).  
Control and Kum embryos submitted to a 60 minute heat-shock did not develop 
further and morphologically remained at stage 11 (Figure 6.6). This duration of 
heat-shock was therefore considered too long and a 30 minute regime used in 
further experiments. Embryos submitted to a 30 minute heat-shock developed to 
stage 16 and appeared to have a grossly normal tracheal system (Figure 6.6). All 
stereotypical tracheal branches were clearly identified in the embryo at 
appropriate positions, including those finer, shorter and often more variable 
ones discussed earlier in this chapter. SERCA inhibition comprising the dominant 
negative Kum170 allele (to target maternally contributed SERCA) and RNAi 4474 
in tracheal cells (targeting zygotic SERCA) therefore did not appear to disrupt 
tracheal branching morphogenesis. Although it was not possible to quantify the 
degree of total SERCA inhibition in specific tracheal cells, reviewing the 
functional effects of Kum170 and RNAi used in isolation, it seems likely that when 
used in combination, they will result in significant reduction in protein function.  
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Figure 6.6 Embryos with maternally derived Kum170 and expressing SERCA RNAi in tracheal 
cells, display grossly normal patterns of branching morphogenesis 
Confocal micrographs (3D projections of z-stacks) of stage 16 Drosophila embryos heterozygous 
for the Kum170 allele and expressing SERCA RNAi in the embryonic tracheal cells (btl>RNAi) vs. 
internal control (RNAi 4474/CyO). The tracheal system is stained with 2A12 antibody (DSHB, 
Iowa). The upper 4 panels show embryos subjected to a 30 minute heat-shock at stage 11, going 
on to develop normally. The lower 2 panels show an embryo subjected to a 60 minute heat-shock 
at stage 11 and failing to develop any further (imaged at 14 hours AEL). The lateral aspect of the 
embryo is shown (anterior to the left) in each case. Scale bar indicates 100 µm. 
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6.5 Effects of targeting Kum170 to tracheal cells 
An alternative method to test the effects on tracheal morphogenesis, of the 
conditional, dominant negative Kum allele, is to specifically target this mutation 
to tracheal cells. The mutated cDNA from Kum170 has been previously been 
cloned into the pUAST vector, permitting misexpression of Kum170 with GAL4 
drivers (Sanyal et al., 2005). This transgene was made use of to target Kum170 
specifically to tracheal cells, using the btl-GAL4 driver. 
6.5.1 Expression of Kum170 in tracheal cells does not disrupt 
branching morphogenic events 
Flies carrying the UAS-Kum170 transgene were crossed to those carrying btl-GAL4. 
Embryos were collected and submitted to heat-shock regimens in order to 
activate the conditional mutation. The spatially restricted expression of Kum170 
enabled different, more intensive heat regimes to be trialled without inducing 
global defects in embryogenesis. Given protein turnover and a likelihood that 
new SERCA may be synthesised in active tracheal cells throughout 
embryogenesis, it was postulated that repeated heat-shocks to activate newly 
formed Kum170 protein, may be most effective at inhibiting SERCA function. A 
PCR thermocycler was therefore used to submit embryos to a regime similar to 
that successfully employed elsewhere (Vanario-Alonso et al., 1995). Repeated 
37°C heat-shocks, of 5-10 minute duration in each hour, interrupted by recovery 
periods of 25 °C, were instigated from 6 hours AEL to 14 hours AEL 
(approximately from stage 11 to 16, the majority of branching morphogenesis). 
Embryos were then fixed, stained and imaged as previously described. 
Embryos submitted to the aforementioned heat regime developed appropriately 
and gross morphology appeared normal. Tracheal branching morphogenesis also 
appeared unaffected by btl>Kum170 expression and repeated heat-shock 
treatments (Figure 6.7). Major and minor branches (as previously listed) were 
evident and appeared appropriate in their position, thus indicating that 
branching events are not influenced by SERCA inhibition with targeted Kum170 
expression. When the diameter of the dorsal trunk was reviewed, there 
appeared to be some discrepancy between groups (Figure 6.7): further 
investigation of tube diameter was therefore warranted. 
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Figure 6.7 Expression of Kum170 in tracheal cells does not disrupt branching morphogenic 
events 
Confocal micrographs (3D projections of z-stacks) of stage 15/16 Drosophila embryos expressing 
Kum170 specifically in the embryonic tracheal cells (btl>Kum170)  vs. control (w1118). Embryos were 
subjected to repeated 5 minute 37°C heat treatments in each hour from 6h AEL until 14h AEL. The 
tracheal system is stained with 2A12 antibody (DSHB, Iowa). The lateral aspect of the embryo is 
shown (anterior to the left) in each case. Scale bar indicates 100 µm.  
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6.5.2  Kum170 expression in tracheal cells does not alter dorsal 
trunk diameter or luminal expansion 
It is known that respiratory tube size in Drosophila is dependent on 
developmental stage. Relatively small differences in maturity can lead to 
significant changes in tube diameter and length: dorsal trunk diameter triples 
over a period of 3 hours, around stages 14 to 16 (Beitel & Krasnow, 2000). 
Although there was an apparent difference in the dorsal trunk diameter between 
btl>Kum170 and w1118 groups (Figure 6.7), one has to be mindful of any potentially 
subtle differences in embryonic stage. In addition to the noticeably wider dorsal 
trunk, the representative  btl>Kum170 example given in Figure 6.7, displays other 
tracheal features that are indicative of this example being slightly more mature 
than its w1118 counterpart. The fine ganglionic and lateral group branches are 
longer and more complex; the visceral branches also appear wider. Since 
developmental stage is a spectrum, with a lack of absolute end-points, these 
features suggest that the w1118 embryo is closer towards stage 15, whilst the 
btl>Kum170 example may be someway through stage 16 (Manning & Krasnow, 
1993). These differences are despite every effort being made to ensure equality 
of developmental stage at the initial assessment, through tight control of 
embryo laying times. The luminal protein staining method could induce further 
influence on apparent tube diameter: false-positives may be implied, for 
example, by tube-size independent changes to protein-antibody interaction. 
To further clarify this issue, a different method of determining tracheal 
diameter was employed, as described by Tsarouhas et al (Tsarouhas et al., 
2007). The apical surfaces of tracheal cells were labelled with fluorescent 
protein (btl>moesin.mRFP) and live imaging techniques employed to interrogate 
changes in diameter of the dorsal trunk (Figure 6.8) (Ribeiro et al., 2004). 
Embryos were mounted for live imaging and selected at stage 16.1 according to 
distinct gut morphology (discussed earlier). Imaging was carried out for 3 hours 
to assess changes in diameter throughout stage 16: dorsal trunk diameter was 
measured at right angles at a number of separate positions within metamere 7, 
to average tube tapering. 
There was no significant difference in dorsal trunk diameter between btl>Kum170 
and w1118 embryos, either at the beginning or end of imaging (Figure 6.8). The 
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increase in tube diameter was of a magnitude similar to that of wild-type 
embryos reported elsewhere, indicating that heat-treatment had not 
significantly influenced these events (Beitel & Krasnow, 2000; Tsarouhas et al., 
2007). Tube expansion, a process that is coupled to secretion of proteins into 
the tracheal lumen, therefore seems unaffected by inhibition of SERCA through 
the targeted over expression of the dominant negative Kum170 allele. 
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Figure 6.8 Kum170 expression in tracheal cells does not alter dorsal trunk diameter or 
luminal expansion 
Upper panel: frame from live fluorescent microscopy of stage 16 embryo. The apical surfaces of 
tracheal cells are labelled with btl>moes.mRFP. The fifth and sixth metameres are shown and the 
technique used to measure diameter illustrated with white bars. Lower panel: mean dorsal trunk 
diameter at the sixth metamere, at the beginning and end of stage 16. Tracheal diameter 
measurements performed by Dr V Tsarouhas. 
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6.6 SERCA function is required for tracheal maturation  
Tracheal maturation comprises a set of distinct cellular events that occur at 
stereotypical points in development and result in characteristic morphological 
changes (Behr, Wingen, Wolf, Schuh, & Hoch, 2007; Beitel & Krasnow, 2000; 
Manning & Krasnow, 1993; Tsarouhas et al., 2007). Firstly, in late stage 13, there 
is COP (coat protein complex) mediated secretion of proteins into the lumen: 
this event is tightly coupled to an expansion in luminal diameter (Grieder et al., 
2008; Jayaram et al., 2008; Tsarouhas et al., 2007). Secondly, there is 
endocytotic clearance of luminal protein material in mid stage 17 (Behr et al., 
2007; Tsarouhas et al., 2007). Thirdly, luminal liquid is rapidly cleared, allowing 
gas filling of the trachea in late stage 17, thus creating functional airways 
(Kaliss, 1939; Manning & Krasnow, 1993). SERCA inhibition, through targeted 
over expression of Kum170 did not appear to disrupt the early event of tracheal 
lumen expansion. SERCA’s role in later maturation events was therefore 
investigated. 
6.6.1 Embryos expressing Kum170 in tracheal cells have defects in 
tracheal gas filling 
To test the effect of Kum170 expression on another, later aspect of tracheal 
maturation, rates of tracheal gas filling were investigated. Tracheal gas filling is 
readily assessable with bright-field microscopy at late stage 17 (prior to embryo 
hatching), due to changes in light refraction. Embryos of genotype btl>Kum170 
and btl>w1118 were submitted to repeated heat treatments between stages 11 
and 16, using a PCR thermocycler, as described above. After dechorionation, 
stage 16 examples were selected and mounted under halocarbon oil. Gas filling 
was assessed just prior to embryo hatching. 
Tracheal gas filling occurred in 80% of control embryos but only 39% of 
btl>Kum170 embryos with heat-activated Kum170 expression in tracheal cells 
(p<0.001) (Figure 6.9); furthermore, without heat activation of Kum170 
expression, btl>Kum170 embryos gas-filled at normal rates (84%; p<0.001 vs heat-
treated). Given that the rate of gas filling in control embryos was unaffected by 
heat treatment (p=0.196) and unheated Kum and control embryos did not differ 
(p=0.602), these data indicate that heat treatment is having a specific affect on 
the Kum170 mutation and together, these conditions act to disrupt gas filling. The 
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proportion of heat-treated btl>Kum170 embryos that do gas fill, might be 
explained by genotype: the UAS-Kum170 line obtained from Subhabrata Sanyal, 
appeared to have P elements inserted on the second and third chromosome, but 
stock viability was maintained with a second chromosome balancer. Half of all 
collected embryos would therefore have two copies of the UAS-Kum transgene, 
whereas half would only have one copy. If two copies are required to prevent 
gas-filling, this would explain why only half the expected number of heat-
treated btl>Kum170 embryos gas fill (39% vs 80% in controls). Although, further 
exploration of this hypothesis could be achieved by introduction of a fluorescent 
conjoined, second and third chromosome balancer into the line, our data show 
that SERCA function is required in the embryonic trachea for normal tracheal 
maturation as manifest by normal rates of gas filling. 
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Figure 6.9 Embryos expressing Kum170 in tracheal cells have defects in tracheal gas filling 
Upper panels: Transmitted light micrographs of stage 17 embryos with normal gas filling of the 
tracheal system (left panel) and failure to gas fill at the expected stage (right).  
Table: Numbers of embryos displaying each tracheal gas filling phenotype at late stage 17 
(btl>Kum vs. control) in heated and unheated groups. 
Graph: Heated mutant embryos gas filled with a significantly lower frequency than controls 
(whether heated or not) and unheated mutants, with the latter three groups all gas filling at similar 
rates to one another (difference between control groups, p=0.196). Heated mutant embryos 
survived to late stage 17 with otherwise normal morphology. 
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6.6.2 Few embryos expressing Kum170 in the trachea have defects 
in luminal protein clearance 
Having witnessed an impairment of gas filling, further aspects of tracheal 
maturation were investigated. Clearance of proteinaceous material from the 
tracheal lumen at stage 17 occurs prior to tracheal gas filling and this process 
has been elegantly interrogated using live imaging approaches (Tsarouhas et al., 
2007). GFP labelled rat atrial natriuretic factor (ANF) was targeted to the 
trachea; its secretion and later endocytotic clearance followed using live 
fluorescent microscopy. ANF is a functionally inert, heterologous secretion 
marker: in Drosophila embryonic trachea, it has been shown to faithfully report 
the secretion and clearance of endogenous luminal proteins (Rao, Lang, Levitan, 
& Deitcher, 2001; Tsarouhas et al., 2007). This technique was employed to 
investigate effects of SERCA inhibition on luminal protein clearance. Strains 
carrying btl-GAL4, UAS-ANF-GFP were crossed to those carrying UAS-Kum170: 
collected embryos were submitted to repeated heat treatments through tracheal 
morphogenesis, as described above. Embryos were mounted around stage 16 and 
imaged with live time-lapse fluorescent microscopy. The distribution of ANF-GFP 
was dynamically tracked over periods of up to eight hours.  
Clearance of luminal ANF-GFP failed to occur only in a small number of 
btl>Kum170 embryos: this contrasted with the control group where clearance was 
always witnessed (Figure 6.10). Difference in tracheal protein clearance rate 
between groups was not statistically significant (Table 6.3). Normal levels of 
SERCA function in tracheal cells do not, therefore, appear to be critical for 
endocytotic protein clearance at the apical cell membrane. However, these data 
are complicated by a number of caveats: (i) residual SERCA function (unaffected 
by Kum170) may have been sufficient for protein clearance to occur in the 
majority of embryos; (ii) findings may have been influenced by presence of one 
vs. two copies of the UAS-Kum170 transgene (discussed above); (iii) small sample 
sizes could predispose to type II error (failure to detect a real difference). 
However, given the marked difference in rates of tracheal gas filling seen with 
the same experimental conditions, and hence also similar caveats (Figure 6.9), 
there appears to be a difference in relative SERCA requirement for these distinct 
tracheal maturation processes. 
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Figure 6.10 Few embryos expressing Kum170 in the trachea have defects in luminal protein 
clearance 
Live fluorescent microscopy of embryos expressing ANF-GFP under the control of the btl-GAL4 
driver. The left hand panels show a control embryo (w1118): ANF-GFP is cleared from the tracheal 
lumen by 200 minutes; followed by tracheal gas filling. All control embryos displayed normal protein 
clearance (n=12). Right hand panels show an example of the small number (3/17) of btl>Kum170 
embryos failing to clear luminal protein: ANF-GFP remains in the tracheal lumen throughout the 
period of imaging. Considerable auto-fluorescence from embryonic gut rudiments is also evident. 
 
 
Table 6.3 Frequency of embryonic tracheal protein clearance 
 
p=0.2463 btl>Kum w1118 
Protein clearance 14 12 
No protein clearance 3 0 
Total embryos 17 12 
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6.7 Discussion 
In this chapter a number of approaches to genetically inhibit SERCA function in 
the embryo have been tested. These have targeted maternal and zygotic SERCA, 
throughout the embryo (homozygous Kum mutants), specifically in tracheal cells 
(btl>Kum) and a combination of the two (Kum and btl>RNAi). Dynamic calcium 
imaging of cells carrying the Kum allele confirmed significant reduction in SERCA 
function. Despite this, all of these approaches failed to significantly perturb 
tracheal branching. In view of the potential for (and high likelihood of) residual 
functional protein with all these methods, it is not possible to conclude that 
SERCA function is unnecessary for embryonic tracheal branching. However, the 
grossly normal phenotype, despite significant SERCA inhibition, suggests this is a 
possibility.  
What might account for the differences between Drosophila embryonic airway 
branching, that is able to tolerate significant SERCA inhibition, and murine lung 
branching, with its striking sensitivity to levels of SERCA function (Lansdale, 
Connell et al., 2010)? One hypothesis is that Drosophila embryos apparently lack 
an organised airway smooth muscle (ASM) layer, in contrast to mammals, who 
depend on ASM for critical biochemical and mechanical regulation of airway 
morphogenesis. SERCA is known to be essential for excitation contraction 
coupling in many systems and is enriched in Drosophila muscle (Harding & 
Hooper, 1996; Jesudason, 2009; Magyar et al., 1995; Mailleux et al., 2005). 
Could a lack of ASM in Drosophila explain this apparent insensitivity to SERCA 
inhibition? Given this hypothesis, the presence of organised ASM in Drosophila 
embryos was investigated by co-staining for both the trachea and muscle myosin 
heavy chain (Figure 6.11) (Kiehart & Feghali, 1986). The segmental pattern of 
muscle myosin fibres was in keeping with other reports, and there was no 
evidence of myosin being organised around the tracheal system (Bate, 1990). 
This was somewhat expected, given no previous suggestion of Drosophila ASM in 
detailed characterisations of the system (Manning & Krasnow, 1993). The 
plausibility of the above hypothesis relies on SERCA’s role in mammalian airway 
branching being solely mediated through ASM function: this seems unlikely given 
findings of a similar, reversible, CPA induced abolition of airway branching in 
epithelial-only (lacking ASM) murine lung explants (courtesy of EC Jesudason, 
unpublished data).  
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Figure 6.11 Muscle myosin expression in the embryo is not organised around the tracheal 
system 
Confocal micrographs (3D projections of z-stacks) of wild-type stage 16/17 Drosophila embryos 
The embryonic tracheal lumen are stained with the mouse monoclonal antibody, 2A12 (DSHB, 
Iowa) in red: embryonic muscle is stained with a rabbit polyclonal antibody to muscle myosin heavy 
chain (Kiehart lab, Duke University, USA) in green. The dorsal and lateral aspects of the central 
metameres of the embryo are shown, as indicated.  
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Another fundamental difference between embryonic tracheal morphogenesis in 
Drosophila and airway branching morphogenesis in mammalian embryos, is the 
requirements for cell proliferation, which is absent from the former but critical 
in the later. Given SERCA’s putative role as a cell cycle regulator, its essential 
requirement in mouse embryonic branching may be for cell proliferative events, 
which are not present in the fly (Legrand et al., 2001; Waldron et al., 1994). 
Further exploration of this hypothesis is performed later in Chapter 7. 
In contrast to apparently normal tracheal branching, SERCA inhibition had a 
marked effect on tracheal maturation, causing a significant aberration of gas 
filling in late stage 17 (Figure 6.9). Gas filling occurs upon liquid clearance from 
the embryonic trachea: this process may be of high translational importance, 
given that human survival is dependent on an ability to rapidly clear the airway 
of liquid shortly after birth, and problems with this process are implicated in 
newborn disease (Jain & Eaton, 2006). Currently there is a relative dearth of 
understanding about the molecular regulation of these fascinating and 
translationally important events. In ongoing work, investigators have screened 
the Drosophila genome to understand the regulation of these processes 
(Samakovlis, 2010). Endocytosis is known to play the key role in clearing tracheal 
luminal proteins prior to liquid clearance and gas filling: there is some 
discordance however, about whether liquid clearance itself is mediated by 
endocytosis. The novel finding of SERCA as a regulator of liquid clearance/gas 
filling, (that may be endocytosis dependent) is interesting, and potentially 
significant, not least because artemisinins (potent anti-malarial drugs) have 
been shown to inhibit the Plasmodium falciparum SERCA orthologue (PfATP6) 
and markedly inhibit endocytosis (Eckstein-Ludwig et al., 2003; Hoppe et al., 
2004). It therefore seems conceivable that SERCA’s effects on tracheal liquid 
clearance in Drosophila may be mediated through changes in endocytosis. 
Contrasting with this is the finding that similar SERCA inhibition did not 
significantly impair clearance of tracheal luminal proteins, a process that is also 
dependent on endocytosis. These data therefore indicate that if tracheal liquid 
clearance/gas filling is dependent on endocytosis, these processes are distinct in 
mechanism from those of endocytotic protein clearance, already known to differ 
temporally. Further work will directly investigate the effects of SERCA inhibition 
on specific markers of endocytotic activity. 
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Another possible explanation for a failure of liquid clearance by SERCA deficient 
cells, is through disruption of apical membrane Ca2+ activated Cl- ion transport: 
although not previously linked to tracheal liquid clearance per se, these protein 
channels have been implicated in determining embryonic tracheal size and are 
likely to be sensitive to changes in SERCA dependent Ca2+ levels (A Uv, Tang, & 
Cavoshi, 2009). Given Cl- ion flux is a key determinant of mammalian lung liquid 
(both secretion and absorption), this hypothesis could partly explain a conserved 
role for SERCA from fly airway maturation events to murine lung morphogenesis 
(Olver & Strang, 1974; Saumon, 2000).  
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Chapter 7 
 
SERCA FUNCTION IS ESSENTIAL FOR DORSAL 
AIR SAC PRIMORDIUM DEVELOPMENT IN 
DROSOPHILA  
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7.1 Introduction 
Drosophila metamorphosis, the process transforming larvae into adult flies, is 
characterised by consumption of differentiated larval cells and formation of 
pupal and adult tissues from the proliferation and differentiation of imaginal 
cells; these tissue-specific progenitors are defined in embryogenesis, but remain 
quiescent until later larval life (Harbecke et al., 1996; Kylsten & Saint, 1997). 
During metamorphosis, respiratory organogenesis proceeds in order to meet new 
aerobic demands of tissues destined for the adult, whilst continuing to satisfy 
those of existing larval and pupal tissues: the tracheal system is entirely 
remodelled, a process beginning in the third larval instar (Manning & Krasnow, 
1993; Whitten, 1980). Previously thought to exclusively involve imaginal cells, it 
is now known that this remodelling occurs when two distinct populations of 
tracheoblasts (dedicated imaginal progenitors and a set derived from previously 
differentiated larval cells that regain multi-potency), populate the scaffold of 
the existing larval tracheal system (Guha et al., 2008; T. Matsuno, 1990; Sato et 
al., 2008; Weaver & Krasnow, 2008). 
7.1.1 The dorsal air sac primordium (ASP) 
In the second thoracic tracheal segment (Tr2), a stereotypical structure buds 
close to a point of bifurcation of the first transverse connective branch, during 
the third larval instar, and extends posteriorly as part of the adepithelial layer 
of the imaginal wing disc (Figure 7.1A) (Sato & Kornberg, 2002). Known as the 
dorsal air sac primordium (ASP), this tubular structure further develops in the 
pupal period to form dorsal air sacs in the adult, the dilated reservoirs that 
juxtapose flight muscles, supplying them with oxygen (Sato & Kornberg, 2002). 
In contrast to tracheal remodelling, seen during metamorphosis when the larval 
system is used as a template, the ASP forms de novo from outgrowth of tracheal 
epithelial cells through the adepithelial layer. ASP development involves cell 
proliferation, cell migration and directed patterning events, leading to a distinct 
structure comprising a proximal ‘stalk’ and distal ‘tip’ (Figure 7.1B-D) 
(Cabernard & Affolter, 2005; Sato & Kornberg, 2002). Tracheal cells, retaining 
epithelial apico-basal polarity, migrate away from the tracheal cuticle to form 
an ASP apical lumen, filled with secreted proteins; this lumen expands through 
cell proliferation and migration. 
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Figure 7.1 The dorsal air sac primordium (ASP) develops late in the third larval instar 
Panel A: schematic diagram of a section through the length of the imaginal wing disc. The ASP 
buds off the first transverse connective (TC, green) tracheal branch; forming in the adepithelial 
layer (AE, red). The peripodial membrane (PM, black) and columnar epithelium (CE, grey) are also 
demonstrated.  Panels B-D, Confocal micrographs of late third instar imaginal wing discs. Panel B: 
the position of the ASP within the wing disc is demonstrated, branching off the transverse 
connective tracheal branch (TC), close to a point of its bifurcation. Tracheoblasts are labelled with 
btl-GAL4, UAS-act.GFP. Scale bar indicates 100 µm. Panel C: 3D projection of z-stack slices 
through the depth of the ASP. The ASP is pseudo-coloured to illustrate depth of its structure 
(colour scale indicates depth measurements). Panels D: representative slices through the ASP 
(upper row) and lateral cross-sectional reconstructions (lower row): tracheoblasts are labelled with 
UAS-act.GFP (cell architecture, left) and UAS-DsRedNLS (nuclei, middle): the merged image is also 
provided (right). Scale bar indicates 20 µm.  
   
 190 
7.1.2 Molecular regulation of ASP development 
In contrast to the wealth of information available regarding molecular regulation 
of embryonic airway morphogenesis, relatively little is known about ASP 
development. Key molecular players have been identified as the epidermal 
growth factor receptor (EGFR) and fibroblast growth factor (FGF) signalling 
pathways: the former is required for tracheoblast proliferation and survival, 
whilst the later, strictly for cell migration at the tip of the ASP (Cabernard & 
Affolter, 2005; Sato & Kornberg, 2002). In order to elicit their effects on 
morphogenesis, both pathways utilise the downstream, Ras/Mitogen-activated 
protein (MAP) kinase signalling cascade (Cabernard & Affolter, 2005). 
Interestingly, pointed, an ETS (E-twenty six) domain transcription factor that 
mediates Ras/MAP kinase signalling, is essential for FGF dependent cell 
migration, but not EGFR mediated cell survival and proliferation (Brunner et al., 
1994; Cabernard & Affolter, 2005; O'Neill, Rebay, Tjian, & Rubin, 1994).  
Cells at the tip of the ASP, marked by escargot expression, are key to 
morphogenic events; they send out actin-based cytoplasmic extensions 
(cytonemes, types of filipodia), known to be specific to individual signalling 
pathway proteins (Roy, Hsiung, & Kornberg, 2011; Sato & Kornberg, 2002). 
Cytonemes expressing the btl receptor extend out from the ASP, directly 
contacting branchless (bnl) expressing cells in the columnar epithelium of the 
wing disc: this Drosophila FGF-FGFR (btl-bnl) interaction is critical for driving 
cell migration in ASP morphogenesis. Spatial restriction of this FGF signalling, a 
key process in determining ASP morphology, is effected by a matrix 
metalloprotease, Mmp2: mmp2 deficient ASPs display an extended tip territory, 
brought about by a failure of repression of FGF-ERK signalling by lateral 
inhibition pathways (Wang, Uhlirova, & Bohmann, 2010).  
7.1.3 The ASP as a model of tubular organogenesis 
Until now, this investigation has focussed on SERCA’s role in Drosophila 
embryonic development, principally tracheal branching morphogenesis, but also 
elements of tracheal maturation. Studies of the embryonic trachea have 
contributed greatly to our understanding of branching morphogenesis and tube 
formation, but whilst these events are genetically homologous to mammalian 
airway development, they differ fundamentally: Drosophila embryonic tracheal 
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morphogenesis proceeds without cell division, a critical component of 
mammalian organogenesis. Investigators have suggested that ASP development, 
being the only recognised case of tubulogenesis in the fly characterised by cell 
division and directed morphogenesis, is a better system with which to model 
mammalian tubular organogenesis, such as that of the lung and kidney (Guha et 
al., 2008). This system was utilised to further interrogate SERCA’s function in 
airway development. 
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7.2 Aims 
In this chapter, ASP development is used to model mammalian prenatal airway 
morphogenesis and explore SERCA’s role in these events. Effects of SERCA 
inhibition on the ASP are tested, with specific aims of determining: 
(i) What is the effect of SERCA inhibition on ASP morphogenesis? 
(ii) Does SERCA inhibition alter ASP cell proliferation or apoptosis? 
(iii) How does SERCA inhibition influence cell fate in the ASP? 
(iv) How are SERCA’s effects on ASP morphogenesis mediated? 
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7.3 Characterising the dorsal air sac primordium 
Prior to investigating effects of SERCA inhibition on ASP development, its normal 
structure was further characterised. The tubular structure of the ASP forms from 
directed enlargement of a ‘sheet’ of tracheal epithelial cells that retain apico-
basal polarity to form a respiratory lumen (Cabernard & Affolter, 2005). This 
process has been elegantly demonstrated by others, but details of epithelial 
structure, including cell orientation, do not appear to have been well 
catalogued.  
7.3.1 Development of the ASP epithelium 
ASP tracheoblasts were dual labelled with nuclear and actin fluorescent proteins 
described in Chapter 4 (btl-GAL4, UAS-act.GFP, UAS-DsRedNLS) and imaged with 
confocal microscopy. Discs-large (Dlg) staining was employed to aid 
characterisation of cell polarity. Throughout much of ASP development, cross-
sectional reconstructions of z-stacks through its structure, indicate it is 
composed of a single layer epithelium, with cells arranged apico-basally around 
the primitive lumen (Figure 7.1). Here, more distal ASP tracheoblasts that are 
arranged in a layer abutting the columnar epithelium of the wing disc proper, 
appear columnar in shape themselves: those opposite, adjacent to the 
outermost surface of the disc, consistently appear more flattened in shape 
(Figures 7.1 & 7.2). Later on in ASP morphogenesis, just prior to pupation, a 
lumen proper can just be seen to be emerging; here it becomes evident that the 
epithelium surrounding this is more than one cell thick (Figure 7.2). The 
structure of this epithelium is interesting: cells lining the neo lumen appear 
flattened, almost squamous like in shape, whilst adjacent, more basal cells 
forming the remaining ASP structure, are more columnar (Figure 7.2). This 
appearance is reminiscent of respiratory epithelia in other species, providing 
further evidence that Drosophila ASP morphogenesis is a good model for studying 
airway development. Since structure and function are intimately related in much 
of biology, it seems plausible that apical epithelial cells have distinct functions, 
as well as a distinct structures, to those located more basally in the ASP. Given 
evidence of secreted luminal proteins early in ASP development, specialised 
apical membrane activity will be required to clear this prior to respiratory 
function (similar to embryonic tracheal maturation discussed in Chapter 6): more 
basal, columnar cells may play a more structural, supportive role in the ASP. 
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Figure 7.2 Development of the air sac primordium (ASP) respiratory epithelium 
Confocal micrographs of late third instar imaginal wing discs. Tracheoblasts are labelled with btl-
GAL4, UAS-act.GFP, UAS-DsRedNLS: Discs-large (Dlg) antibody staining (DSHB, Iowa) is shown in 
grey in left panels. Upper left three panels: lateral cross-sectional reconstructions through the wing 
disc. The position of the ASP in the adepithelial layer is illustrated; the columnar epithelium (CE) of 
the wing disc proper and peripodial membrane (PM) are labelled. More distal ASP tracheoblasts in 
a layer abutting the columnar epithelium (labelled *), appear columnar in shape: those close to the 
outer aspect of the wing disc (labelled #) consistently appear flattened in shape. Remaining panels: 
section through an ASP present just prior to pupation. The emerging respiratory lumen is evident 
(labelled with arrows) and appears to be lined by flattened, squamous-like tracheoblasts: adjacent 
cells, located more basally, appear more columnar in shape. Scale bar indicates 20 µm.  
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7.4 SERCA is required for dorsal air sac primordium 
(ASP) development 
7.4.1 Targeted SERCA RNAi disrupts ASP development 
To test the requirement of SERCA function for ASP morphogenesis, flies carrying 
the SERCA RNAi construct, VDRC 4474 (discussed in Chapter 5), were crossed to 
those carrying btl-GAL4, UAS-act.GFP. Embryos were collected over short time 
periods and aged to the wandering third instar, at approximately 120 hours AEL. 
Wing discs were dissected from larvae and mounted for confocal imaging. ASP 
morphogenesis in wing discs from RNAi larvae was compared to that of controls 
(w1118 x btl-GAL4, UAS-act.GFP). ASP development was disrupted by btl>RNAi 
expression and a spectrum of phenotypes were witnessed (Figure 7.3). Most 
severely affected examples displayed ASPs that were limited to a number of 
disordered cytoneme like strands, arising from around the bifurcation of the 
transverse connective tracheal branch, with no real body of ASP cells. Less 
affected examples displayed smaller, similarly disordered looking ASPs, that 
were characterised by being widest at their proximal aspect (immediately 
adjacent to the trachea), therefore contrasting starkly with control ASPs 
displaying a thin ‘stalk’ proximally. The least affected examples appeared more 
in keeping with control ASPs, although the ‘stalk’ of the ASP never appeared 
entirely normal.  
Further exploration of this phenotype was carried out by making use of 
previously characterised, more potent SERCA RNAi lines, created from 
recombination of RNAi 4474 with Dicer2 or RNAi 107446 (Chapter 5). Given these 
lines were shown to induce lethality in the second instar when driven by btl-
GAL4 (Chapter 5), it was necessary to temporally restrict their expression, using 
temperature sensitive genetic elements. The tubGAL80ts transgene, carried on 
the third chromosome was therefore combined with btl-GAL4, UAS-act.GFP on 
the second, using the crossing scheme detailed in Figure 7.4 (S. E. McGuire et 
al., 2003; S. E. McGuire et al., 2004). In order to restrict RNAi expression early 
in development, larvae were kept at 18°C until late in the second instar, when 
they were transferred to 29°C and aged to the wandering third instar. At 18°C, 
tubGAL80ts represses the transcriptional activity of btl-GAL4 and effects of the 
RNAi construct will be limited: at 29°C, tubGAL80ts is not active, hence btl-GAL4 
will drive expression of SERCA RNAi in tracheal cells, specifically in the third 
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instar, during which time the ASP develops. It is also of note that GAL4 activity 
(and hence also RNAi expression) will be boosted at 29°C, compared with the 
standard experimental temperature of 25°C (Brand & Perrimon, 1993; Duffy, 
2002).  
The more potent SERCA RNAi lines (described earlier) were crossed to btl-GAL4, 
UAS-act.GFP; tubGAL80ts; temperature shifts instigated and ASP phenotype 
assessed as above. RNAi 4474 recombined with either Dicer2 or RNAi 107446, 
resulted in a similar, but more consistently abnormal ASP phenotype, compared 
to RNAi 4474 alone (Figure 7.3). ASP morphology was always abnormal with no 
evidence of the ‘stalk’ and ‘tip’ phenotype that characterises the wild-type ASP; 
the SERCA deficient ASP was at its widest proximally, immediately adjacent to 
the trachea. The border of the ASP also appeared irregular, as opposed to the 
smooth edge seen in controls. Increased phenotypic consistency is likely to be 
due to a combination of increased potency of SERCA knockdown, higher GAL4 
activity at 29°C, and tight temporal control of RNAi action with GAL80: RNAi will 
mediate its actions solely in the third instar, during ASP development, 
contrasting with RNAi 4474 experiments, when the RNAi will have been active 
since embryogenesis.  
Early in the third instar (approximately 80 hours AEL), the wild-type ASP buds 
from the trachea, being relatively small and displaying a wide based, rounded, 
approximately triangular appearance (Cabernard & Affolter, 2005). Possibility of 
the SERCA deficient, RNAi phenotype being solely explained by this early wild-
type ASP appearance was discounted: larvae were carefully aged to at least 120 
hours AEL and were seen to ‘wander;’ the RNAi phenotype was considerably 
disordered and roughened in appearance compared to the smooth, apico-basally 
ordered wild-type; many RNAi affected examples failed to display any significant 
ASP cellular substance other than isolated cytonemes. 
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Figure 7.3 Targeted SERCA RNAi disrupts dorsal air sac primordium (ASP) development 
Confocal micrographs of third instar larval imaginal wing discs. The tracheal system is 
demonstrated using btl-GAL4 driven UAS-actin.GFP. Targeted SERCA inhibition is achieved using 
btl-GAL4 driven UAS-RNAi constructs +/- UAS-dicer2 and compared to a control (btl-Gal4, UAS-
act.GFP x w1118). Upper panels show representative phenotypes for the control, and RNAi 4474 
recombined with either Dicer2 or RNAi 107446 (as indicated). Lower panels illustrate the range of 
phenotypes seen with a weaker degree of knockdown (RNAi 4474 alone). Scale bar indicates 25 
µm. 
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Figure 7.4 Genetic crossing scheme used to generate Drosophila to permit spatial and 
temporal restriction of transgene expression, along with tracheal cell fluorescent labelling.  
The heat sensitive GAL4 repressor, GAL80, under control of a tubulin promoter (tubGAL80ts) on 
the third chromosome, was combined with btl-GAL4, UAS-act.GFP on the second chromosome.  
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7.4.2 SERCA RNAi decreases G-CaMP3 fluorescence in the ASP 
Having previously shown SERCA RNAi to be effective at reducing SERCA function 
in embryos (Chapter 5), we confirmed that targeted SERCA RNAi expression was 
effective in the ASP in vivo by using the genetically encoded Ca2+ indicator 
(GECI) G-CaMP3. G-CaMP3 is an ‘improved’ GECI: it is brighter, possesses greater 
protein stability, and has a larger dynamic range and higher affinity for Ca2+ 
compared to previous versions (Tian et al., 2009). G-CaMP3 has been cloned to 
the pUAST vector and its targeted expression used to image Ca2+ in neurons of 
Drosophila in vivo (Brand & Perrimon, 1993; Tian et al., 2009; Xiang et al., 
2010). In an attempt to quantify intracellular Ca2+ levels in cells of the ASP, G-
CaMP3 expression was driven with btl-GAL4 and confocal imaging of live imaginal 
wing discs undertaken, using a protocol adapted from that of Aldaz et al (Aldaz 
et al., 2010). SERCA RNAi 4474 was targeted to the ASP (btl>RNAi) and compared 
to controls (btl>w1118). 
The intensity of G-CaMP3 fluorescence was markedly and consistently lower in 
ASP tracheoblasts expressing RNAi 4474, compared to controls: mean +/- SEM 
fluorescent pixel intensity was 74.5 +/- 6.0 vs. 150.2 +/- 2.8 (n≥6 in each group, 
p=0.000) (Figure 7.5). Wing discs were imaged for periods up to 30 minutes: 
there was no suggestion of propagating Ca2+ waves in this system over such 
durations. At first glance, reduced G-CaMP3 emission indicates that intracellular 
Ca2+ concentration is lower in cells expressing RNAi. However, given that this is 
directly opposite to previous observations in this thesis (Chapter 5) and wholly 
inconsistent with published reports, this is almost certainly not the case (Abell 
et al., 2011; Raymond-Delpech et al., 2004; Zhang et al., 2006). The most likely 
explanation for these findings is that SERCA knockdown with RNAi alters the 
expression level of mature G-CaMP3 protein. G-CaMP GECIs are based on single 
fluorescent proteins and do not offer the benefits of ratiometric measurement; 
their emission is therefore dependent on expression level (Nakai et al., 2001). 
Given that SERCA is likely to play fundamental roles in post-translational 
modifications, e.g. protein folding, it is probable that significant SERCA 
knockdown with RNAi alters expression of the circular permuted G-CaMP 
molecule (Caspersen et al., 2000; Hojmann Larsen et al., 2001). Despite this 
limitation precluding accurate Ca2+ quantification, markedly reduced G-CaMP 
fluorescence does indicate that SERCA RNAi is having a substantial effect in cells 
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of the ASP. In view of previous confirmation of RNAi 4474 inducing specific 
SERCA knockdown in embryonic cells (Chapter 5), this effect is highly likely to be 
a result of similar, effective SERCA knockdown in ASP tracheoblasts.  
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Figure 7.5 SERCA RNAi decreases G-CaMP3 fluorescence in the dorsal air sac primordium  
Confocal micrographs of third instar larval imaginal wing discs. The genetically encoded calcium 
indicator G-CaMP3 (green) is expressed within cells of the dorsal air sac primordium (ASP) using 
btl-GAL4. Targeted SERCA inhibition is achieved using btl-GAL4 driven UAS-RNAi 4474 and 
compared to a control (w1118). Scale bar indicates 20 µm. 
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7.4.3 Effects of SERCA inhibition on ASP development are 
dependent on number of deficient cells  
To test whether effects on ASP development from SERCA knockdown are: (i) 
specifically due to SERCA deficient tracheoblasts; and (ii) dependent on the 
number of deficient cells, random, ‘flip-out’ clones were generated (Figure 7.6). 
In this technique, heat-shock induced FLP-recombinase removes a 
transcriptional-termination cassette that is inserted between a defined promoter 
and GAL4: in this case, act>y>GAL4 was used (Duffy et al., 1998; Struhl & Basler, 
1993). Random SERCA loss of function clones (expressing RNAi 4474) were 
produced, labelled with GFP (UAS-GFP), and the trachea/ASP labelled with 
btl>moesin.RFP (a construct that places moesin.RFP directly under the control 
of the btl promoter) (Ribeiro et al., 2004). ASP morphology was assessed in wing 
discs dissected from wandering third instar larvae, as above. 
RNAi 4474 flies were crossed to those of genotype hsFLP; act>y>GAL4, UAS-GFP; 
btl>moes.RFP and the FLP-recombinase activated with a late second instar 37°C 
heat-shock (Wang et al., 2010). When relatively short heat-shocks were used 
(15-30 minutes), the ASP developed fairly normally (Figure 7.7), with a defined 
‘stalk’ and ‘tip’ morphology being evident. GFP-labelled RNAi clones were seen 
at various points in the ASP; their distribution is considered later in Section 
7.6.2. When larvae were subjected to 60 minute heat-shocks, ASP morphology 
was grossly disrupted; an abundance of GFP-labelled clones were evident, 
collected in a group at the point of tracheal branch bifurcation where the ASP 
should form. This phenotype was not dissimilar to that witnessed in btl>RNAi 
experiments described above (Figure 7.3). Given that longer duration heat-
shocks will induce more cells to ‘flip-out,’ express RNAi, and be SERCA deficient 
early in ASP development (from the beginning of L3), it is apparent that SERCA 
deficient cell number is critical in determining ASP morphology. These data also 
indicate that the observed ASP phenotype is specifically due to ASP 
tracheoblasts being SERCA deficient, rather than being a more generalised effect 
of RNAi expression elsewhere in the tracheal system.  
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Figure 7.6 Schematic illustration of ‘flip-out’ clone generation 
Two FLP recombination target (FRT) sites flank a wild-type copy of yellow and a transcriptional-
termination cassette (T), inserted between an actin promoter and the GAL4 coding region: 
transcription therefore terminates before GAL4. In cells where heat-shock treatment induces FLP-
recombinase to catalyze recombination between the FRT sites, the yellow+ termination cassette is 
excised and GAL4 transcription occurs under the control of an actin promoter (actin>GAL4). In 
these cells, Gal4 can therefore bind to the UAS transgenes (GFP and RNAi in this case), resulting 
in their transcriptional activation.  
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Figure 7.7 Effects of SERCA inhibition on dorsal air sac primordium (ASP) development are 
dependent on the number of deficient cells  
Confocal micrographs (representative slice through the ASP) of third instar larval imaginal wing 
discs. Random SERCA RNAi flip-out clones were generated using hsFLP recombinase and 
actin>y>GAL4. Clones are marked using UAS-GFP. The tracheal system is demonstrated using 
btl>moesRFP. Larvae were submitted to a heat-shock of either 30 mins (Top Panels) or 60 mins 
(Bottom panels) at late second instar. Scale bar indicates 25 µm. 
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7.4.4 Presence of SERCA mutant clones in the ASP territory 
disrupts its development  
To confirm that disrupted ASP morphology is due to SERCA loss of function, 
rather than a non-specific effect of RNAi, SERCA mutant clones were studied. 
The mosaic analysis with a repressible cell marker (MARCM) technique was 
exploited to randomly generate cells homozygous for the hypomorphic SERCA 
mutant allele k08308ab, and positively mark them with GFP (T. Lee & Luo, 1999, 
2001; Periz & Fortini, 1999). MARCM relies on specific recombination events at 
FRT sites during mitosis, and produces cells that are either, homozygous for the 
mutation of interest, but lack tubGAL80 (and hence express act-GAL4, UAS-
GFP), or are homozygous for tubGAL80 (therefore do not express GAL4 
dependent GFP) but lack the mutant allele (Figure 7.8) (Wu & Luo, 2006). In 
order to induce GFP marked mitotic clones and fluorescently label the ASP with 
a contrasting colour, hsFLP, FRT42D, Ca-P60Ak08308ab (SERCA mutation) and 
btl>moes.RFP were combined in one fly line and FRT42D, tubGAL80, 
A>CD2>GAL4 and UAS-GFP in another (Figure 7.9).  
 
Figure 7.8 Schematic illustration of the mosaic analysis with a repressible cell marker 
(MARCM) technique 
Illustration taken from Wu et al. 2007. Mitotic recombination occurs at specific FRT sites (black 
arrowheads), producing two daughter cells, each of which is homozygous for the chromosome arm 
distal to the FRT sites. Ubiquitous GAL80 expression represses GAL4 driven GFP expression 
(UAS-GFP) in cells without the mutation. Loss of GAL80 expression in homozygous mutant cells 
results in specific expression of GFP.  
This text box is where the unabridged thesis included the following third 
party copyrighted material: 
 
Wu JS & Luo L. (2006). A protocol for mosaic analysis with a repressible 
cell marker (MARCM) in Drosophila. Nature Protocols, 1(6), 2583-2589. 
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Figure 7.9 Genetic crossing scheme used to produce stable stocks of Drosophila for 
generation of positively labelled SERCA mutant clones.  
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Clones were produced in larvae by crossing hsFLP122; FRT42D, Ca-P60Ak08308ab / 
CyO; btl>moes.RFP / TM6B with FRT42D, tubGAL80; A>CD2>GAL4, UAS-GFP. 
Embryos were collected over short time periods and allowed to develop to 
second instar, when FLP-recombinase was activated with a one hour 37°C heat-
shock. Wandering third instar larvae were selected for dissection by presence of 
GFP marked clones in thoracic imaginal discs, using fluorescent microscopy. 
SERCA mutant clones were compared to controls (FRT42D, whiteun-1). 
In both groups, few clones were seen within the ASP or tracheal system, 
compared to other regions of the imaginal wing disc (Figure 7.10). When 
sufficient SERCA mutant cells were present within or directly adjacent to the 
ASP, an abnormal morphology was evident (Figure 7.10). This proximally ‘wide-
based’ appearance of the ASP approximately phenocopied the RNAi experiments 
above and contrasted to ASPs containing control clones, that appeared relatively 
normal (Figure 7.10). These findings indicate that when sufficient tracheoblasts 
lack SERCA function, the ASP is unable to develop normally, in-keeping with the 
results of btl>RNAi and RNAi flip-out clones described above. Collectively, these 
data indicate that SERCA function is essential for normal ASP development. It is 
important to acknowledge however, that in these MARCM experiments, although 
clearly abnormal ASP morphology was seen, there were relatively few clonal 
cells within the ASP itself, particularly when compared to the surrounding 
tissues. This observation raises the question of whether or not SERCA is required 
in the surrounding, bnl expressing cells for normal ASP development: this 
hypothesis has not been tested in this thesis. Importantly, RNAi experiments 
above (Figures 7.3 and 7.7) confirm that SERCA deficiency in the ASP alone is 
sufficient to induce the phenotype. The small size of clones (often single cells) 
relative to previous reports of MARCM in the ASP, is probably explained by 
different timings of FLP-recombinase activation: heat-shock was applied in the 
second instar here, as opposed to late in embryogenesis in other studies 
(Cabernard & Affolter, 2005; Chanut-Delalande et al., 2007).  
Further analysis of mitotic clones was aided by Discs-large (Dlg) staining (4F3, 
DSHB); during imaging, z-stacks were taken through the full thickness of the 
disc. It was apparent that most clones within, or directly adjacent to the ASP, 
were small in size (usually single cells) and predominantly in a single layer at the 
interface of the ASP and columnar epithelium of the wing disc proper: clones in 
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other regions contrasted markedly, being much larger and extending through the 
depth of the disc (Figure 7.11). It is not entirely clear why this specific 
phenotype was evident in both control and mutant groups, but it appears most 
likely to be due to higher mitotic activity in these regions. Another explanation 
may be that clone cells are extruded from the ASP epithelium at this junctional 
region: this seems much less likely though, given that ‘wild-type’ clone cells 
displayed this pattern. Findings of negligible levels of apoptosis in ASP clones, 
discussed later in Section 7.5.2, also support the proposal that high rates of 
clone extrusion from the epithelium are unlikely. 
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Figure 7.10 Presence of SERCA mutant clones in the dorsal air sac primordium (ASP) 
territory disrupts its development  
Confocal micrographs (representative slice through the ASP) of third instar larval imaginal wing 
discs. The tracheal system is demonstrated using btl>moes.RFP. Random positively marked 
mitotic clones were generated using hsFLP recombinase and FRT, GAL80, A>CD2>GAL4, UAS-
GFP crossed to either FRT, SERCAk08308ab (mutant) or FRT, whiteun-1 (control).  Scale bar 
indicates 20 µm.  
   
 210 
 
Figure 7.11 Control and SERCA mutant clones related to the air sac primordium (ASP) are 
small and most frequently found in a single layer at the interface of the ASP epithelium and 
columnar epithelium. 
Confocal micrographs of third instar larval imaginal wing disc (representative slices from z-stacks). 
The tracheal system is demonstrated using btl>moes.RFP. Random positively marked mitotic 
clones were generated using hsFLP recombinase and FRT, GAL80, A>CD2>GAL4, UAS-GFP 
crossed to either FRT, SERCAk08308ab  (mutant) or FRT, whiteun-1 (control). Discs large is labelled 
with 4F3 anti-discs large antibody (DSHB, Iowa) (grey). Upper four panels are slices at 
approximately the mid-point of the ASP (mid-ASP): middle four, at the interface of the ASP and the 
columnar epithelium (ASP/CE): lower panels are x-z reconstructions through the imaginal disc. 
Scale bar indicates 20 µm for each panel. 
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7.5 Effect of SERCA inhibition on ASP cell proliferation 
and apoptosis 
Having demonstrated that SERCA loss of function results in a consistently 
abnormal ASP phenotype, it was hypothesised that this may be due, in part, to 
consequent changes in cell proliferation and / or apoptosis. 
7.5.1 SERCA inhibition reduces ASP tracheoblast proliferation 
To test the effect of SERCA knockdown on ASP cell proliferation, RNAi 4474 was 
targeted to the tracheal system and ASP, using the btl-GAL4 driver and 
proliferating cells were labelled with Phospho-Histone H3 (Ser10) antibody (Cell 
Signaling, Inc), referred to as PH3 hereafter. Phosphorylation at serine 10 is a 
specific and highly conserved modification that occurs during chromosome 
condensation, during mitosis: PH3 staining is a reliable and widely used method 
to demonstrate mitosis (Hendzel et al., 1997). The tracheal system and ASP 
were labelled with btl-GAL4, UAS-act.GFP. The ASP was imaged through its full 
thickness, with z-stack confocal microscopy and compared to controls 
(btl>w1118). Mitotic (PH3 positive) cells in each ASP were counted in both groups: 
the ASP was defined as the region distal to the transverse connective branch 
lumen, marked with GFP. 
When SERCA knockdown was induced with btl>RNAi, mitotic cells were rarely 
seen within the ASP structure, contrasting markedly with control ASPs that 
frequently contained a number of mitotically active cells (Figure 7.12). When 
quantified, the difference in proliferating tracheoblasts between groups was 
highly significant (median 0 vs. 2.5, p=0.000, Figure 7.12). This finding indicates 
that when tracheoblasts lack SERCA function, they are unable to proliferate 
normally; consistent with studies in other systems and also with murine lung 
explant findings reported in Chapter 3 (Legrand et al., 2001; Waldron et al., 
1994). Given ASP morphogenesis relies upon cell proliferation, inadequate 
tracheoblast proliferation may partly explain the disrupted ASP phenotype 
witnessed upon SERCA inhibition (Cabernard & Affolter, 2005; Sato & Kornberg, 
2002). Given that SERCA deficient ASPs display abnormal shape as well as size, it 
seems likely that abnormalities in cell migration and / or patterning also play a 
role in this phenotype (discussed in Section 7.6.2). 
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Figure 7.12 SERCA inhibition reduces air sac primordium (ASP) tracheoblast proliferation 
Upper panel: Confocal micrographs of third instar larval imaginal wing discs (representative slices). 
The tracheal system is demonstrated using btl-GAL4 driven UAS-actin.GFP. Mitotic cells are 
labelled with anti-phospho-Histone H3 (ser10) antibody (Cell Signalling Technology) SERCA 
inhibition is achieved using btl-GAL4 driven RNAi 4474 and compared to controls (w1118). 
Lower panel: Mitotic cells per air sac (median and IQR) for RNAi and control groups. Difference 
between groups is statistically significant, p=0.000. n=18 in both groups. 
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7.5.2 SERCA inhibition does not affect apoptosis in the ASP 
To test the effect of SERCA knockdown on ASP cell apoptosis, cells were labelled 
with Cleaved Caspase-3 (Asp175) antibody (Cell Signaling Inc.). Caspase-3 plays a 
key role in the execution phase of apoptosis, its active form being responsible 
for proteolytic cleavage of important cellular proteins (Fernandes-Alnemri, 
Litwack, & Alnemri, 1994). Activated caspase-3 staining is a specific and widely 
used method to detect apoptotic cells. Caspase-3 staining of imaginal wing discs 
from larvae with targeted SERCA knockdown (btl>RNAi) was compared to 
controls (btl>w1118), and also carried out in animals containing SERCA mutant 
clones (MARCM), as described earlier. ASP phenotype was assessed as previously 
indicated. 
In all groups, apoptotic cells were almost never seen in the ASP or tracheal 
system (Figure 7.13). From a total of 42 wing discs imaged, only one 
demonstrated a single apoptotic cell in the ASP. To confirm that Caspase-3 
staining was efficiently detecting apoptotic cells, a positive control was 
analysed: a region of the disc known to have higher rates of apoptosis at this 
stage, the wing/notum border was used (Milan, Campuzano, & Garcia-Bellido, 
1997). Strong staining of compact, rounded cells was evident in the positive 
control group, confirming efficacy of the staining protocol (Figure 7.13). These 
data indicate that apoptosis does not play an important role in dictating ASP 
dysmorphogenesis in SERCA deficient environments.  
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Figure 7.13 SERCA inhibition does not affect apoptosis in the air sac primordium (ASP) 
Confocal micrographs of third instar larval imaginal wing discs. The tracheal system is 
demonstrated using btl-GAL4, UAS-actin.GFP or btl>moes.RFP. Upper row: control ASP. Second 
row: targeted SERCA inhibition with btl-GAL4 driven RNAi 4474. Third row: random Ca-
P60Ak08308ab mutant mitotic clones (MARCM). Clones are marked using UAS-GFP. Apoptotic cells 
are labelled with Cleaved Caspase-3 (Asp175) antibody (Cell Signaling Technology, Inc.), shown in 
magenta. The white arrow demonstrates an apoptotic cell outside of the air sac. The scale bars 
represent 20 µm for each row. Table illustrates the number of biological repeats in each group and 
number of activated caspase-3 positive cells seen per ASP. Positive control confirms efficacy of 
apoptotic cell labelling. 
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7.6 Effect of SERCA inhibition on ASP cell fate 
To explore the effect of SERCA inhibition on ASP tracheoblast fate, random ‘flip-
out’ clones were produced, as described above (SERCA RNAi 4474 vs. control). 
Given that clones were frequently seen to be confluent, making determination 
of individual clone identity difficult, a shorter, 15 minute heat-shock was 
employed in late second instar larvae, to active FLP-recombinase in fewer cells. 
In view of previous findings (Figure 7.7), this relatively small number of ‘flipped’ 
cells ensured that ASP morphogenesis proceeded normally: individual SERCA 
deficient cells were in an otherwise normal, ‘wild-type’ background. 
7.6.1 Similar proportions of ASPs contained SERCA RNAi or 
control ‘flip-out’ clones 
Firstly, the proportion of ASPs in each group that contained any clonal cells was 
determined. Larvae that apparently contained GFP marked clones in thoracic 
imaginal discs were selected for dissection under fluorescent microscopy. Once 
imaginal wing discs were mounted and imaged with confocal microscopy, the 
proportion with clones in the ASP was determined. There was no significant 
difference in proportion of ASPs containing clone cells in the SERCA RNAi or 
control group (Table 7.1). This indicates that the process of clone formation 
itself is not unduly influenced by SERCA deficiency. It also confirms that SERCA 
deficient cells do not appear to be eliminated from the ASP epithelium to any 
significant degree: findings supported by absence of any significant levels of 
apoptosis (Figure 7.13). 
Table 7.1 Proportion of air sac primordia (ASPs) containing clone cells. 
 
Clones in dorsal air sac primordium (ASP) 
Genotype 
Yes No 
Total 
RNAi 4474 13 22 35 
w1118 12 12 24 
Total 25 34 p=0.423 
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7.6.2 SERCA deficient cells rarely populate the ASP tip domain 
The distribution of clone cells within the ASP was determined by arbitrarily 
dividing it into three distinct domains: the ‘stalk’ being most proximal, the ‘mid-
zone’ and the ‘tip’ most distally (Figure 7.14). These distinctions were based on 
observations of previous studies that demonstrated an escargot defined tip 
territory occupying approximately one third of the wild-type ASP (Wang et al., 
2010). GFP-labelled clone cells in each domain were counted for RNAi 4474 and 
w1118 groups and expressed as a ratio of total clone cells: the nuclei of all cells 
was labelled with TO-PRO-3 (Invitrogen) to aid cell counting. 
The distribution of SERCA deficient, RNAi clones was markedly different to that 
of controls (Figure 7.14). SERCA RNAi clones were significantly less likely to be in 
the ASP tip domain than control cells (p=0.002): they were significantly more 
frequently found in the stalk region (p=0.006). There was no significant 
difference between RNAi and control groups in the proportion of cells found in 
the mid-zone of the ASP (p=0.310). These data indicate that SERCA deficient 
cells have their fate restricted and are frequently unable to populate the ASP 
tip. Adoption of tip position in the ASP has previously been studied as an 
indicator of cell migratory behaviour: in approximately 70% of ASPs, wild-type 
cells labelled with MARCM techniques are known to contribute to the tip domain 
(Cabernard & Affolter, 2005; Chanut-Delalande et al., 2007). Although slightly 
different methods of assessment have been used here, findings of SERCA 
deficient cells being significantly less likely to reach the tip are largely 
comparable to those in studies demonstrating essential roles for FGF and 
Ras/MAP kinase signalling, as well as other genes such as Mhc and stam 
(Cabernard & Affolter, 2005; Chanut-Delalande et al., 2007). SERCA function 
therefore appears essential for normal ASP tracheoblast migration. 
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Figure 7.14 SERCA deficient cells rarely populate the air sac primordium (ASP) tip domain 
Upper panel: confocal micrographs (representative slice through the ASP) of third instar larval 
imaginal wing discs. Random SERCA RNAi or control (w1118) flip-out clones were generated 
using hsFLP recombinase and actin>y>GAL4. Clones are marked using UAS-GFP. The tracheal 
system is demonstrated using btl>moesRFP. All nuclei are labelled with TO-PRO-3 (Invitrogen, 
shown in magenta) to aid cell counting. The air sac is divided into 3 regions of equal length (stalk, 
mid-zone and tip). 
Lower panel: Proportion of flip out clone cells found per region of ASP (median and IQR) for RNAi 
and control groups. n=14 air sacs in both groups. 
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7.6.3 SERCA deficient ASP clones comprise fewer cells 
Given findings of reduced levels of mitosis in SERCA deficient ASPs (Figure 7.12), 
the ability of these cells to replicate was further investigated. The relative sizes 
of SERCA RNAi and control flip-out clones was determined by counting the 
number of individual cells in each clone ‘patch.’ Clones were induced and 
assessed in the same way as for clone distribution experiments discussed above: 
individual clones were defined as a ‘patch’ of GFP labelled cells in continuity 
with each other and surrounded by non-GFP labelled cells.  
SERCA deficient clones were significantly smaller in size than controls: median 
(IQR) number of GFP labelled cells in clone patches was 2 (3) vs. 6 (19), p=0.001 
(Figure 7.15). Given the likelihood of the largest patches of GFP labelled cells 
actually representing two or more clones becoming confluent, a sub-analysis was 
carried out of those clones with less than 12 cells, after reviewing the 
distribution of raw data, plotted in clone size frequency histograms (Figure 7.15) 
Despite this sub-analysis, the difference in clone size remained significantly 
different between groups (2 [2] vs. 5 [5], p=0.000) The ability of clones to 
expand during development relies on proliferation and clone size will be 
inversely related to cell-doubling time. SERCA RNAi clones were significantly 
smaller and hence SERCA deficient cells appear to have prolonged cell-doubling 
times. These data are entirely in keeping with those from PH3 staining in SERCA 
RNAi expressing ASPs (Figure 7.12) and CPA treated murine lung experiments 
(Chapter 3). Furthermore, these novel in vivo findings lend further credence to 
previous in vitro studies and confirm SERCA function is required for normal cell 
proliferative events (Legrand et al., 2001; Waldron et al., 1994).  
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Figure 7.15 SERCA deficient ASP clones comprise fewer cells 
Upper panels: histograms of frequency vs. clone size (number of cells) for SERCA RNAi and 
control (w1118) groups. 14 ASPs were analysed in each group. Lower panel: sub-analysis for clones 
<12 cells in size: scatter plot of individual clones and group median (horizontal line) are shown. 
   
 220 
7.7 Exploring mechanisms of SERCA dependent ASP 
morphogenesis 
Given suggestions of ASP development serving as a superior model for tubular 
organogenesis e.g. lung or kidney, further insight into the molecular regulation 
of these events is desirable. Data presented here show SERCA function is 
essential for normal ASP development; when lacking, defects in cell proliferation 
and migration occur. The underlying mechanism(s) behind these findings are 
important: further elaboration of SERCA’s role in tubular organogenesis may 
have high translational importance. To determine further the molecular events 
surrounding these effects, candidate pathways were selected based on prior 
findings in Drosophila ASPs and interrogated with established techniques.    
7.7.1 Targeted SERCA inhibition expands the escargot 
expressing ASP tip domain 
The zinc-finger transcription factor coded for by escargot (esg), is known to be 
strongly expressed in imaginal cells and functions to inhibit endoreplication and 
maintain diploidy (Fuse, Hirose, & Hayashi, 1994). In the embryonic trachea, esg 
is essential for epithelial tube fusion; it has been shown to regulate cell 
adhesion and motility, inducing tip cell fusion through E-Cadherin recruitment 
(Samakovlis, Manning et al., 1996; Tanaka-Matakatsu et al., 1996). In ASP 
development, esg is expressed in the distal part (tip) of the ASP from around 
mid-third instar (Sato & Kornberg, 2002). It has been shown that over-expression 
of esg in the ASP can lead to a multi-tipped phenotype, indicating it plays an 
important role in determining tip cell fate (Wang et al., 2010). Interestingly, we 
occasionally witnessed a multi-tipped ASP phenotype when SERCA was inhibited 
with RNAi.  
To test what effect SERCA inhibition has on esg expression, the esg-lacZ 
enhancer trap was utilised in SERCA deficient (btl>RNAi) and control ASPs. Flies 
of genotype btl-GAL4, UAS-act.GFP, esg-LacZ were crossed to RNAi 4474 or w1118 
(controls). To determine the esg expression pattern, late third instar wing discs 
were stained with an anti-β-galactosidase antibody and imaged by confocal 
microscopy. In the SERCA RNAi group, esg expression was considerably expanded 
relative to that in controls, being evident throughout the dysmorphic ASP, 
including in most proximal locations, adjacent to the trachea (Figure 7.16). 
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Controls were seen to express esg only in the distal half/one third of the ASP, as 
previously reported (Sato & Kornberg, 2002; Wang et al., 2010). SERCA deficient 
ASP tracheoblasts therefore display markedly different esg expression. This 
ectopic expression pattern likely indicates a failure to repress esg, and therefore 
also a failure to repress tip cell identity, in more proximal cells. Previous reports 
have proposed that tip cells expressing esg, restrict the fate of more proximal 
stalk cells, preventing them from becoming tip cells; given esg regulates cell 
adhesion and motility, these findings may also go some way to explaining 
differences in the distribution of SERCA deficient cells compared to controls 
(Figure 7.14) (Tanaka-Matakatsu et al., 1996; Wang et al., 2010). Failure of 
SERCA deficient ASP tracheoblasts to restrict the fate of their more proximal 
neighbours may also explain witnessed defects in ASP shape: an abundance of 
‘tip’ cells and lack of ‘stalk’ cells would conceivably result in a wide-based 
structure, with all cells sending out btl expressing cytonemes towards foci of bnl 
expression; a situation not dissimilar to that in the displayed phenotype (Figure 
7.3). 
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Figure 7.16 Targeted SERCA inhibition expands the escargot expressing ASP tip domain. 
Confocal micrographs of third instar larval imaginal wing discs (representative slices). The tracheal 
system is demonstrated using btl-GAL4 driven UAS-actin.GFP. Targeted SERCA inhibition is 
achieved using the btl-Gal4 driven SERCA RNAi 4474 construct. Escargot expression is 
demonstrated using esg-lacZ and anti β-galactosidase immuno-histo-chemistry. Top panels: 
control (w1118). Lower panels: blt> RNAi. Scale bar indicates 20 µm. 
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7.7.2 Targeted SERCA inhibition reduces Cut expressing ‘stalk’ 
cells in the ASP 
Cut proteins are a highly conserved group of homeodomain proteins containing 
one or more DNA binding domains; in Drosophila, cut functions to specify cell 
fate (Nepveu, 2001). Cut proteins play important roles during Drosophila 
respiratory organogenesis: (i) in the embryonic trachea, cut mutants fail to 
undergo normal gas filling and have defective spiracles; (ii) during 
metamorphosis, cut appears to determine cell fate in tracheal remodelling: 
graded Cut expression in the spiracular tracheal branch correlates with 
differential growth activity and differentiation (Blochlinger, Bodmer, Jan, & Jan, 
1990; Pitsouli & Perrimon, 2010; Wieschaus, Nüsslein-Volhard, & Jürgens, 1984). 
Given these roles, it was hypothesised that SERCA inhibition induced changes in 
ASP cell fate, demonstrated by an expanded esg expressing tip domain, may be 
accompanied by changes in Cut expression. To test what effect SERCA inhibition 
has on Cut levels and distribution, SERCA deficient (btl>RNAi) and control ASPs 
were stained with the monoclonal antibody, 2B10 Anti-cut protein (DSHB). 
In both groups (RNAi and control), the majority of ASP tracheoblasts did not 
stain with Cut antibody, contrasting with surrounding cells of the wing disc that 
were strongly positive (Figure 7.17). Cut expression was weak and limited to 
more proximal, ‘stalk’ cells of the wild-type ASP, whereas no real expression 
was seen in any part of SERCA deficient (RNAi 4474) ASPs that displayed 
significantly abnormal morphology. Although relatively weak, patterns of Cut 
positivity appear approximately reciprocal to that of esg (Figure 7.16), indicating 
that Cut may be a marker of ‘stalk’ cell identity in the ASP. In the spiracular 
tracheal branch of larvae undergoing metamorphic remodelling, distinct groups 
of cells, displaying distinct behaviours are characterised by differential esg and 
cut expression (Pitsouli & Perrimon, 2010). Based on data presented here, this 
may also be the case in the ASP. Collectively, findings of expanded esg positivity 
and absence of proximal Cut protein expression in SERCA deficient ASPs, support 
the hypothesis that SERCA function is required for ASP ‘tip’ and ‘stalk’ cell 
determination. Given esg positive tip cells have distinct functions during ASP 
morphogenesis, through cytoneme dependent signalling, alterations in tip/stalk 
cell fate may be responsible for ASP dysmorphogenesis seen in SERCA loss of 
function environments. 
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Figure 7.17 Targeted SERCA inhibition reduce Cut expressing ‘stalk’ cells in the ASP 
Confocal micrographs of third instar larval imaginal wing discs (representative slices). The tracheal 
system is demonstrated using btl-GAL4 driven UAS-actin.GFP. Targeted SERCA inhibition is 
achieved using the btl-Gal4 driven SERCA RNAi 4474 construct. Cut protein is labelled with the 
2B10 Anti-cut protein antibody in red (DSHB, Iowa). Top panels: control (w1118). Lower panels: blt> 
RNAi. Scale bar indicates 20 µm. 
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7.7.3 SERCA’s effects on ASP morphogenesis appear 
independent of MAP kinase signalling 
Two key aspects of ASP morphogenesis, cell proliferation and migration, are 
driven by FGF and EGFR growth factors that both rely on the MAP kinase 
signalling cascade (Cabernard & Affolter, 2005). Given profound effects of SERCA 
inhibition on ASP morphogenesis, cell migration and proliferation, it was 
hypothesised that these effects were mediated via changes in MAP kinase 
signalling. To test what effect SERCA deficiency had on this pathway, SERCA 
RNAi ‘flip-out’ and mutant mitotic clones were produced and cells stained for an 
active, dually-phosphorylated form of MAP kinase (dpERK), using a monoclonal 
Anti-MAP Kinase, Activated (Diphosphorylated ERK-1&2) antibody (Sigma) (Yung 
et al., 1997). dpERK staining has been shown to provide a reliable, 
spatiotemporal readout of receptor tyrosine kinase signalling activity in 
Drosophila, including FGF and EGFR pathways (Gabay, Seger, & Shilo, 1997; 
Vincent, Wilson, Coelho, Affolter, & Leptin, 1998). 
SERCA deficient cells (RNAi or mutant) did not display significantly different 
dpERK staining to their wild-type neighbours (Figure 7.18). The distribution of 
staining appeared normal, being largely cytoplasmic; levels of activated MAP 
kinase also appeared relatively constant between SERCA deficient and wild-type 
cells. To confirm that antibody staining was efficiently and specifically detecting 
altered levels of MAP kinase, a positive control was analysed whereby ‘flip-out’ 
clones expressing oncogenic Ras (RasV12) were produced in the wing disc (Karim 
& Rubin, 1998). In these cells, levels of activated MAP kinase staining were 
increased compared to wild-type neighbours, consistent with previous reports 
and thus confirming efficacy of the staining protocol (Figure 7.18) (Prober & 
Edgar, 2002). Collectively these data indicate that SERCA inhibition-induced ASP 
dysmorphogenesis is unlikely to be mediated through changes in MAP kinase 
signalling. The key ASP regulators, EGFR and FGF are principally mediated 
downstream through the MAP kinase cascade; it therefore appears that SERCA’s 
role in ASP morphogenesis is independent of these pathways. Clearly this 
assumption relies on adequate sensitivity of the MAP kinase assay: SERCA 
inhibition could theoretically induce small changes in MAP kinase activity 
sufficient for dysmorphogenesis, but not detectable by dpERK staining.  
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Figure 7.18 SERCA’s effects on ASP morphogenesis appear independent of MAP kinase 
signalling 
Upper two rows: confocal micrographs of third instar larval imaginal wing discs (representative 
slices). The tracheal system is demonstrated using btl>RFP. Random SERCA RNAi ‘flip-out’ 
clones and SERCAk08308ab mutant mitotic clones are positively labelled with GFP as previously 
indicated. The active, dually-phosphorylated form of MAP kinase (dpERK) is labelled using a 
monoclonal Anti-MAP Kinase, Activated (Diphosphorylated ERK-1&2) antibody (Sigma) in 
magenta. Lower row: positive control demonstrating increased dpERK staining in oncogenic Ras 
(RasV12), positively marked (GFP) ‘flip-out’ clones. Scale bars in each row indicate 20 µm. 
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7.7.4 SERCA’s effects on ASP morphogenesis appear 
independent of Notch signalling 
The Notch receptor is part of a highly conserved signalling pathway, playing 
fundamental roles in determination of developmental cell fate (Artavanis-
Tsakonas, Rand, & Lake, 1999). A classical example of Notch-dependent 
development is lateral inhibition, the process whereby a single cell is chosen to 
adopt a distinct fate from within a cluster of similar cells, the other cells of 
which adopt different fates: local Notch signalling between neighbouring cells 
underpins lateral inhibition (Heitzler & Simpson, 1991). A number of pieces of 
evidence implicated Notch signalling as a candidate in SERCA dependent ASP 
morphogenesis: (i) the morphology of SERCA deficient ASPs, comprising a wide 
base and abundance of tip cells, implied a failure of lateral inhibition signalling 
between tip cells and neighbouring stalk precursors; (ii) Notch signalling 
spatially restricts esg expression, therefore disruptions in Notch could 
conceivably explain the demonstrated expansion in ASP esg expression; and (iii) 
SERCA function is essential for intracellular trafficking of the Notch receptor 
(Ikeya & Hayashi, 1999; Periz & Fortini, 1999). Given this seemingly strong 
association of SERCA and Notch, it was hypothesised that witnessed ASP 
dysmorphogenesis may be due to a loss of SERCA-dependent, Notch-signalled 
lateral inhibition between tip and stalk cells.  
To test what effect SERCA deficiency had on Notch signalling in the ASP, SERCA 
RNAi ‘flip-out’ and mutant mitotic clones were produced and cells stained for 
the intra-cellular domain (ICD) of the Notch receptor using a monoclonal 
antibody (C17.9C6, DSHB). SERCA deficient cells (RNAi or mutant) labelled with 
GFP, did not display significant differences in Notch ICD staining, compared to 
their wild-type (GFP negative) neighbours (Figure 7.19). Not only were levels of 
Notch ICD approximately equivalent between cells, but importantly, the 
distribution of Notch also appeared unaffected by SERCA loss of function. These 
data infer that Notch signalling was unchanged between SERCA deficient and 
control cells. To confirm antibody staining was efficiently and specifically 
detecting altered levels of Notch ICD, a positive control was analysed whereby 
deltex was over-expressed along the antero-posterior boundary of the wing disc 
(Ptc-GAL4, UAS-deltex). deltex is an X-linked gene, coding for a cytoplasmic 
protein Deltex, which is known to be a positive regulator of Notch (K. Matsuno, 
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Diederich, Go, Blaumueller, & Artavanis-Tsakonas, 1995; Xu & Artavanis-
Tsakonas, 1990). Cells over-expressing deltex, also labelled with GFP (UAS-GFP), 
displayed increased levels of Notch staining that appeared abnormally 
distributed (Figure 7.19), consistent with previous reports, where deltex over-
expression resulted in Notch ICD accumulation in endosomes (Hori et al., 2004). 
This confirms efficacy of the assay at detecting changes in Notch ICD distribution 
and abundance, and strongly suggests that findings of apparently unchanged 
Notch ICD in SERCA deficient cells are a ‘true negative’ finding.  
These results contrast with those of Periz and Fortini, where SERCA mutant 
clones in the eye disc induced gross changes in Notch localisation; grossly 
abnormal intracellular accumulation of Notch ICD was demonstrated in these 
clones using similar staining protocols to those adopted here (Periz & Fortini, 
1999). The most likely explanation for this discrepancy is the relative potency of 
SERCA inhibition between studies: Periz and Fortini used a strong SERCA mutant 
allele (Ca-P60AS5) to generate such effect, demonstrated by cells homozygous for 
this allele failing to survive in the adult retina; conversely, mutant and RNAi 
clones used in this investigation result in less severe SERCA knockdown, as 
confirmed by their continued viability. Importantly however, ASP 
dysmorphogenesis demonstrated here, was induced with these less severe SERCA 
knockdown methods (Figures 7.3, 7.7 and 7.10) and therefore appears 
independent of significant changes in Notch signalling. 
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Figure 7.19 SERCA’s effects on ASP morphogenesis appear independent of Notch 
signalling 
Upper two rows: confocal micrographs of third instar larval imaginal wing discs (representative 
slices). The tracheal system is demonstrated using btl>RFP. Random SERCA RNAi ‘flip-out’ 
clones and SERCAk08308ab mutant mitotic clones are positively labelled with GFP as previously 
indicated. The intracellular domain (ICD) of the Notch receptor is labelled using a monoclonal anti-
notch antibody (C17.9C6, DSHB) in magenta. Lower row: positive control demonstrating an 
accumulation of Notch ICD staining in cells over-expressing deltex under control of the Ptc-GAL4 
driver. UAS-GFP is also driven by Ptc-GAL4 to illustrate the distribution of these cells in the wing 
disc. Scale bars in each row indicate 20 µm. 
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7.8 Conclusions 
Data presented here allow a number of conclusions to be drawn regarding 
SERCA’s role in ASP morphogenesis; given SERCA’s role in murine lung 
development, some of these points may also be more generally applicable to 
epithelial tubulogenesis in other organs and in other species. 
7.8.1 ASP morphogenesis requires SERCA function for cell 
proliferation and migration events 
RNAi and mutant loss of function data presented here demonstrate that normal 
ASP morphogenesis depends on adequate SERCA function in tracheoblasts cells 
(Figures 7.3, 7.7 and 7.10). This requirement is for two distinct processes known 
to be essential for ASP development: (i) cell proliferation: SERCA deficient ASPs 
display reduced numbers of proliferating cells and SERCA loss of function clones 
are reduced in size compared to wild type controls (Figures 7.12 and 7.15); and 
(ii) cell migration: SERCA deficient clones are unable to populate the tip domain 
of the ASP at an expected frequency; this inability to reach the tip has been 
characterised by others to represent a change in cell migration (Figure 7.14) 
(Cabernard & Affolter, 2005; Chanut-Delalande et al., 2007). Interestingly, 
SERCA’s role in these two processes appears to be independent of Notch and 
MAP kinase signalling (Figures 7.18 and 7.19). 
Control of cell proliferation is known to depend on intracellular Ca2+ levels: 
extracellular signals that induce mitosis (mitogens, e.g. growth factors, 
hormones and signalling molecules) depend on Ca2+ influx via plasma membrane 
channels to mediate their action (Barbiero et al., 1995; Husain et al., 1997; 
Kotturi, Carlow, Lee, Ziltener, & Jefferies, 2003). There is increasing evidence 
that Ca2+ influx necessary for cell proliferation is store operated, dependent on 
channels such as TRPC and Orai, known to be activated upon endoplasmic 
reticulum (ER) Ca2+ depletion; it is through this mechanism that SERCA is likely 
to regulate mitosis [reviewed in (Lipskaia & Lompr√©, 2004)]. In addition to the 
essential role of inositol-1,4,5-triphosphate (IP3R) in activating store operated 
rises in cytosolic Ca2+, SERCA, through its control of store refilling, probably 
‘fine-tunes’ these Ca2+ transients (Camacho & Lechleiter, 1993; Moccia et al., 
2003). Whether SERCA function, necessary for replenishing ER Ca2+ stores, 
promotes or inhibits cell proliferation is variably reported and may depend on 
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factors such as cell type, SERCA isoform and degree of Ca2+ store depletion 
[reviewed in (Lipskaia, Hulot, & Lompr√©, 2009)].  A number of studies suggest 
that ER Ca2+ store depletion from SERCA inhibition, leads to calcium influx and 
promotes cell proliferation; others report opposite findings, consistent with data 
presented here. In prostate cancer cell lines, SERCA inhibition with RNAi or 
thapsigargin inhibits growth and prevents growth factor stimulation of cell 
proliferation; furthermore, SERCA is upregulated during stimulated cell 
proliferation and reciprocally downregulated when proliferation is reduced 
(Crepin et al., 2007; Humez et al., 2004; Legrand et al., 2001). Similar findings 
have also been reported in smooth muscle cells (Magnier et al., 1992; Waldron et 
al., 1994). Given these in vitro reports, as well as findings in CPA treated murine 
lung explants (Chapter 3), novel in vivo data here strongly indicate a conserved 
requirement for SERCA function in the mitotic cycle. Whether this requirement 
is specifically for SERCA per se, rather than one simply for adequate intracellular 
Ca2+ stores, is not entirely clear and is difficult to conclusively establish. 
However, specific SERCA requirements for cell cycle progression are indicated by 
an inability to recreate SERCA inhibition induced cell cycle effects, through 
alterations of cytosolic Ca2+ alone (Simon & Moran, 2001).  
Effects of SERCA inhibition on cell migration are less well documented, but given 
the ubiquity of calcium’s role in biology and the requirement for SERCA in its 
regulation, data presented here demonstrating reduced migration seem plausible 
(Berridge et al., 2000). Support is leant from reports of calcium playing 
fundamental roles in cell migration: (i) eosinophils migrating toward 
chemotactic stimuli display an intracellular Ca2+ gradient, with levels being low 
at the leading edge and high at the trailing edge, this polarisation being required 
for migratory cytoskeletal changes; (ii) integrins, key effectors of cell adhesion 
and migration, are known to be highly sensitive to changes in Ca2+ e.g. through 
actions of their Ca2+ dependent inhibitor, calpain; and (iii) when intracellular 
Ca2+ transients are blocked in migrating neutrophils, they become stuck to 
extracellular matrix proteins (Brundage, Fogarty, Tuft, & Fay, 1991; 
Huttenlocher et al., 1997; Lawson & Maxfield, 1995; Marks, Hendey, & Maxfield, 
1991).  
Looking specifically at tubular organogenesis, calcium transients are required for 
angiogenesis and SERCA appears to have a specific role here; blockage with 
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thapsigargin or CPA results in defects in endothelial cell migration (Kimura, 
Oike, Koyama, & Ito, 2001; Kohn, Alessandro, Spoonster, Wersto, & Liotta, 
1995). These in vitro findings, support novel in vivo data here and suggest an 
essential role for SERCA in tubular epithelial cell migration. A putative 
mechanism for this role involves a requirement for SERCA dependent ER Ca2+ 
stores to maintain intracellular Ca2+ gradients necessary for the continual 
replenishment of cell adhesion receptors e.g. integrins, at the leading edge of 
the migrating cell (Kimura et al., 2001; Lawson & Maxfield, 1995).  
7.8.2 SERCA function is required for determination of ASP cell 
fate  
SERCA inhibition resulted in an expansion of the escargot labelled ‘tip’ domain 
and absence of Cut protein labelled ‘stalk’ cells in the developing ASP. Given 
reported roles of ‘tip’ cells in morphogenic signalling, this tip/stalk cell fate 
imbalance is likely, in part, to explain structural changes in the ASP: a wide-
based ASP morphology, such as that witnessed during SERCA inhibition, removes 
the normal restraint on number of tracheoblasts able to stem cytoneme 
processes towards surrounding foci of bnl expression. Tip/stalk cell fate 
determination and ASP morphogenesis therefore appears tightly coupled, as 
supported by reports of ectopic esg expression induced manipulation of cell fate, 
resulting in changes to ASP morphology (Wang et al., 2010). One explanation for 
an apparent abundance of tip cells in SERCA deficient ASPs, is a failure of ‘tip’ 
cells to restrict the fate of their more proximal neighbours, a mechanism 
proposed to be dependent on a competitive lateral inhibition mechanism (Q. 
Wang et al., 2010). If this restrictive feedback mechanism is dependent on 
SERCA function, SERCA deficiency would result in a lack of feedback and hence 
cells not adopting a stalk fate. Given Notch is a key mediator of lateral 
inhibition, spatially restricts esg expression and has a strong association with 
SERCA, it was speculated that its dysregulation upon SERCA inhibition was 
responsible for a lack of tip cell lateral inhibition: RNAi and mutant clone data 
here do not support this potential mechanism (Figure 7.19).  
A further putative mechanism behind SERCA inhibition induced aberrations in 
ASP cell fate, may depend on differential activation of transcription factors, as 
suggested by altered esg and Cut protein expression (Figure 7.16 and 7.17). 
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Activation of transcription factors is known to depend on increases in 
intracellular Ca2+ concentration; furthermore, specificity of individual 
transcription factor activation depends on characteristics of Ca2+ transients, such 
as amplitude and duration (Dolmetsch, Lewis, Goodnow, & Healy, 1997). SERCA 
therefore appears to regulate Ca2+-dependent transcription pathways, through 
control of Ca2+ wave amplitude and kinetics (Camacho & Lechleiter, 1993; 
Lipskaia et al., 2009; Lipskaia & Lompr√©, 2004; Moccia et al., 2003). A well-
characterised example of this mechanism is the activation of the transcription 
factor NFAT (nuclear factor of activated T-lymphocytes): SERCA function inhibits 
store operated Ca2+ entry and downstream calcineurin/NFAT activity by 
modifying agonist-induced intracellular Ca2+ transients from a steady-state to an 
oscillatory mode (Bobe et al., 2011). SERCA is therefore able to finely tune gene 
transcription through spatial and temporal alterations in Ca2+. Similar 
mechanisms might regulate escargot and cut transcription factors in the ASP 
epithelium. 
7.8.3 SERCA function has a conserved role in airway 
morphogenesis 
This thesis has demonstrated SERCA function is essential for Drosophila ASP 
morphogenesis in vivo and murine embryonic lung development in vitro, 
confirming a conserved role for SERCA in respiratory organogenesis. The key 
similarity in airway development between these two evolutionarily disparate 
organisms is a dependence on FGF signalling to induce fundamental morphogenic 
events. Given that FGF signalling underpins development of a number of 
branched tubular organs in vertebrates, including the kidney, endocrine and 
exocrine glands, and blood vessels, it seems possible that demonstrated 
requirements for SERCA in airway development might also apply to epithelial 
tubulogenesis more widely (Alarid et al., 1994; Celli, LaRochelle, Mackem, 
Sharp, & Merlino, 1998; Folkman & Klagsbrun, 1987; D. Jackson et al., 1997).  
Another similarity between species is the reduction in cell proliferation seen 
when SERCA is inhibited in the airway (Chapter 3; Figures 7.12 and 7.15). 
Interestingly, Drosophila embryonic branching morphogenesis, a process 
independent of cell proliferation, did not appear to have a requirement for 
significant SERCA function. This conserved SERCA requirement for airway 
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development processes that are dependent on cell proliferation is particularly 
significant, given the opposite effect of SERCA inhibition in other systems (e.g. 
SERCA mutations in humans and mice resulting in increased rates of malignancy 
(Korosec, Glavaç, Rott, & Ravnik-Glavaç, 2006; L. H. Liu et al., 2001)). Although 
supported by findings in prostate cancer and smooth muscle cell lines (discussed 
above), the reason for this dependence is unclear. When SERCA inhibition has 
been shown to have the opposite effect and stimulate cell proliferation, this 
consequence has been mediated through the calcineurin/NFAT pathway. One 
explanation for the conserved, seemingly reverse effect in respiratory 
organogenesis is that this pathway does not operate similarly in this context: 
further investigation is needed to test this (Bobe et al., 2011). 
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Chapter 8  
 
SUMMARY AND CONCLUDING REMARKS 
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8.1 Disorders of lung development are a global health 
problem 
Defects in lung organogenesis result in a spectrum of disease that presents as 
structural lung anomalies and/or inadequate respiratory function. A number of 
comparatively common problems that manifest in the infant, e.g. respiratory 
distress syndrome (1:100 births) or pulmonary hypoplasia associated with 
congenital diaphragmatic hernia (1:2500 births), feature inadequate or 
disordered pulmonary development: the short and long-term outcomes of such 
are frequently poor (e.g. high mortality, impaired respiratory function and 
persistent oxygen dependency) (Baraldi & Filippone, 2007; J. Colvin et al., 2005; 
Muratore et al., 2001; Rodriguez et al., 2002). Development of new treatments 
for these conditions e.g. surfactant replacement or fetal endoscopic tracheal 
occlusion (FETO), relied upon novel insights into biochemical and biomechanical 
regulators of lung development (Avery & Mead, 1959; Wilson et al., 1993). There 
is now increasing evidence to suggest a number of ‘adult’ diseases also have 
their origins in fetal life. Asthma and COPD, both characterised as global 
epidemics, result in a considerable burden of acute mortality and long-term 
morbidity, as well as high levels of healthcare expenditure (Masoli et al., 2004; 
World Health Organization, 2008). Factors responsible for early lung 
development have been implicated in the pathogenesis of asthma and COPD; it is 
recognised that these may present future treatment targets (Bousquet et al., 
2000; H. Chen et al., 2005). Understanding normal pulmonary development is 
therefore paramount to discovery of novel therapeutics for a range of pulmonary 
diseases that commonly afflict the young and old. 
8.2 SERCA appears a promising novel target 
SERCA, a P-type ATPase, pumps Ca2+ ions from the cytoplasm to the lumen of the 
ER and other specialised compartments (e.g. SR and Golgi): SERCA is therefore 
responsible for both returning cytosolic free Ca2+ concentration back to its 
resting level following cell activation, and also maintaining high concentrations 
of Ca2+ in organellar lumens (creating important Ca2+ gradients across the cell) 
(Skou, 1957; Wuytack et al., 2002). 
A number of pieces of evidence link SERCA to lung function. Firstly, SERCA 
appears to have an important role in pulmonary development: SERCA blockade, 
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with the specific inhibitor cyclopiazonic acid (CPA), reduces both airway 
branching and peristalsis reversibly and dose dependently, whilst also reversibly 
halting pulmonary myogenesis in vitro (N. Featherstone et al., 2006; N. 
Featherstone et al., 2005; N. C. Featherstone et al., 2005; Lansdale, Connell et 
al., 2010; Seidler et al., 1989). Secondly, SERCA has been implicated in the 
pathogenesis of asthma and explored as a potential treatment target: SERCA2 
mRNA and protein expression is reduced in airway smooth muscle (ASM) of 
patients with asthma; this reduction correlates with disease severity and is 
associated with corresponding changes in Ca2+ homeostasis (Mahn et al., 2009). 
Interestingly, ASM taken from asthmatics, or healthy subjects then subjected to 
siRNA mediated SERCA knockdown, displays a similar asthmatic-like phenotype 
(increased cell proliferation, cell-spreading and cytokine secretion). Finally, 
SERCA pump inhibitors (thapsigargin, curcumin and cyclopiazonic acid) have 
been explored for use clinically, with the aim of correcting the cystic fibrosis 
phenotype, by depleting ER Ca2+ stores, inhibiting chaperone proteins retaining 
the CFTR and hence allowing it to function as a Cl- ion channel at the cell 
surface (Dalemans et al., 1991; Egan et al., 2002; Rubenstein et al., 1997).  
There is therefore evidence for SERCA playing diverse roles in the lung in health 
and disease: this thesis further explored its role in airway development by 
exploiting an established murine culture model and developing a range of tools 
in Drosophila embryos and larvae. Drosophila provided a genetically tractable 
model of airway development, where existing genetic tools (including RNAi, 
conditional mutants; ‘flip-out’ and MARCM clonal analysis) allowed the elegant 
spatial and temporal manipulation of SERCA function. The in vivo study of airway 
morphogenesis and quantification of SERCA function was achieved using fixed 
and live confocal imaging techniques, immunostaining, single and dual-labelled 
fluorescent proteins and dynamic calcium imaging (Chapters 4-7).  
8.3  SERCA has an essential, conserved role in airway 
development across species 
Data presented here and from others, show that SERCA function is essential for 
Drosophila air sac progenitor (ASP) morphogenesis and murine embryonic lung 
development, confirming a conserved role for SERCA in respiratory 
organogenesis. The abrogation of larval air sac budding, seen upon targeted 
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SERCA inhibition with RNAi (Chapter 7), provides in vivo support for those in 
vitro findings already described (N. Featherstone et al., 2006; N. Featherstone 
et al., 2005; N. C. Featherstone et al., 2005; Lansdale, Connell et al., 2010). 
Importantly, these data also negate the possibility that previous findings were 
due to off-target effects of the SERCA inhibitor CPA, given they result from 
genetic SERCA ‘knock-down.’ 
Further conservation of SERCA’s role in airway development is seen when cell 
proliferation is considered: SERCA function regulates the number of mitotic cells 
in the murine lung epithelium and mesenchyme in vitro (Chapter 3), whilst in 
the Drosophila air sac, a similar pattern is seen in vivo (Chapter 7). This 
relationship is maintained when studies of random ‘flip-out’ clones are reviewed 
(Chapter 7): SERCA-deficient cells have a cell autonomous proliferation defect, 
since ‘clumps’ of SERCA RNAi cells comprised fewer cells than control clones 
(rates of apoptosis were negligible in each). Given similar reports in smooth 
muscle and cancer cell lines, as well as an inability to recreate SERCA inhibitor 
induced cell-cycle arrest through alterations of Ca2+ alone, it appears SERCA has 
a specific role in regulating aspects of the cell cycle (Legrand et al., 2001; Simon 
& Moran, 2001; Waldron et al., 1994).  
SERCA-dependent cell proliferation could explain the stark difference between 
embryonic and larval phenotypes in the fly airway: mutant and RNAi induced 
SERCA knockdown in the embryo failed to disrupt tracheal branching 
morphogenesis (known to proceed without cell proliferation) (Chapters 5 & 6), 
whereas cell proliferation-dependent ASP development was severely disrupted 
upon targeted SERCA inhibition (Chapter 7). However, this difference more likely 
reflects demonstrated residual SERCA function during embryogenesis upon 
knockdown (Chapters 5 & 6), particularly given preliminary findings of CPA 
induced tracheal branching defects in the embryo (courtesy of EC Jesudason, 
unpublished work). If SERCA is required for airway morphogenesis in a cell 
proliferation free system such as the embryo, demonstrated changes in cell 
proliferation alone seem unlikely to explain the complex, conserved phenotypes 
associated with SERCA loss-of-function in mouse and fly air sac: other changes in 
fundamental cell processes are therefore likely e.g. cell migration.  
   
 239 
Data presented here demonstrate that cell migration appears to be regulated by 
SERCA in the Drosophila airway: SERCA RNAi cells have a cell autonomous 
migration defect, with proportionately fewer reaching the air sac tip and 
commensurately more remaining in the maldeveloped stalk, compared to control 
clones (Chapter 7). These findings are supported by those of others, both in a 
monolayer wound closure model where CPA reduces basal and EGF-stimulated 
migration in a dose-related manner and in zebrafish vasculature where CPA also 
reduces cell migration (courtesy of EC Jesudason, unpublished work). A 
plausible, but as of yet untested explanation for these findings, is requirement 
for SERCA dependent Ca2+ stores to maintain intracellular Ca2+ gradients required 
for the continual replenishment of cell adhesion receptors e.g. integrins, critical 
for cell migration (Kimura et al., 2001; Lawson & Maxfield, 1995).  
Witnessed expansion in the expression of the ASP tip cell marker escargot, could 
indicate that SERCA deficient cells preferentially adopt a ‘tip’ cell type fate, 
rather than the usual balance of ‘tip’ and ‘stalk’ fates seen in control ASPs 
(Chapter 7). This difference in escargot expression is supported by a paradoxical 
reduction in cut expression (a ‘stalk’ cell marker). Alterations in tip/stalk cell 
balance such as this could explain changes in ASP morphogenesis seen upon 
SERCA inhibition, owing to the purported roles that tip cells play in morphogenic 
signalling (Roy et al., 2011; Sato & Kornberg, 2002). This hypothesis is further 
supported by findings of ectopic escargot expression-induced manipulation of 
cell fate, resulting in changes to ASP morphology (Wang et al., 2010).  
SERCA knockdown in the larval ASP was associated with abnormal expression of 
escargot in some cells of the proximal air sac, but maintenance of typical 
expression distally (Chapter 7): normal SERCA function therefore does not 
appear necessary for distal escargot expression and escargot expression in the 
proximal region is not a necessary outcome of SERCA knockdown. An alternative 
interpretation of changes in the spatial expression pattern may therefore be that 
SERCA inhibition does not dysregulate escargot expression so much as the 
migration of cells that happen to be expressing it, thus lending further support 
to the above findings of SERCA as a key regulator of airway epithelial cell 
migration (rather than a determinant of cell fate per se). 
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8.4 SERCA’s role in airway branching morphogenesis 
may have wider significance 
A key similarity between airway development in the mouse and fly is a reliance 
on FGF signalling to induce fundamental morphogenic events. Given that FGF 
signalling underpins development of a number of other branched tubular organs 
(e.g. kidney, endocrine and exocrine glands and blood vessels), it seems 
plausible that demonstrable requirements for SERCA in airway development 
might also apply to epithelial tubulogenesis in other organs, with obvious 
implications for wider research.  
Ca2+ cycling has been indicated as a regulator of budding in fungi and plants 
(Torralba & Heath, 2001; Trewavas & Knight, 1994): could this system also apply 
to animal species and provide a generic mechanism to explain the control of 
iterative biological branching in diverse tissue types with differing growth 
factors? This type of mechanism could shed light onto previously unexplained 
propagating Ca2+ waves that are present in Drosophila trachea (courtesy of C 
Samakovlis, unpublished data) and mammalian lung (known to be SERCA 
dependent) (N. C. Featherstone et al., 2005). Furthermore, the generic 
regulation of branching via SERCA dependent Ca2+ cycling/gradients would 
explain SERCA’s conserved role in the fly and mouse airway (Chapters 3 & 7) and 
imply SERCA’s role is independent of specific morphogens. Indeed, data here 
indicate that the effect of SERCA inhibition on branching morphogenesis may be 
independent of FGF. When random SERCA loss of function clones were produced, 
defects in ASP morphology were observed and cell autonomous changes in 
proliferation and migration were present (Chapter 7), despite surrounding 
tissues being ‘wild-type’ and hence presumably having normal levels of FGF 
(implying compensation from surrounding cells did not occur). Findings here of 
SERCA as a regulator of branching, may therefore have wider relevance across 
biology, whenever iterative epithelial bud formation occurs.  
Finally, demonstrated SERCA regulation of cell proliferation and cell migration 
also has implications for research into proliferative disease, metastasis and 
tissue regeneration. 
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Appendix 1 
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SERCA Phylogeny 
Drosophila melanogaster SERCA isoforms 
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Alignment of predicted protein sequences for Drosophila melanogaster’s reported eight Ca-
P60A mRNAs 
FlyBase (available at http://flybase.org) reports the Drosophila SERCA gene, Ca-P60A to have 
eight different mRNAs (A-H). When the predicted translations are aligned using ClustalW2 at the 
European Bioinformatics Institute (available at http://www.ebi.ac.uk/Tools/msa/clustalw2/), isoforms 
B–H have identical protein sequences: Drosophila therefore has two protein isoforms (A with 1002 
residues and B with 1020), differing only at the final 27 residues (9 of the short isoform) at the C 
terminus. 
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Drosophila melanogaster protein sequences in principal model 
organisms and humans  
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Alignment of predicted protein sequences for SERCA in a number of model organisms and 
humans 
Multiple protein sequence alignments were undertaken between various paralogues and splice 
variants of SERCA, using ClustalW2 at the European Bioinformatics Institute (available at 
http://www.ebi.ac.uk/Tools/msa/clustalw2/), after retrieving predicted protein sequences from the 
National Center for Biotechnology (NCBI, available at http://www.ncbi.nlm.nih.gov) and Flybase 
(available at http://flybase.org/) databases. Key: Homo.s = Homo sapiens (Human); Mus.m = Mus 
musculus (Mouse); Xeno_t = Xenopus tropicalis (Western claw frog); Dros.m = Drosophila 
melanogaster (Fruitfly) Danio.r = Danio rerio (Zebrafish); Caen.e = Caenorhabditis elegans 
(Roundworm). 
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Appendix 2 
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Assessment of potential off-target effects of 
SERCA RNAi 
 
RNAi 4474 (VDRC Transformant ID 4474; Construct ID GD436) 
 
 
RNAi 107446 (VDRC Transformant ID 107446; Construct ID KK107371) 
 
RNAi constructs used were checked for predicted off-target effects by inputting their DNA 
sequence into dsCheck (available at http://dscheck.rnai.jp/). This software predicts genes that the 
RNAi could potentially interfere with, other than the gene intended for knockdown. It 'dices' the 
input sequence into 19 nucleotide lengths of small interfering RNA (siRNA) and performs 
exhaustive scans for each 'diced siRNA' to find off-target gene candidates, simulating the 
biochemical process of dsRNA-mediated RNAi in vivo. The software then provides the number of 
hits with a complete match (mis=0 column), one mismatch (mis=1) and two mismatches (mis=2) for 
every off-target gene candidate individually. 
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